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Friday morning, 09:30. The telephone of the paediatric resident rings. One of the 
obstetricians is calling to inform that an ambulance will arrive any minute, presenting 
a woman who has been pregnant for 25 weeks. This morning, she woke up having 
severe abdominal pain and backache, recurring every 30 minutes. To calm herself 
down she took a shower, but she noticed the pain only got worse. She contacted her 
midwife, who decided to visit her. After a physical examination, the midwife concluded 
that the pregnant woman was 8 cm diluted and the delivery was imminent. She called 
an ambulance and 15 minutes later they arrived at the obstetric ward of a hospital with 
a third-level Neonatal Intensive Care Unit (NICU). 
Directly after the call of the obstetrician, the NICU resident contacts her supervising 
neonatal consultant and together with one of the NICU nurses they rush to the obstetric 
ward to prepare a resuscitation table. The NICU nurse pours water in the humidifier, 
turns up the heater above the resuscitation table and tees up the polyethylene 
wrap. Meanwhile, the consultant arrives and together with the resident they prepare 
the T-piece resuscitator and the intubation supplies. They just finish setting up the 
respiratory function monitor, when suddenly the door opens and the obstetric nurse 
comes through, carrying a small boy, that she places on the resuscitation table.
The NICU nurse starts the Apgar timer and the recording of the respiratory function 
monitor, and closes the polyethylene wrap around the little boy to keep him warm. 
Only his right hand protrudes the wrap so the nurse can attach the pulse oximeter to 
measure the heart rate and oxygen saturation of the infant. The young man who just 
became father comes over from the delivery suite to meet his newborn son. The NICU 
nurse encourages him to touch the boy and talk to him. After the initial assessment, 
the neonatal consultant places a face mask over the nose and mouth of the little boy 
to provide him with continuous positive airway pressure to support his respiratory 
transition. During the 30-second evaluation that follows, the consultant and resident do 
not notice any raising of the chest wall implicating spontaneous breathing, upon which 
they decide to administer a sustained inflation. During a second clinical evaluation, 
still no raising of the chest wall is visible. However, the respiratory function monitor 
shows an irregular undulatory pattern of the flow curve, possibly representing minor 
spontaneous respiratory effort of the infant. As the oxygen saturation does not reach 
the predefined target range, they decide to increase the fraction of inspired oxygen and 
grant the infant some more time to enhance his respiratory effort. Meanwhile, the NICU 




of the infant increases slowly, but oxygen saturations remain below target ranges. The 
infant is then provided with positive pressure ventilation by face mask, and the fraction 
of inspired oxygen is increased up to 1.0. Every 30 seconds, the infant is clinically 
evaluated, and the fraction of inspired oxygen is adjusted according to the oxygen 
saturations. Unfortunately, the need for ventilation persists and the infant is intubated 
15 minutes after birth.
After this impressive start of this small boy’s life, the NICU nurse deliberates with her 
colleagues: “Isn’t there something else we could do to help these tiny babies breathe 




Most infants worldwide are born at term, defined as a gestation of a minimum of 37 weeks. 
Approximately 15 million infants are born prematurely every year.(1) Preterm birth is one 
of the leading causes of neonatal mortality, and premature infants are at risk of major 
morbidities, influencing both short- and long-term neurodevelopmental outcomes. The risk 
of complications is closely related to the gestational age at birth, with extreme preterm 
infants (born < 28th week of gestation) having the greatest risk.(2)
As the incidence of prematurity continues to increase, considerable effort is being made 
to reduce the risk of adverse outcomes, even in the smallest infants. At birth, the transition 
from foetus to neonate requires possibly the most substantial physiological adjustments 
that occur in human life. This transition is complicated in preterm infants due to the 
immaturity of many organ systems. Most preterm infants therefore require support during 
their transition at birth.
Respiratory transition of the term infant at birth
While the foetus is in utero, gas exchange occurs across the placenta rather than the lungs.
(3) The foetus shows breathing movements, but these are not aimed at gas exchange; 
instead, they enable small volumes of lung liquid to move in and out of the airways. The 
pattern of foetal breathing movements changes with the arousal state of the foetus. During 
the REM (rapid eye movement) sleep state, rhythmic breathing movements are shallow, 
becoming deeper in the non-REM state.(4, 5) During apnea the larynx remains closed, 
restraining the efflux of lung liquid.(5, 6) This process is necessary for lung development 
and growth.(7) 
After birth, the site of gas exchange changes to the lungs, where oxygen and carbon 
dioxide are exchanged via the alveoli to the surrounding capillaries and vice versa.(3) 
However, to enable gas exchange the lung needs to be cleared of liquid. During labour, 
uterine contractions induce a change in the posture of the foetus, leading to an increase in 
abdominal pressure and together with the increase in transpulmonary pressure this results 
in the efflux of lung liquid.(3, 8) In addition, the increase in stress hormones during labour 
stimulates the uptake of Na+ across the airway epithelium thereby changing the osmotic 
gradient, which leads to reabsorption of lung liquid.(9) Next, the remaining lung liquid 
needs to move across the distal wall of the airway. This appears during inspiration, as 
inspiratory muscles create a negative pressure by expanding the chest wall. The created 
pressure gradient between interstitial tissue and airway lumen results in the uptake of liquid 
from the airways into the interstitial tissue.(3) This movement of liquid appears to be rapid, 




A liquid-filled lung generates a resistance around 100 times higher than that of the air-
filled lung after transition.(12) The lung fills with air progressively during the first breaths 
after birth, which decreases the resistance and makes the lung more compliant.(12) 
However, the interstitial space fills with liquid, thereby increasing interstitial pressure. 
Until this liquid is cleared from the interstitial space and the pressure reduces again, 
this could lead to the re-entry of liquid into the airways.(3) In term infants, the pressure 
gradient that emerges during inspiration is much greater than the pressure gradient 
during expiration. The amount of liquid that re-enters the lung during expiration is 
therefore much smaller than the amount of liquid that is cleared during inspiration.
(13, 14) In addition, surfactant present in the alveoli leads to a decrease in surface 
tension, reducing the pressure gradient between alveoli and interstitial space. This in 
turn reduces the potential for liquid re-entry.(15, 16)
Consequences of prematurity on respiratory transition
When an infant is born preterm, there are many obstacles to this process of respiratory 
transition. Firstly, it can be impacted by the structural immaturity of the lung. While 
alveolarization begins from a gestational age of 32 weeks and upwards, the lungs 
of preterm infants born earlier in gestation will be comprised mainly of sacculi. This 
compromises the surface available for gas exchange. In addition, infants born preterm 
will suffer from surfactant deficiency as the type-II alveolar epithelial cells responsible 
for the production of surfactant develop late in gestation.(17) This might lead to the 
collapse of the small airways at end-expiration, which also decreases the surface area 
available for gas exchange and leads to an increase in the effort it takes to breathe.
The preterm lungs have difficulty clearing airway liquid, as they do not have access 
to the Na+ uptake mechanism which reverses the osmotic gradient leading to airway 
liquid reabsorption.(18) In addition, this process may be further negatively affected in 
the case of caesarean delivery, when less adrenalin is released.(19) The lower muscle 
tension of the preterm infant results in a smaller pressure gradient during inspiration. 
Lung liquid may therefore flow back into the airways from the interstitial space more 
easily than in term infants. Additionally, the ratio between the amount of liquid cleared 
during inspiration and liquid re-entering the lung during expiration appears to be smaller, 
leading to loss of functional residual capacity (FRC).(20, 21) The preterm infant tries 
to maintain FRC by increasing the airway pressure when breathing out by prolonging 
expiration time with expiratory braking maneuvers and grunting.(22)
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Supporting the preterm infant in transitioning
While most interventions aimed at respiratory support of the preterm infant are 
performed postnatally, maturation of the lung – and thus the presence and amount 
of different surfactant-proteins - can be influenced prenatally. Maternal glucocorticoid 
treatment is often combined with beta-sympathomimetic drugs to stimulate secretion 
of the major component of surfactant and decrease the secretion rate of lung fluid.(23) 
In addition, the administration of these agents leads to a reduction in the gas diffusion 
distance.(15, 24)
Nevertheless, many preterm infants need respiratory support to facilitate respiratory 
transition at birth. While the lung undergoes different phases of lung liquid clearance 
(movement of liquid from proximal to distal airways, uptake of liquid in the interstitial 
space, clearance of liquid from the interstitial space), respiratory support should be 
adapted to these different phases to prevent the lung from injury. This is extremely 
difficult to achieve.(3) High pressures or long inflation times are necessary to move 
liquid through the lung to enter the interstitial space, but as soon as the liquid is cleared 
from the interstitial space these high pressures could lead to an overexpansion of the 
lung and cause injury.(3) It is difficult, if not impossible, to determine which phase of 
lung liquid clearance the infant has reached. In addition, the rate of lung aeration may 
not be equal in the different regions of the lung, increasing the complexity of respiratory 
support.(3)
To support the infant, positive pressure can be used to facilitate the change in pressure 
gradient between the airways and the interstitial pressure, leading to an uptake of 
lung liquid and prevention of liquid flowing back into the lung.(25) In addition, positive 
pressure can prevent the compliant chest wall from recoiling. However, it has been 
shown that intubation and subsequent invasive mechanical ventilation increase the risk 
of ventilator-induced lung injury.(26) Using nasal continuous positive airway pressure 
(CPAP) as respiratory support at birth enhances the aeration of the lung and decreases 
the work of breathing.(21) This technique of respiratory support can be used to prevent 
the need for intubation and subsequent mechanical ventilation, thereby decreasing the 
risk of ventilator-induced lung injury.(26, 27) Furthermore, non-invasive positive pressure 
ventilation can be used in case of apnea or insufficient spontaneous respiratory effort. 
However, providing adequate ventilation using a face mask has been shown to 
be difficult due to mask leak or obstruction.(28, 29) While efforts have been made 
to decrease the incidence of these causes of ineffective non-invasive ventilation, 




obstruction. Active larynx adduction promotes lung development in the foetus but 
prevents air from entering the lung after birth.(7, 30) This was recently demonstrated in 
a preterm rabbit model showing that the larynx is predominantly closed at birth during 
apnea, and opens only briefly when a breath is taken.(31) Applying positive pressure 
ventilation using a face mask results in distension of the upper airway instead of 
aeration of the lung.(32) Inflations administered without spontaneous breathing lead to 
ineffective ventilation.(33) The pattern of the mainly closed larynx only opening during 
spontaneous breathing changes once a stable breathing pattern is obtained; then the 
larynx remains mainly open.(31) It therefore seems logical that stimulating spontaneous 
breathing should result in more effective respiratory support, which would lead to an 
increase in oxygenation and a smoother respiratory transition. 
Supporting the preterm infant after transition at birth
While the majority of preterm infants leave the delivery room supported by non-invasive 
ventilation, a proportion of them will suffer from severe respiratory distress syndrome 
(RDS) and administration of exogenous surfactant may be necessary. This was first 
described as beneficial in preterm infants  by Fujiwara et al.(34) in 1980. Since then, 
many studies have focused on the dosage, timing and method of administration. Recent 
trials have demonstrated the feasibility and efficacy of administration of surfactant in 
a minimal invasive way, thereby omitting intubation.(35, 36) A stable respiratory drive 
is a prerequisite for making this procedure successful and avoiding intubation and 
mechanical ventilation. While stimulation of spontaneous breathing is an important 
focus during transition at birth, after birth maintenance of spontaneous breathing is 
essential. Interventions focusing on these aspects of neonatal care for preterm infants 
may have the potential to improve outcomes for infants born at the limit of viability.
AIM AND OUTLINE OF THE THESIS
The general aim of this thesis was to evaluate the effect of interventions performed 
in the delivery room and shortly after arrival at the neonatal intensive care unit on 
the respiratory effort of preterm infants at birth. This thesis comprises experimental, 
observational and randomized clinical trials. The interventions evaluated in this thesis 
are aimed at stimulation of spontaneous breathing (part two) and maintenance of 
spontaneous breathing (part three).
Part two of this thesis focuses on interventions that can be used to stimulate 
spontaneous breathing of preterm infants directly at birth. Tactile stimulation to 
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stimulate breathing of infants at birth has been common practice from earliest living 
memory and was recommended even before the first version of the resuscitation 
guidelines was developed. Although most interventions in the delivery room have been 
evaluated thoroughly, the use of tactile stimulation and its effect on respiratory effort 
in human preterm infants have not previously been described. Chapter 1 describes 
an observational study performed at the Leiden University Medical Center (LUMC) 
evaluating the incidence, duration and timing of tactile stimulation during transition 
of preterm infants at birth, and differentiating the methods used for stimulation. While 
this study showed that stimulation could be applied either repetitively or based on 
clinical indication, we designed a randomized trial to assess the effect of these patterns 
of stimulation on the respiratory effort of preterm infants at birth. The results of this 
randomized trial conducted at the LUMC are presented in Chapter 2. 
The second intervention evaluated in this thesis is the use of oxygen during stabilization 
at birth. Previous studies have shown that hypoxia inhibits the respiratory center in 
the foetal situation, causing larynx adduction.(37) Although this effect changes in the 
first days of life, it is likely to be present during transition at birth.(38) To stimulate 
spontaneous breathing, we should therefore focus on preventing hypoxia. In 
collaboration with Professor Stuart Hooper’s research group, the effect of administering 
100% oxygen was evaluated in an experimental setting, described in Chapter 3. By 
using phase contrast X-ray imaging and a custom-built mechanical ventilator to apply 
CPAP, the breathing pattern and aeration of the lung of preterm rabbits during transition 
could be visualized. This study compared the effect of 100% oxygen with 21% oxygen. 
During the stabilization of human preterm infants at birth, however, we use an oxygen 
blender that mixes oxygen with room air in order to enable titration of the fraction of 
inspired oxygen (FiO2), after which the gas mixture is administered to the infant using a 
T-piece resuscitator. FiO2 is titrated based on the oxygen saturation (SpO2) target range 
described by Dawson et al.(39) to prevent the occurrence of prolonged hypoxia and 
hyperoxia. However, while the adjustment of FiO2 is performed with the oxygen blender, 
it is unknown how long it takes for the gas mixture with the desired oxygen concentration 
to reach the infant at the distal part of the T-piece resuscitator. Chapter 4 describes the 
evaluation of the duration between adjustment of FiO2 at the oxygen blender and the 
achievement of the desired FiO2 at the distal part of the T-piece resuscitator, which 
was assessed in a bench test and during clinical observations of the stabilization of 
preterm infants born at the LUMC. Chapter 5 describes a study protocol for a multi-
center randomized controlled trial. The aim of this trial was to compare the effect of 
initiating stabilization at birth with 100% O2 to 30% O2 on the respiratory effort of preterm 




target internationally recommended SpO2 reference ranges. The results of this trial are 
presented in Chapter 6.
The third intervention evaluated in this thesis focusing on stimulating breathing of 
preterm infants in the delivery room is the administration of caffeine. Caffeine has been 
shown to be safe and effective in the prevention of apnea of prematurity. In recent 
years, the timing of administration of caffeine has shifted from the first days to the 
first hours after birth. As caffeine antagonizes adenosine at its receptor, its use might 
be extended to administration in the delivery room to stimulate breathing directly at 
birth. The randomized controlled trial conducted at the LUMC, which is described in 
Chapter 7, evaluated the effect of administration of caffeine in the delivery room on the 
respiratory effort of preterm infants at birth. 
Part Three of this thesis then focuses on an intervention aimed at maintenance of 
spontaneous breathing after admission to the NICU. After transition has been 
successfully established and the infant is supported by CPAP, RDS can cause difficulty 
in reaching an appropriate level of oxygenation. A high oxygen requirement is one 
of the main causes of CPAP failure, which can be prevented by the application of 
exogenous surfactant while the infant remains on CPAP. Administering surfactant 
to a spontaneously breathing infant in a minimal invasive way still involves the use 
of a laryngoscope to visualize the trachea. As laryngoscopy has been shown to be 
uncomfortable, the use of propofol as premedication has been evaluated in Chapters 8 
and 9. Chapter 8 describes an observational study of comfort during minimal invasive 
surfactant therapy performed in the LUMC. Additionally, Chapter 9 evaluates this 
practice using a randomized controlled trial. 
In Part Four of this thesis, the main findings of the studies presented are discussed 
and future perspectives are considered. The thesis concludes with a summary of the 
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Tactile stimulation to stimulate spontaneous 
breathing during stabilization of preterm infants 












Tactile maneuvers to stimulate breathing in preterm infants are recommended during 
the initial assessment at birth, but it is not known how often and how this is applied. 
We evaluated the occurrence and patterns of tactile stimulation during stabilization of 
preterm infants at birth.
METHODS
Recordings of physiological parameters and videos of infants < 32 weeks gestational 
age were retrospectively analyzed. Details of tactile stimulation during the first 7 minutes 
after birth (timing, duration, type, and indication) were noted.
RESULTS
Stimulation was performed in 164/245 (67%) infants. The median (IQR) gestational age 
was 28+6 (27+2 – 30+1) weeks, birth weight 1153 (880 – 1385) grams, Apgar score at 5 
minutes was 8 (7 – 9). 140/245 (57%) infants were born after caesarean section, and 
134/245 (55%) were male. There were no significant differences between the stimulated 
and the non-stimulated infants with regard to basic characteristics. In the stimulated 
infants, the first episode of stimulation was given at a median (IQR) of 114 (73 – 182) 
s after birth. Stimulation was repeated 3 (1 – 5) times, with a median (IQR) duration of 
8 (4 – 16) s and a total duration of 32 (15 – 64) s. Modes of stimulation were: rubbing 
(68%) or flicking (2%) the soles of the feet, rubbing the back (12%), a combination 
(9%), or other (8%). In 67% of the stimulation episodes, a clear indication was noted 
(25% bradycardia, 57% apnea, 48% hypoxaemia, 43% combination) and an effect was 
observed in 18% of these indicated stimulation episodes. A total effect of all stimulation 
episodes per infant remains unclear, but infants who did not receive stimulation were 
more often intubated in the delivery room (14/79 (18%) vs 12/164 (7%), p<0.05). 
CONCLUSION
There was a large variation in the use of tactile stimulation in preterm infants during 
stabilization at birth. In most cases, there was an indication for stimulation, but only in a 
small proportion an effect could be observed.




Most preterm infants initiate breathing after birth, but their respiratory drive is weak 
and often insufficient.(1-5) However, in the last decade, the focus of respiratory care 
in the delivery room has shifted from intubation and mechanical ventilation toward 
non-invasive ventilation and supporting spontaneous breathing.(2, 6) Both local and 
international resuscitation guidelines recommend to assess respiratory effort, and if 
necessary, stimulate and support spontaneous breathing.(7-9)
Tactile stimulation (warming, drying, and rubbing the back or the soles of the feet) 
has been recommended in the guidelines to stimulate spontaneous breathing.(7-9) 
Although this is now a commonly accepted intervention, the effect remains unclear. 
Experimental studies have shown a positive effect of tactile stimulation on spontaneous 
breathing at birth(10, 11), but there is very little human data demonstrating the effect of 
stimulation, especially in preterm infants.
Although most interventions in the delivery room have been evaluated, frequency and 
method of tactile stimulation have not been evaluated objectively.(12-17) Besides the 
description of several studies that neonatal caregivers often defer from the resuscitation 
guidelines(12-17), the use of tactile stimulation might be influenced by the current 
practice that preterm infants are not dried but placed in a plastic wrap to prevent 
hypothermia.(18, 19)
We, therefore, evaluated the occurrence and methods of tactile stimulation of preterm 
infants directly after birth.
METHODS
In a retrospective study, we reviewed all neonatal stabilization procedures at birth of 
infants with a gestational age of < 32 weeks from January 2007 until June 2016 in 
the Leiden University Medical Center (LUMC). In this study, recordings of videos and 
physiological parameters of neonatal resuscitation in the delivery room were used. The 
recording of videos and physiological parameters of resuscitation in the delivery room 
for auditing is standard of care at the LUMC.
Videos and respiratory function monitoring (RFM), including heart rate, oxygen saturation, 
and fraction of inspired oxygen were recorded as soon as the infants’ shoulder was 
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out during delivery. Respiratory parameters were recorded with either a Florian RFM 
(Acutronic Medical Systems AG, Hirzel, Switzerland), using a hot wire anemometer, 
or a New Life Box (Applied Biosignals, Weener, Germany) connected to a MRT-A RFM 
(Applied Biosignals, Weener, Germany), using a variable orifice pneumometer (AVEA 
Varflex Flow transdurer, Carefusion, Yorba Linda, CA, USA). Oxygen saturation and 
heart rate were recorded using a Masimo SET pulse oximeter (Masimo Radical, Masimo 
Corporation, Irvine, CA, USA). The pulse oximetry probe was placed around the infants’ 
right wrist. In case the Florian RFM was used, gas flow, pressures given, tidal volume, 
oxygen saturation, heart rate, and breathing signals were digitized using the Spectra 
physiological software (Grove Medical Limited, Hampton, UK). Polybench software 
(Applied Biosignals, Weener, Germany) was used when making use of the New Life 
Box.
The videos and physiological parameters were independently reviewed and analyzed 
by two researchers involved in the study (Janneke Dekker and Tessa Martherus). In 
case of doubt, consensus was achieved with the help of a third researcher (Arjan B. te 
Pas), to guarantee objectivity of the analyzing process. The logging of the occurrence 
and methods of tactile stimulation was started after the infant was dried or put in the 
plastic wrap, the cap was put on, and the pulse oximeter and face mask were placed.
For all included infants, we collected the following patient characteristics: gestational 
age at birth (GA), birth weight, gender, mode of delivery, Apgar score at 5 minutes after 
birth, antenatal corticosteroids, and intubation in the delivery room.
The main variable of interest was the occurrence of tactile stimulation of the neonate in 
the first 7 minutes after birth, as the majority of infants are being prepared for transport 
to the Neonatal Intensive Care Unit (NICU) after 7 minutes. We also noted the frequency 
and duration of tactile stimulation per infant, the time points and the method of stimulation 
(rubbing the back, rubbing the soles of the feet, flicking the soles of the feet, other). If 
stimulation was performed, we noted whether there was an indication for stimulation 
based on clinical signs such as apnea/irregular breathing, wherefore the infant needed 
positive pressure ventilation, bradycardia (a heart rate < 100 bpm), or hypoxia (oxygen 
saturation below the recommended target range described by Wyllie et al.(20)). In case 
of a clear clinical indication, we also noted the effect (recovery of heart rate > 100 bpm 
and/or regaining breathing/increased breathing effort). When tactile stimulation was not 
performed, we noted whether stimulation could have been indicated.
After all data of individual stimulation episodes was logged, a categorical scheme was 
drafted by two of the researchers (Janneke Dekker and Tessa Martherus) in which 
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patterns of stimulation were explicated. After this, all videos were reviewed and coded 
to one of the patterns.
This study was conducted according to the principles of the Declaration of Helsinki 
and in accordance with the Medical Research Involving Human Subjects Act (WMO). 
In the Netherlands, no ethical approval is required for anonymized studies with medical 
charts, and patient data that are used for daily care. The Research Ethics Committee 
issued a statement of no objection.
Statistical analysis
Results are presented as mean ± SD for normally distributed values or medians (IQR) 
for non-normally distributed values. The demographical data of stimulated infants were 
compared with non-stimulated infants using Student’s t-test for parametric variables, 
the Mann-Whitney U test for non-parametric comparisons, and the χ2 test for categorical 
variables. P-values <0.05 were considered statistically significant, reported p-values 
are two sided. Data analysis was performed using IBM SPSS Statistics version 23 (IBM 
Software, New York, NY, USA, 2012). Missing values were excluded case wise from the 
































analysis if they represented less than 5% of total values. Otherwise, multiple imputation 
was used. The remaining missing values were excluded case wise.
RESULTS
A total of 673 infants were recorded, of which 321 recordings were complete and of 
good quality. From these, 245 recordings included stabilization at birth of infants born 
with a GA < 32 weeks and were included in the analysis (Figure 1). The median (IQR) 
GA was 28+6 (27+2 – 30+1) weeks, birth weight was 1153 (880 – 1385) grams, Apgar 
score at 5 minutes was 8 (7 – 9), 140/245 (57%) infants were born after caesarean 
section, 153/245 (62%) received antenatal corticosteroids, and 134/245 (55%) infants 
were male.
 
Tactile stimulation was performed in 164/245 (67%) infants. GA, birth weight, gender, 
mode of delivery, antenatal corticosteroids, and Apgar score did not differ significantly 
between stimulated and non-stimulated infants (Table 1). The first moment of stimulation 
started at median (IQR) 114 (73 – 182) s after birth. Each stimulation episode had a 
median (IQR) duration of 8 (4 – 16) s. The total time of stimulation was 32 (15 – 64) 
s. Four different stimulation patterns could be identified and categorized, based on 
information about indication and repetitiveness of stimulation (Table 2).
Table 1  |  Demographical data
Stimulated Non-stimulated p-value
infants infants
n = 164 n = 81
Gestational age (weeks)a 29 0/7 (27 3/7 – 30 2/7) 28 4/7 (26 6/7 – 30 0/7) 0.298
Gender (% male)b 94/163 (58%) 40/80 (50%) 0.419
Birth weight (grams)a 1165 (875 – 1418) 1121 (880 – 1363) 0.543
Mode of delivery (% caesarean section)b 93/164 (57%) 47/81 (58%) 0.893
Antenatal corticosteroids (% full course)b 106/149 (71%) 47/70 (67%) 0.636
Apgar score at 5 minutes after birtha 8 (6 – 9) 8 (7 – 9) 0.669
Data are presented as median (IQR) for non-parametric data (a) and n (%) for categorical data (b)
In the 164 infants that received stimulation, a total of 585 stimulation episodes were 
observed with median (IQR) 3 (1 – 5) stimulations per infant. Stimulation was performed 
most often by rubbing the soles of the feet (Table 3). In 387/578 (67%) of stimulation 
Tactile stimulation to stimulate spontaneous breathing during stabilization of preterm infants at birth 
33
1
episodes, a clear clinical indication for stimulation could be observed, which were 
bradycardia (25%), apnea/irregular breathing (57%), hypoxia (48%), or a combination 
of these (43%). An effect could be observed in 68/387 (18%) of these stimulation 
episodes. 
Table 2  |  Stimulation types
Stimulation type Incidence, n (%)
Indicated repetitive stimulation 29/164 (18)
Non-indicated repetitive stimulation 2/164 (1)
Indicated non-repetitive stimulation 101/164 (62)
Non-indicated non-repetitive stimulation 32/164 (20)
Table 3  |  Methods of stimulation
Method of stimulation Incidence, n (%)
Rubbing the soles of the feet 400/585 (68)
Rubbing the back   70/585 (12)
Flicking the soles of the feet   10/585 (2)
Combination of abovementioned methods   55/585 (9)
Other (vigorous rubbing, drying, rubbing extended to the lower extremities)   49/585 (8)
Although 81/245 (33%) infants received no stimulation during resuscitation, a clinical 
indication during the resuscitation could be observed in 72/81 (89%) infants (bradycardia 
67%, apnea 70%, hypoxia 70%, or a combination of these 69%).
A total of 26/243 (11%) infants were intubated in the delivery room. The incidence 
of intubation in the delivery room was significantly higher in infants who received no 
stimulation compared to the stimulated infants (14/79 (18%) vs 12/164 (7%), p<0.05). 
When comparing infants with a clinical indication for stimulation, the incidence of 






This is the first study in which recordings of video and physiological parameters were 
used to review the use of tactile stimulation in preterm infants at birth. In the majority of 
infants, tactile stimulation was applied during stabilization at birth. In most cases, there 
was a clinical indication for stimulation, although still a proportion of infants did not 
receive stimulation while this was indicated. In addition, the starting time, duration, and 
method of tactile stimulation varied between infants. Although we could not observe 
a clear direct effect of each stimulation episode in infants where stimulation was 
indicated, a total effect of all stimulation periods in an infant remains unclear. Indeed, 
when stimulation was indicated, infants who did not receive stimulation were more often 
intubated.
Tactile stimulation is suggested in international guidelines(7-9), but there are no clear 
recommendations on indication, timing, and method of tactile stimulation. This is 
probably due to the scarcity in data how tactile stimulation can be best used during 
stabilization of preterm infants at birth. The lack of a definition in the guidelines on timing 
and method of tactile stimulation probably explains the large variation we observed in 
practice.
Although the effect of tactile stimulation as single intervention has not been described 
in human preterm infants at birth, this has been demonstrated in animals. Faridy et 
al.(10) described that maternal rats perform rolling, licking, biting, and pushing of the 
newborn rat to stimulate its breathing. When newborn rats were removed from their 
mother directly after birth, they developed respiratory distress.(10) In apneic term 
lambs, spontaneous breathing commenced when they were stimulated with both 
mechanical and electrical stimuli.(11)
Breathing is initiated by the respiratory center in the medulla by different stimuli 
including hypoxia and hypercapnia.(21, 22) On the other hand, the respiratory center 
can be depressed by the level of adenosine present at birth, which may vary widely 
under different conditions such as mode of delivery and timing of cord clamping.(23-
25) Breathing effort can be increased by changing the state of arousal of the infant 
by the use of tactile stimulation. The response on arousal may vary according to the 
location of the nerves that are stimulated.(26) Ioffe et al.(27) conducted a study in fetal 
lambs to test the respiratory response to somatic stimuli and found that the sleep state 
(NREM, REM, awake) changed when stimuli were given. According to this study, the 
respiratory response was greatest when fetal lambs were in REM sleep or awake at the 
end of stimulation.(27, 28)
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However, the effect of tactile stimulation on breathing by means of arousal is not clear 
as infants are exposed to other stimuli at birth, which might change their arousal state, 
such as light, cold, and sound. In addition, most preterm infants receive respiratory 
support, which could also stimulate breathing effort.(29) In contrast, it could be 
possible that in the effort of applying tactile stimulation, the focus shifts away from other 
interventions during stabilization. In addition, vigorous stimulation could potentially lead 
to displacement of the mask.
In contrast to tactile stimulation at birth, stimulation to counteract apnea of prematurity 
after admittance to the NICU has been well studied in human infants, with stimulation 
performed in different ways. In the study of Kattwinkel et al.(30), when extremities 
were rubbed repetitively as method of tactile stimulation, the frequency of apnea was 
significantly reduced during repetitive stimulation in the 2 hours after the repetitive 
stimulation. In addition, the use of a stochastic resonance mattress is shown to reduce 
the incidence of apnea.(31, 32) However, other methods of stimulation like the use 
of kinaesthetic stimulation have not shown to be effective as treatment for apnea of 
prematurity in the NICU.(33) It is assumed that underdevelopment of the respiratory 
center in the medulla, hypoxia, or altered sensitivity of chemoreceptors to carbon 
dioxide or oxygen might be the cause of apnea of prematurity.(30) However, the 
mechanisms underlying apnea during prematurity might differ from the mechanisms of 
apnea at birth.
Although this study is limited by its retrospective design, objective parameters and videos 
could be used to observe the current practice in tactile stimulation as also the effect 
of stimulation. However, the decision to apply stimulation remains to the discretion of 
caregivers. Neither the motivation whether stimulation was performed nor the preferred 
methods were noted. Since we reviewed the recordings from 2007 to 2016, it is possible 
that the use of stimulation has changed since our practice has changed toward more 
support of spontaneous breathing. However, we could not observe a change along the 
timeline of analyzed recordings. As the video recordings were made anonymous with 
regard to the caregivers in charge of the stabilization procedure, we could not assess 
patterns in stimulation among different caregivers. Although there were no differences 
in characteristics between the groups, it is possible that other unmeasured variables 




In summary, we observed that there was a large variability in the use of tactile stimulation 
during stabilization of preterm infants at birth. When stimulation was applied, most often 
this was indicated, while there was also often an indication when no stimulation was 
given at all. We could not observe a direct effect of stimulation in most occasions. 
While there is increasing awareness that most preterm infants breathe at birth and 
there is more emphasis on supporting this, stimulating breathing effort will also play an 
important role in this. The variation observed in current practice indicates that studies 
are warranted on duration and type of tactile stimulation leading to a better definition in 
guidelines when and how stimulation should be performed.
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To evaluate the direct effect of repetitive tactile stimulation on breathing effort of preterm 
infants at birth.
METHODS
This randomized controlled trial compared the effect of repetitive stimulation on 
respiratory effort during the first 4 minutes after birth with standard stimulation based on 
clinical indication in preterm infants with a gestational age of 27 – 32 weeks. All details 
of the stimulation performed were noted. The main study parameter measured was 
respiratory minute volume, other study parameters assessed measures of respiratory 
effort; tidal volumes, rate of rise to maximum tidal volumes, percentage of recruitment 
breaths, and oxygenation of the infant.
RESULTS
There was no significant difference in respiratory minute volume in the repetitive 
stimulation group when compared to the standard group. Oxygen saturation was 
significantly higher (87.6 ± 3.3% vs 81.7 ± 8.7%, p=0.01) while the level of FiO2 given 
during transport to the NICU was lower (0.28 (0.23 – 0.35) vs 0.34 (0.29 – 0.44), p=0.04). 
There was no significant difference in administration of positive pressure ventilation 
(52% vs 78%, p=0.13), or the duration of ventilation (median (IQR) time 8 (0 – 118) s 
vs 35 (13 – 131) s, p=0.23). Caregivers decided less often to administer caffeine in the 
delivery room to stimulate breathing in the repetitive stimulation group (10% vs 39%, 
p=0.036).
CONCLUSION
Although the increase in respiratory effort during repetitive stimulation did not reach 
significance, oxygenation significantly improved with a lower level of FiO2 at transport 
to the NICU. Repetitive tactile stimulation could be of added value to improve breathing 
effort at birth.




Most preterm infants need respiratory support for lung aeration during transition at 
birth.(1-3) In order to avoid injury to the still developing lungs and brain, the focus 
of respiratory support at birth has shifted from intubation and mechanical ventilation 
towards non-invasive ventilation.(4-7) However, there is still a high failure rate of 
continuous positive airway pressure (CPAP) in preterm infants after birth(4), which 
requires the infant to breath effectively. Studies have shown that most preterm infants 
breathe at birth(3), even during and in between positive pressure ventilation (PPV)(1, 
2), but in the majority of infants their respiratory drive is weak and insufficient to aerate 
their lungs. Little attention has focussed on strategies that stimulate breathing during 
the immediate new-born period. Stimulating preterm infants to increase their respiratory 
effort could enhance the efficacy of CPAP support and might reduce the risk of CPAP 
failure. Thereby, it has been shown that preterm infants in whom mechanical ventilation 
is avoided after birth have better lung mechanics and decreased work of breathing at 
8 weeks post-term.(8)
Currently, tactile maneuvers (warming, drying and rubbing the back or the soles of the 
feet) to stimulate breathing are recommended during the initial assessment of the infant 
at birth.(9, 10) This recommendation is largely based on many years of experience 
and expert opinion as at the time the recommendations were published, there were no 
studies available that specifically examined the effect of tactile stimulation of infants at 
birth. Only experimental studies, in apneic lambs and newborn rats after birth, have 
demonstrated increased spontaneous breathing after tactile stimulation.(11, 12)
We recently reported our current practice in tactile stimulation by reviewing previously 
recorded video and physiological parameters made in the delivery room. In this study 
we observed that duration and method of stimulation in preterm infants were variable 
and often not performed despite being clearly indicated.(13) Frequent omission of 
stimulation of infants at birth was also found by Gaertner et al.(14) Omitting stimulation 
could be related to the use of polyethylene wraps and the use of more extensive 
respiratory support.(14-16) The observed variation could be explained by the fact that 
the guidelines are not clear on how the stimulation should be used, possibly due to 
scarcity of data on this topic. 
Our aim was to test the effect of systematically applied tactile stimulation at birth in a 
randomized controlled trial. We demonstrated in a recent observational study(13) that 
only 67% of preterm infants were stimulated and an effect could be observed in 18% of 
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stimulation episodes. However, it is difficult to interpret this result as we also observed 
that in 1/3 of episodes stimulation was not given while there was no indication and in 
1/3 of infants, stimulation was not given while this was indicated. Colleagues of the 
neonatal team were still very reluctant to not stimulate infants as tactile stimulation 
is one of the most basic interventions during neonatal resuscitation. It would be 
therefore difficult to achieve clinical equipoise for a study in which tactile stimulation 
was compared to the omission of stimulation. In this recent observational study, we 
determined that stimulation could be applied either repetitively or when needed based 
on clinical indication.(13) It is possible that repetitive stimulation could improve the 
infant’s breathing effort, as continuous stimulation might result in habituation.(17) We 
aimed to evaluate the direct effect of a standardized repetitive tactile stimulation on 
breathing effort of preterm infants at birth compared to standard stimulation based on 
clinical indication.
METHODS
A single blinded randomized controlled trial was conducted at the Leiden University 
Medical Center. Preterm infants with a gestational age between 27 and 32 weeks were 
included. Infants with congenital abnormalities or conditions that might have an adverse 
effect on breathing effort or ventilation were excluded. Infants were randomized using 
sequentially numbered opaque sealed envelopes to either be stimulated repetitively or 
to receive standard stimulation after birth. Allocation was stratified by gestational age 
(27+0 – 28+6 weeks vs 29+0 – 31+6 weeks), using variable block (4 – 6) sizes. 
The interventions consisted of repetitive stimulation in the first 4 minutes after birth, 
defined as gently rubbing the back or the soles of the feet during 10 s, alternated with 10 
s of rest. We have demonstrated in an observational study that stimulation was applied 
either repetitively or based on clinical indication.(13) For this reason we compared 
repetitive stimulation with standard stimulation, in conformation with the World Health 
Organization guidelines: gently rubbing the back or the soles of the feet when clinicians 
considered the breathing to be insufficient or absent.(7) After 4 minutes after birth, both 
groups received similar treatment, and stimulation was performed on discretion of the 
caregiver. The intervention was performed solely in the first 4 minutes after birth, as 
most preterm infants have a stable breathing pattern after this time interval.(18)
In both groups standard care was provided in the delivery room. Local resuscitation 
guidelines were followed using a NeopuffTM T-Piece Resuscitator, including delayed 
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cord clamping of 30 s, oxygen administration to target oxygen saturations based on the 
international normograms(19), and caffeine administration in the delivery room based 
on discretion of the caregiver, as previously described in the study of Dekker et al.(20). 
In both groups, physiological parameters, including respiratory function monitoring 
(RFM) were recorded during stabilization in the first 10 minutes of life. This RFM uses 
a small (dead space 1 mL) variable orifice anemometer to measure gas flow in and 
out of a face mask, thereby calculating inflation pressures, flow and tidal volumes. The 
difference between inspired and expired tidal volume equals the leak from the face 
mask. The minute volume (MV), rate of rise to maximum tidal volumes (RoR) and time 
of positive pressure ventilation (PPV) given were calculated. Oxygenation and heart 
rate were measured with the Masimo SET pulse oximeter. A pulse oximetry probe was 
placed around the ulnar aspect of the infant’s right wrist. Fraction of inspired oxygen 
(FiO2) was measured with a Teledyne oxygen analyzer inserted into the inspiratory 
limb of the NeopuffTM circuit. All signals measured were recorded at 200 Hz using the 
New Life Box physiological recording system with Polybench software (Advanced Life 
Diagnostics, Weener, Germany). Pulmochart software (Advanced Life Diagnostics, 
Weener, Germany) was used for analysing recorded data.
The main study parameter was the average MV at 1 – 4 minutes after birth. Other 
respiratory effort parameters which were blindly assessed, were: MV in the first 7 
minutes after birth, tidal volumes, RoR, respiratory rate, percentage of tidal volumes 
> 4 mL/kg or 8 mL/kg (recruitment breaths), respiratory support given (CPAP vs 
PPV) and caffeine administration in the delivery room. Time of PPV, oxygen delivery, 
oxygen saturation and heart rate were also compared between groups. The following 
demographic data were collected: gestational age (GA), birth weight, gender, Apgar 
score, antenatal use of corticosteroids, mode of delivery. Short-term clinical outcomes 
were noted: intraventricular hemorrhage, intubation during resuscitation or within the 
first 24 hours after birth and need for surfactant.
Mian et al.(21) measured an average MV of 150 ± 70 mL/kg/min over the first 100 
breaths in preterm infants < 33 weeks GA. The study of Huberts et al.(18) shows that 
MV in spontaneous breathing preterm infants increases with 60% from minute 2 to 
minute 5, but this increase was lower in infants receiving PPV. We therefore considered 
an increase of 40% in average MV at 1 – 4 minutes clinically relevant, for this a sample 
size of 44 infants would be needed (α of 0.05 and power (1 – β) of 0.8, 2-sided t-test).
The ethical committee of the LUMC approved the study protocol. Informed parental 
consent was obtained antenatally when possible. Consent was asked retrospectively in 
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case of an emergency situation (e.g. mother in full labour or when immediate delivery 
was necessary) or when obtaining antenatal consent was inappropriate (e.g. if the 
condition of the mother did not allow for proper consideration on participation). This 
study was registered in www.trialregister.nl, with registration number NTR6021.
Statistical analysis was performed with SPSS software version 23.0 (SPSS, Chicago, 
Illinois). The parameters of both groups were assessed for normality using the 
Kolmogorov-Smirnov and Shapiro-Wilkinson test. Demographics of the repetitive 
and standard stimulation groups were compared by χ2 test for categorical variables, 
Student’s t-test for normally distributed data, or Mann-Whitney U test for non-normally 
distributed data. Parameters of respiratory effort were compared between the groups 
over time using a linear mixed-effect regression model after appropriate transformation 
to meet the normality assumption, in which the time after birth, stratification group 
and randomization group were entered. We allowed for interaction between time 
and randomization group. Study parameters that were only assessed once over time 
were compared by a two-way factorial ANOVA, including both the randomization and 
stratification group. Categorical outcomes were assessed by Fisher’s exact test.
For the calculation of parameters of respiratory effort, tidal volumes during inspiration 
were used, as this is the active part of a breath and represents effort, expired tidal 
volumes represent expiration and are passive, which does not completely represent 
respiratory effort. However, when there is mask leak, inspired tidal volumes cannot 
be used; the best approximation to measure effort is then only expired tidal volume. 
Whenever there was a mask leakage of 100%, MV was calculated for that minute 
using only tidal volumes recorded without 100% mask leakage, and dividing it by the 
number of seconds for which data was present. Calculations of the other variables were 
made based on available data. Two-sided p-values <0.05 were considered statistically 
significant.
RESULTS
A total of 75 eligible infants were born in the LUMC between September 2016 and 
April 2017. During this period 24 infants could not be included due to inclusion in other 
studies, antenatal consent was refused or due to logistical reasons. Thus, 51 infants 
were randomized to receive either repetitive or standard stimulation, but 7 infants were 
excluded from the analysis because there was no retrospective consent, there was no 
recording obtained or the recording could not be analyzed because of persistent 100% 
leak (Figure 1).
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Figure 1  |  CONSORT flow diagram






Gestational age (weeks)a 29+0 (27+5 – 31+0) 29+5 (28+1 – 30+6) 0.487
Gender (% male)b 14/23 (61%) 11/21 (52%) 0.570
Birth weight (grams)a 1252 (1050 – 1388) 1350 (1073 – 1580) 0.597
Apgar score at 1 minutesc 6 ± 3 6 ± 2 0.897
Apgar score at 5 minutesa 8 (7 – 9) 8 (7 – 9) 0.655
Apgar score at 10 minutesa 9 (8 – 9) 9 (9 – 9) 0.492
Mode of delivery (% caesarean section)b 17/23 (74%) 12/21 (57%) 0.241
Antenatal corticosteroids (% full course)b 14/23 (61%) 13/21 (62%) 0.944
Data are presented as median (IQR) for non-parametric data (a), n (%) for categorical data (b) and mean ± SD 
for parametric data (c)
There were no significant differences between the repetitive and standard stimulation 
groups with regard to GA, birth weight, gender, Apgar score at 1, 5 and 10 minutes, 




At least one tactile stimulation episode was performed in all infants in the repetitive 
stimulation group and in 22/23 (96%) infants in the standard stimulation group. Infants 
in the repetitive stimulation group were stimulated significantly more often (8 (7 – 10) 
vs 3 (3 – 6) episodes, p<0.001), although there were no significant differences in 
starting time, episode duration, or total stimulation time (Table 2). According to the 
study protocol, the standard stimulation group received significantly more episodes of 
stimulation based on clinical indication (46% vs 63%, p=0.009) (Table 2).






Stimulation performed (%)a 22/23 (96%) 21/21 (100%) 1.000
Time stimulation started (s after birth)b 74.5 ± 42.9 71.3 ± 34.1 0.794
Duration of stimulation episodes (s)c 12 (4 – 24) 10 (9 – 11) 0.076
Total stimulation time (s)c 59 (24 – 120) 86 (63 – 105) 0.388
Number of stimulation episodesc 3 (3 – 6) 8 (7 – 10) <0.001
Type of stimulationa 0.271
Rubbing the back 4/92 (4%) 2/168 (1%)
Rubbing soles of the feet 84/92 (91%) 160/168 (95%)
Both 4/92 (4%) 6/168 (4%)
Clinical indication for stimulationa 57/91 (63%) 76/166 (46%) 0.009
Type of indicationa 0.048
Bradycardia 3/57 (5%) 4/76 (5%)
Apnea 14/57 (25%) 36/76 (47%)
Hypoxia 15/57 (26%) 11/76 (15%)
Combination 25/57 (44%) 25/76 (33%)
Data are presented as n (%) for categorical data (a), mean ± SD for parametric data (b) and median (IQR) for 
non-parametric data (c).
Effect of tactile stimulation on breathing effort
There was no significant difference in the median (IQR) MV at minutes 1 – 4 and 1 
– 7 (1 – 4 minutes: 51.5 (5.3 – 114.2) mL/kg vs 69.2 (11.5 – 153.9) mL/kg, p=0.439, 
1 – 7 minutes: 89.6 (21.4 – 141.7) mL/kg vs 110.5 (42.3 – 166.8) mL/kg, p=0.324). In 
addition, there were no significant differences in respiratory rate, tidal volume and RoR 
of spontaneous breaths on CPAP in the repetitive stimulation group when compared to 
the standard stimulation group during the intervention (1 – 4 minutes) and during the 
total period (1 – 7 minutes) (Table 3, Figure 2). The period of mask ventilation did not 
significantly differ between the groups either (median (IQR) time 8 (0 – 118) s vs 35 (13 
– 131) s, p=0.231). There were no differences in percentage of tidal volumes > 4 mL/
kg or > 8 mL/kg (Table 3).
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Figure 3  |  Average FiO2 over time
There were no significant differences between the groups in pulse rate but the average 
oxygen saturation was significantly higher in the repetitive stimulation group (87.6 ± 
3.3% vs 81.7 ± 8.7%, p=0.007), while there was no significant difference in the FiO2 
given at each minute (p=0.121) (Figure 3). While the maximum FiO2 during stabilization 
was not different, the requirement for a lower FiO2 extended well beyond the 7 minutes 
stabilization period. This was reflected by a significantly lower FiO2 requirement at the 
time of transport to the NICU in the repetitive stimulation group (0.28 (0.23 – 0.35) vs 
Figure 2  |  Average minute volume of spontaneous breaths (observed means) 
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Tidal volume at 1 – 4 minutes after birth (mL/kg)a 2.7 (1.0 – 5.7) 3.6 (1.7 – 6.3) 0.131
Tidal volume at 1 – 7 minutes after birth (mL/kg)a 2.9 (1.3 – 5.4) 3.7 (2.1 – 5.9) 0.134
Rate of rise to maximum tidal volumes at 1 – 4 
minutes after birth (mL/kg/s)a
7.4 (3.7 – 13.6) 10.3 (4.5 – 19.3) 0.213
Rate of rise to maximum tidal volumes at 1 – 7 
minutes after birth (mL/kg/s)a
8.4 (4.5 – 14.1) 10.8 (6.0 – 17.5) 0.219
Respiratory rate/min at 1 – 4 minutes after birtha 23 (7 – 36) 24 (8 – 45) 0.795
Respiratory rate/min at 1 – 7 minutes after birthb 32 ± 19 35 ± 19 0.627
Oxygen saturation (%)b 81.7 ± 8.7 87.6 ± 3.3 0.007
Pulse rateb 143 (133 – 150) 138 (133 – 151) 0.581
Percentage of tidal volumes > 4 mL/kg (%)b 39.7 ± 21.2 47.1 ± 25.0 0.315
Percentage of tidal volumes > 8 mL/kg (%)b 5.0 (2.0 – 14.0) 6.0 (1.5 – 22.5) 0.673
Time of mask ventilation (s)b 35 (13 – 131) 16 (0 – 118) 0.231
Maximum FiO2 during resuscitation
b 0.93 (0.49 – 1.0) 0.62 (0.35 – 0.99) 0.110
Time at which infant is transported to NICU 
(min:sec)b
15:06 (10:34 – 19:09) 12:32 (9:24 – 16:21) 0.258
FiO2 at start of transport to NICU
b 0.34 (0.29 – 0.44) 0.28 (0.23 – 0.35) 0.036
Caffeine administered during stabilization at birthc 9/23 (39%) 2/21 (10%) 0.036
Time after birth of caffeine administration (min)b 06:32 (05:25 – 07:46) 06:00 (04:10 – 06:00) 0.661
Respiratory support after birth (% CPAP only)c 5/23 (22%) 10/21 (48%) 0.112
Intraventricular hemorrhage ≥ grade 3c 0/23 (0%) 1/21 (5%) 0.477
Surfactant administration at NICUc 4/23 (17%) 5/21 (24%) 0.716
Data is presented as median (IQR) or mean ± SD of the raw data; p-values are presented of the linear mixed 
model (a). Data is presented as median (IQR) or mean ± SD of the raw data; p-values are presented of the two-
way factorial ANOVA (b). Data is presented as n (%) or categorical data, p-values are presented of the Fisher’s 
exact test (c).
0.34 (0.29 – 0.44), p=0.036), while there was no difference in the time at which infants 
were transported (Table 3). None of the infants were intubated in the delivery room. 
There was no significant difference in administration of PPV (48% vs 22%, p=0.130) 
or the duration of PPV administered (16 (0 – 118) s vs 35 (13 – 131) s, p=0.231). 
Caregivers decided less often to administer caffeine in the delivery room to stimulate 
breathing in the repetitive stimulation group (10% vs 39%, p=0.036) (Table 3). Caffeine 
was administered at a mean ± SD time point of 06:25 ± 01:13 minutes after birth.
Effect of tactile stimulation on clinical outcomes
There were no significant differences in incidence of intraventricular hemorrhage (IVH) 
or administration of surfactant during NICU admission (Table 3).




This randomized trial is the first study quantifying the respiratory minute volume as a 
direct effect of tactile stimulation. Tactile stimulation to stimulate breathing of infants at 
birth has been common practice before living memory and has been recommended 
even before the first version of the resuscitation guidelines.(22) Sharing the observations 
of the retrospective study and the lack of clinical equipoise in the neonatal team in “not 
to stimulate” could have resulted in bias prior to the start of the trial. For this reason, 
we tested the effect of tactile stimulation by comparing standard stimulation, which is 
dependent upon discretion of the caregiver, with an unambiguous protocol of repetitive 
stimulation. Performing a trial of this nature could have influenced the caregiver’s 
performance in all patients (Hawthorne effect). We considered this to be unavoidable 
and for this reason we noted all details of the tactile stimulation performed. 
While there was no significant difference in MVs, tidal volumes and RoR, all respiratory 
effort values were increased in the repetitive stimulation group and thus all point in the 
same direction. Therefore, although no significant statistical differences were observed, 
the findings might be clinically relevant. This is also expressed by a significant increase 
in oxygen saturations. Also, fewer infants in the repetitive stimulation group received 
caffeine at birth when compared to the standard stimulation group. As caffeine was 
administered at the discretion of the caregiver, this indicates that infants in the repetitive 
stimulation group were assessed to have a better respiratory effort. These results 
indicate that repetitive tactile stimulation at birth has value in improving breathing efforts 
in preterm infants at birth and should not be overlooked as an important contributor to 
the provision of respiratory support in the delivery room.
Respiratory care at birth has shifted towards non-invasive ventilation and the need 
to avoid intubation and mechanical ventilation.(2, 5, 23, 24) However, it has become 
clear that mask ventilation is often inadequate and ineffective(1) and that the larynx 
is mostly closed at birth in apneic newborns and only opens during a spontaneous 
breath, which is demonstrated in newborn sheep.(25) The larynx must be open to 
ventilate the lung non-invasively, and the best way to do so is to stimulate breathing. 
We recently demonstrated that caffeine at birth increases respiratory effort(20) and we 
now observed similar positive effects with tactile stimulation. While we were unable 
to achieve statistical significance in the respiratory parameters examined, the higher 
oxygenation state indicates that respiratory function was substantially better in the 
repetitive stimulation group. 
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Although the effect of tactile stimulation has been described previously in animal 
models(11, 12), the effect in human preterm infants has only just recently gained 
attention.(13, 14) In these studies, the incidence of stimulation was much lower than 
the high incidence of stimulation we observed in both stimulation groups in this trial. 
Initiating this trial therefore substantially increased awareness on and the incidence 
of tactile stimulation. Indeed, while infants in the standard stimulation group would 
normally only be stimulated when there was a clinical indication, we found that only 
63% of stimulations were clinically indicated. This could have resulted in reducing 
the difference in primary outcome between the two groups. As a result, together with 
a higher than expected between patient variability in the primary outcome, a larger 
sample size would be needed to demonstrate statistical differences between the 
groups. Nevertheless, we demonstrated significant differences in oxygenation between 
the groups, indicating that the non-statistical differences in respiratory function between 
the two groups were biologically significant.
The most frequently used method of stimulation in this randomized trial was rubbing the 
soles of the feet, thereby activating proprioceptors which are known to reduce breathing 
pauses in preterm infants with apnea of prematurity(26) and increase the frequency of 
breathing.(27) In contrast, in the study of Gaertner et al.(14), infants were more often 
stimulated by chest or back rub, and they noted a larger increase in crying, compared 
to stimulation by rubbing the soles of the feet. Stimulation by chest or back rub might 
affect the respiratory center via somatic or visceral mechanoreceptors in the thorax 
region.(28, 29) However, Binks et al.(30) showed that this could also inhibit inspiration, 
as vibration of the thoracic surface could also excite intrapulmonary receptors and 
suggesting that the lung volume is already increased. More data is needed on the 
effect of different stimulation locations to inform caregivers in what is the best and most 
effective way of stimulating preterm infants to enhance respiratory efforts. Although 
we do not introduce a new intervention, merely a repetition, caution should be taken to 
ensure the stimulation is performed gently and with care.




In this randomized trial, there were no differences in respiratory parameters between 
the repetitive tactile stimulation and standard tactile stimulation groups. Nevertheless, 
tactile stimulation overall improved oxygenation with a lower maximum FiO2 level, lower 
level of FiO2 at transport to the NICU and the need for less post transport caffeine 
administration. This suggests tactile stimulation improves respiration function. Future 
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CHAPTER 3
Increasing respiratory effort with 100% oxygen 






















Spontaneous breathing is essential for the success of non-invasive respiratory support 
at birth. As hypoxia is a potent inhibitor of spontaneous breathing, using a high O2 
concentration at birth might lead to higher respiratory effort.
METHODS
Preterm rabbits (29 days gestation, term ~32 days) received continuous positive 
airway pressure containing either 21% O2 or 100% O2, based on randomization. 
If apnea occurred, positive pressure ventilation with either 21% O2 or 100% O2 was 
applied. Respiratory rate and variability in inter-breath interval were measured using an 
oesophageal tube, functional residual capacity was deduced of phase-contrast X-ray 
images.
RESULTS
Apnea occurred more frequently in kittens who started breathing in 21% O2 compared 
to 100% O2 (11/12 vs 1/8, p=0.001). Kittens starting in 21% O2 had a significantly higher 
inter-breath interval at the start of the experiment and after rescue from apnea (start: 
68.5 ± 11.9% vs 40.1 ± 4.2%, p=0.042, after rescue: 83.6 ± 32.2% vs 9.5 ± 1.3%; 
p=0.014). Similarly, respiratory rate/minute was significantly lower in the 21% O2 group 
at both timepoints. FRC values did not differ between study groups at both timepoints.
CONCLUSION
Initiating resuscitation with a high O2 concentration might result in increased respiratory 
effort thereby positively influencing respiratory transition at birth. 




Most preterm infants breathe at birth, but struggle to achieve sufficient pulmonary gas 
exchange due to a weak respiratory drive, low respiratory muscle strength and immaturity 
of the lung.(1-5) As a result, non-invasive respiratory strategies are commonly used to 
assist preterm infants, which mostly focus on supporting the mechanics of breathing. For 
instance, continuous positive airway pressure (CPAP) is applied to support the infant’s 
breathing efforts, or if these are absent (i.e. during apnea), positive pressure ventilation 
(PPV) is used to replace them.(6, 7) However, several studies have demonstrated that 
non-invasive ventilation using a face mask is often inadequate due to mask leakage 
or airway obstruction.(1, 2) In particular, it has recently been demonstrated that larynx 
adduction can prevent air from entering the lung during non-invasive mask ventilation.
(8, 9) Larynx adduction during apnea plays an important role in lung growth and 
development before birth, a process which persists well after birth.(1, 2, 8, 10) Thus, as 
the larynx needs to be open after birth to allow lung aeration, spontaneous breathing is 
now considered essential for the success of non-invasively applied respiratory support 
in very preterm infants. Indeed, several studies have now shown that lung aeration only 
occurs when newborns are breathing spontaneously.(2, 9) 
It is now becoming increasingly clear that non-invasive respiratory strategies should 
not only focus on supporting the mechanics of breathing, but should also focus on 
stimulating spontaneous breathing. Spontaneous breathing can be stimulated by 
a number of mechanisms, including tactile stimulation, CPAP and caffeine.(11-17) 
However, as hypoxia is a potent inhibitor of spontaneous breathing, these interventions 
may not be sufficient to stabilize infants after birth when using an inspired gas with 
low oxygen concentrations. Historically, 100% O2 was used to resuscitate preterm 
infants without titrating the inspired oxygen content or consistently monitoring oxygen 
saturation (SpO2) levels.(4, 18) However, this practice changed when it became clear 
that hyperoxia can be toxic to the lungs(19, 20) and instead, current guidelines are now 
heavily focused on prevention of hyperoxia. This led to the recommendation of starting 
resuscitation with a low O2 concentration, and then titrating based on the infants SpO2.
(21-24) As a result, we now accept a longer duration of hypoxia after birth, without 
questioning the impact of this. 
In very preterm infants, when hypoxia is present at 5 minutes after birth, it is associated 
with a lower heart rate, a higher mortality before hospital discharge and a higher risk of 
intraventricular hemorrhage.(25) In addition, it is well established that, in the foetus and 
newborn, hypoxia is a potent inhibitor of the respiratory center, causing a suppression 
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of breathing and adduction of the larynx.(26) Although this inhibitory effect of hypoxia 
gradually changes during the first few weeks after birth, it must be present at birth.
(27) As a result, avoiding levels of hypoxia that inhibit breathing would appear to be an 
important component of any strategy designed to stimulate spontaneous breathing at 
birth. However, translating this knowledge into decisions as to what O2 levels should 
be used to achieve an adequate oxygenation of the infant at birth, is extraordinarily 
complex. This is because the presence of airway liquid greatly reduces the surface 
area for gas exchange, necessitating the use of a higher partial pressure gradient for 
O2 diffusion. However, as the surface area increases exponentially with lung aeration, 
the need for this higher partial pressure gradient dramatically decreases, necessitating 
a rapid reduction in the required O2 concentration to avoid hyperoxia.
As partial lung aeration is common after birth in very preterm neonates, we hypothesized 
that the use of a high O2 concentration at birth reduces the risk of a hypoxia-induced 
inhibition of breathing, leading to a higher respiratory rate and a more stable breathing 
pattern. Furthermore, we hypothesized that a more stable breathing pattern will lead to 
better aeration of the lung (measured as functional residual capacity; FRC), leading to 
a reduced need for O2.
METHODS
All animal procedures were approved by the SPring-8 Animal Care and Monash 
University’s Animal Ethics Committees. The study was conducted in experimental hutch 
3 of beamline 20B2 in the Biomedical Imaging Center at the SPring-8 synchrotron, 
Japan. 
Experimental procedure
Pregnant New Zealand White rabbits at 29 days gestation (term ~ 32 days) were 
sedated using propofol (8 mg/kg iv bolus, Rapinovet, Merck Animal Health), followed 
by a maintenance dose of 50 mg/kg/h. A 22G epidural catheter (BD 405254) was then 
inserted into the epidural space on the lower spine to administer 2% lignocaine (4 mg/
kg) + 0.5% bupivacaine (1 mg/kg). After establishing a spinal anaesthesia, the propofol 
infusion ceased, but sedation continued with an infusion of butorphanol (0.5 mg/kg/h) 
and midazolam (1.0 mg/kg/h). The rabbit’s reflexes, respiratory rate, oxygen saturation 
and heart rate were constantly monitored. A caesarean section was performed to deliver 
rabbit kittens one at a time. An oesophageal tube was inserted and a face mask applied 
before the umbilical cord was cut. The kittens were weighed and a dose of caffeine 
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base (20 mg/kg), naloxone (1 mg/kg) and anexate (10 µg/kg) were administered 
intraperitoneally. The kittens were placed laterally (right side) on a heated platform in 
the expected path of the X-ray beam. Electrocardiogram leads were attached and the 
face mask was connected to a custom-built mechanical ventilator(28) to apply CPAP. All 
kittens started on CPAP as means of respiratory support, commencing with a pressure 
of 15 cm H2O, which was titrated down to 8 cm H2O, with a rate of 2 cm/30 seconds. A 
gas blender attached to the ventilator was used to regulate the O2 concentration. Kitten 
heart rate and face mask and oesophageal pressures were recorded using Labchart 
(Powerlab, ADInstruments, Sydney, Australia).
The experiment commenced when the kitten was attached to the equipment and was 
breathing spontaneously in order to determine the effect of the O2 concentration on the 
breathing pattern. The experiment consisted of two phases. Kittens were initially divided 
into two groups and commenced breathing in either 21% O2 or 100% O2 (phase 1), with 
the breathing pattern being monitored. If kittens became apneic, a rescue intervention 
was performed with PPV using a ventilation rate of 60 breaths per minute, peak inflation 
pressure of 25 cmH2O and PEEP of 8 cmH2O. The O2 concentration during the rescue 
ventilation depended on the group. Kittens that commenced in 21% O2 received either 
21% O2 or 100% O2, whereas kittens that commenced in 100% O2 remained in 100% O2. 
Whenever ventilation alone was not sufficient for regaining a stable breathing pattern, 
physical stimulation was applied. When breathing was restored, breathing pattern was 
again analyzed (phase 2). Kittens were randomly allocated prior to delivery for starting 
the experiment in 21% O2 or 100% O2, and for rescue intervention in case of apnea with 
21% O2 or 100% O2 (Figure 1).
All animals were humanely euthanized at the end of the experiment using pentobarbitone 
sodium (> 100 mg/kg) administered intravenously in the doe and intraperitoneally in the 
kittens. 
Phase-contrast X-ray imaging
High resolution phase-contrast X-ray imaging was used to measure lung gas volumes, 
as described previously by Kitchen et al.(29), using a Hamamatsu ORCA flash C11440-
22C detector (effective pixel size 15.2 µm). A synchrotron source tuned to 24 keV was 
used, with the X-ray source-to-kitten distance was ~210 m, and the kitten-to-detector 




Data on stability of spontaneous breathing during the total experiment and during both 
phases (at start of the experiment and after rescue intervention) were gathered and 
compared between the randomization groups. We aimed to compare the stability of 
breathing at phase 2 (after rescue intervention), but we could not predict if apnea would 
occur evenly in the randomization groups. We measured the timepoints at which apnea 
occurred and when a stable breathing pattern was regained, which was considered as 
the start of phase 2. The averages of these timepoints were considered as the start of 
phase 2 in the non-apneic kittens as well, in order to compare the breathing variability 
and breathing rate at phase 2 in all kittens.
Stability of breathing was assessed during the different phases of the experiment 
using respiratory rate and inter-breath interval variability from oesophageal pressure 
recordings. The timepoint of occurrence of apnea, duration of apnea and amount of 
rescue intervention needed (none/PPV/PPV and stimulation/could not be rescued) were 
also compared. 
Imaging was used to determine the average FRC during phase 1 (stable breathing in 
21% O2 or 100% O2) and during phase 2 (breathing pattern after rescue intervention 
with either 21% O2 or 100% O2). In addition, the differences between the FRC at the 
start and end of each phase were compared between the groups.
Statistical analysis
Statistical analysis was performed with SPSS software version 23.0 (SPSS, Chicago, 
Illinois, USA). When outcomes were assessed to be normally distributed, groups were 
compared using either a Student’s t-test or one-way ANOVA. When the data were 
assessed as being non-parametric we used either a Mann-Whitney U test or Kruskal-
Wallis test. Fisher’s exact test was used to test categorical variables. Two-sided p-values 
<0.05 were considered statistically significant.
RESULTS
A total of 26 kittens were randomized to start the experiment in 21% O2 or in 100% 
O2 (Figure 1); 16 in the 21% O2 group and 10 in the 100% O2 group. 6 kittens were 
excluded before the experiment commenced because a stable breathing pattern 
was not reached, allowing the onset of imaging. There were no differences between 
randomization groups with regard to birth weight or caffeine dose administered (Table 
1).


































Birthweight (grams) 34.6 ± 4.5 31.8 ± 5.7 0.229
Caffeine dose (mg/kg) 18.7 ± 1.4 19.2 ± 2.9 0.593
Data is presented as mean ± SD.
Effect of tactile stimulation on breathing effort
Apnea
11/12 kittens who started breathing in 21% O2 became apneic and needed rescue 
intervention, compared to 1/8 kittens in the 100% O2 group (p=0.001). The time point 
(3.7 minutes) at which apnea occurred in the 1 kitten in the 100% O2 group that became 
apneic was not different from the mean ± SD time that kittens started in 21% O2 became 
apneic (3.2 ± 0.5 minutes, p=0.802). 
Of 11 kittens that became apneic after starting the experiment in 21% O2, 5 received 
rescue intervention with 100% O2 and 6 were allocated to rescue intervention with 21% 
O2 (Figure 1). Rescue intervention was started after kittens became apneic at a median 
(IQR) time of 2.8 (8.4 – 30.2) s. Additional physical stimulation was needed in 5/5 kittens 
who were rescued with 100% O2 and 4/6 kittens who were rescued with 21% O2. Rescue 
failed in 1 kitten that received 21% O2 as the rescue treatment (Table 2). The duration of 
rescue intervention was comparable, whether this was performed with 21% O2 or 100% 
O2 (206.5 ± 31.7 s vs 186.2 ± 23.6 s). 
The only kitten that became apneic after starting the experiment in 100% O2, also 
received rescue intervention with 100% O2. This rescue intervention started 58 seconds 
after initiation of apnea and consisted solely of PPV. After 91.6 seconds, the rescue 
intervention was discontinued as the kitten had regained a spontaneous breathing 
pattern. 
Stability of breathing
During the total experiment, the median (IQR) respiratory rate was significantly different 
between all groups (21% O2/100% O2 group 42.7 (33.1 – 52.2) breaths/minute, 21% 
O2/21% O2 group 29.9 (22.0 – 37.2) breaths/minute, 100% O2 group 46.4 (37.0 – 54.3) 
breaths/minute, p<0.001)(Figure 2, Figure 3). 
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Table 2  |  Effect of tactile stimulation on breathing effort
21%/100% O2  
group
n = 5
21%/21% O2  
group
n = 6




Duration of apnea (minutes)a 3.0 ± 0.8 (n = 5) 2.9 ± 0.6 (n = 5) 2.4 (n = 1) 0.725
Duration of rescue therapy (s)a 206.5 ± 31.7 186.2 ± 32.6 91.6 0.299
Rescue therapyc 0.106
PPV 0 (0%) 2 (33%) 1 (100%)
PPV & physical stimulation 5 (100%) 3 (50%) 0 (0%)
Could not be rescued 0 (0%) 1 (17%) 0 (0%)
Variability of inter-breath interval (%)a 9.5 ± 1.3 83.6 ± 32.2 27.2 ± 6.1 0.014
Average respiratory rate/minb 43 (33 – 46) 27 (18 – 31) 45 (39 – 50) 0.007
Data is presented as mean ± SE (a), median (IQR) (b) or n (%) (c).
Figure 2  |  Respiratory rate during phase 1 of the experiment







Respiratory rate during phase 1































During phase 1 at the beginning of the experiment, the variability in inter-breath interval 
was significantly higher in kittens who started in 21% O2 compared to kittens started 
in 100% O2 (68.5 ± 11.9% vs 40.1 ± 4.2%, p=0.042). The average respiratory rate per 
minute was significantly lower in the 21% O2 group (29 ± 4 vs 42 ± 3, p=0.038).
During phase 2 (following the restoration of breathing) the variability of inter-breath 
interval was markedly higher in kittens that received rescue intervention with 21% O2 
(21% O2/21% O2 group; 83.6 ± 32.2 %) vs kittens that were rescued with 100% O2 (21% 
O2/100% O2 group; 9.5 ± 1.3 %; p=0.014) (Table 2). In addition, the average respiratory 
rate was significantly lower in kittens in the 21% O2/21% O2 group compared to kittens 
in the 100% O2 group (27 (18 – 31) breaths/minute vs 45 (39 – 50) breaths/minute; 
p=0.007) (Table 2). 
Imaging
At the start of the experiment (phase 1), FRC values were not different between the 
study groups (Table 3). Similarly, FRCs measured at the start and end of this phase did 
not significantly differ between study groups (p=0.876) (Figure 4).











Average FRC at start of experiment 
(phase 1) (mL/kg)
22.68 ± 2.35 21.87 ± 5.50 15.19 ± 10.40 0.381
FRC difference between start and 
end of phase (mL/kg)
0.81 ± 0.60 1.45 ± 1.62 0.50 ± 4.74 0.876
Data is presented as mean ± SD, p-values are reported of Kruskal-Wallis test.
In the kittens who started resuscitation in 21% O2 and became apneic, FRC levels 
were again measured once they returned to a stable breathing pattern after the rescue 
intervention (phase 2). The average FRC during this phase did not differ between 
kittens receiving rescue intervention with either 21% O2 or 100% O2 (Table 4). Again, 
the difference between FRC at the start and end of this phase did not significantly differ 
between the study groups (p=0.915) (Table 4, Figure 4).
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Average FRC after rescue intervention 
(phase 2) (mL/kg)
24.21 ± 1.64 23.87 ± 6.24 0.908
FRC difference between start and end of 
phase (mL/kg)
-0.08 ± 0.74 -0.02 ± 1.14 0.915
Data is presented as mean ± SD, p-values are reported of Student’s t-test.
DISCUSSION
We have shown that initiating resuscitation of preterm kittens with 21% O2 resulted 
in a more unstable breathing pattern (higher variability in inter-breath interval), a 
lower respiratory rate and a higher incidence of apnea compared to kittens starting 
resuscitation in 100% O2. Furthermore, the kittens who were rescued with 21% O2 after 
apnea, also had a higher inter-breath variability and lower respiratory rate than kittens 
rescued with 100% O2. On the other hand, being resuscitated or rescued from apnea 
with 21% O2 vs 100% O2 did not significantly affect the degree of lung aeration as 
assessed by measuring FRC. These data indicate that oxygenation is the predominant 
factor determining the stability of breathing and the avoidance of apnea in the newborn 
immediately after birth. As the degree of lung aeration was similar between the two 
groups, despite a much higher respiratory activity, apparently respiratory activity alone 
is not the primary determinant of lung aeration during transition after birth. 
It is well accepted that hypoxia is a potent inhibitor of breathing movements in the fetus 
and this inhibitory effect of hypoxia persists well into the newborn period. However, the 
application of this knowledge has been overwhelmed by concerns of hyperoxia and 

































because it is widely considered that PPV can replace spontaneous breathing if the 
infant is apneic. However, we now know that the presence of spontaneous breathing 
is essential for the success of non-invasive respiratory support at birth, as it ensures 
an open larynx. As a result, a focus on supporting breathing has become a priority. 
We found that resuscitation of preterm rabbits with 21% O2 resulted in an unstable 
breathing pattern and a markedly lower breathing rate than resuscitation with 100% 
O2. As partial lung aeration reduces the surface area for gas exchange, it is likely 
that breathing air was insufficient to sustain the oxygen needs of our preterm kittens, 
initially resulting in an unstable breathing pattern that eventually led to apnea in 11/12 
kittens. However, increasing O2 to 100%, increased the partial pressure gradient for 
oxygen diffusion, which likely overcame the surface area limitation, thereby increasing 
oxygenation levels. This was reflected by a greater breathing stability and a higher 
breathing rate, with only 1/8 kittens resuscitated with 100% oxygen becoming apneic.  
Our study also showed that, following apnea, kittens rescued with 100% O2 had a more 
stable breathing pattern (lower inter-breath variability) and a higher respiratory rate than 
kittens rescued with 21% O2. These findings are consistent with those of van Vonderen 
et al.(30), who showed a similar increase in respiratory effort in preterm infants after O2 
was increased from 21% to 100%. By increasing the fraction of inspired oxygen, the 
level of hypoxia was reduced, thereby increasing breathing stability. These findings 
are consistent with the concept that hypoxia at birth leads to respiratory instability and/
or suppression, which compromises lung aeration and causes the larynx to open only 
during a breath.(9) This in turn leads to persisting hypoxia and the onset of a vicious 
cycle that opposes successful transition and necessitates escalated interventions that 
increase the risk on adverse outcomes. This scenario is consistent with the findings of 
Oei et al.(25), who showed that initiating resuscitation with a lower O2 concentration 
(< 30%) resulted in a higher risk of maintaining a SpO2 < 80% at 5 minutes after birth. 
This in turn was associated with an increased risk of intraventricular hemorrhage, 
neurodevelopmental impairment or death.(25, 31) 
We found that FRC was similar in all groups, indicating that the degree of lung aeration 
is not necessarily linked to the level of breathing activity in preterm newborns as we 
hypothesized. However, this study is limited by the difference in time after birth at 
which imaging commenced, which in turn is used to measure FRC. As the kittens are 
very fragile, providing them with medication, an oesophageal tube, a face mask and 
attaching them to the ventilator is a delicate process, which can vary the delay between 
birth and imaging onset. However, while this delay is not well defined in our study, 
human preterm infants likely experience similar variations in the delay between birth 
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and resuscitation onset. Indeed, the start of resuscitation depends on infant vitality and 
the moment of cord clamping. Nevertheless, we predicted that increased breathing 
activity would be associated with higher FRC levels, but the two were clearly unrelated in 
this study. We have previously demonstrated that the pressure gradients generated by 
inspiration are responsible for a large proportion (>95%) of lung aeration (airway liquid 
clearance) in near term rabbit kittens. As a result, an FRC of ~15 mL/kg can rapidly (3 
- 5 breaths) accumulate in the absence of any end-expiratory pressure. However, the 
inability of some preterm kittens to accumulate an appropriate FRC, despite ongoing 
spontaneous breathing, indicates that in preterm neonates, spontaneous breathing by 
itself is insufficient to facilitate lung aeration. Other interventions to improve aeration 
could possibly comprise higher pressure levels of non-invasive respiratory support, 
although this has not yet been confirmed.    
An observational study investigating SpO2 and heart rate changes at birth demonstrated 
that, using current guidelines, infants ≥ 25 weeks of gestation had values similar to 
the reference ranges reported by Dawson et al.(24, 32) On the other hand, using 
current resuscitation guidelines, infants < 25 weeks of gestation had lower SpO2 values 
and a higher incidence of bradycardia, despite all efforts to improve their clinical 
situation.(32) However, an oxygen titration protocol was used that commenced with 
a O2 concentration of 30% and incorporated O2 increments of 10 – 20% every 30 - 60 
seconds. This incremental increase in oxygenation was likely insufficient to overcome 
the limitation associated with a reduced surface area for gas exchange, leading to 
progressive hypoxia and a suppression of breathing. In addition, it has been recently 
shown that, when using a T-piece ventilator, there is a delay apparent between the 
moment of titration of oxygen at the oxygen blender and the moment at which the infant 
receives the oxygen at the distal part of the circuit.(33) It is still not clear which titrating 
protocol results in optimizing oxygenation directly at birth. However, the current study 
suggests that initiating resuscitation with a higher O2 concentration might lead to better 
oxygenation, thereby reducing the hypoxia-inhibiting effect on breathing which might 
result in better aeration. 
This study is also limited by our inability to accurately measure the level of oxygenation 
in our preterm kittens. While we administered 21% O2 or 100% O2, we do not know 
what PaO2 and oxygen saturation levels were achieved and, therefore, to what extent 
oxygenation of the kittens influenced the results. It is clear that hyperoxia is detrimental 
for preterm infants as it increases free radical production and can overwhelm their 
immature antioxidant capacity, causing organ damage.(34-36) On the other hand, 
we have now shown that using too little oxygen leads to breathing instability, a lower 
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breathing rate and a high risk of apnea that will necessitate a rapid escalation in the level 
and type of intervention. Thus, while the administration of 100% O2 has been actively 
discouraged for the last few years (since 2010), it is time to question whether this is 
appropriate. Indeed, with appropriate monitoring the risk of hyperoxia can be minimized 
by titrating the O2 concentration to keep SpO2 values within defined ranges, bearing 
in mind that the required O2 concentration depends upon the gas exchange surface 
area. However, the optimal oxygen saturation range that we should aim for is not clear 
in those extreme preterm infants, as the internationally recommended target ranges are 
based on healthy term and preterm infants not requiring any resuscitation.(24) Trials are 
underway to test the effect of initiating resuscitation with O2 concentrations of 100% on 
breathing effort, while avoiding both hypoxia and hyperoxia, as well as determining the 
optimal oxygen saturation target range for extreme preterm infants.
CONCLUSION
Administration of 100% O2 to preterm rabbit kittens at birth increased both the stability 
of breathing and respiratory rate when given immediately after birth or as a rescue 
treatment following apnea. The results of this study provide evidence that initiating 
resuscitation with a high O2 concentration might result in an increase of respiratory 
effort thereby positively influencing respiratory transition at birth. However, further 
studies in human preterm infants are mandatory to confirm the effect of 100% O2 on 
respiratory effort and oxygenation. In addition, it needs to be demonstrated to what 
extent hyperoxia can be avoided after initiation of resuscitation with 100% oxygen, 
using a titration protocol based on oxygen saturation.
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To determine the time between adjustment of fraction of inspired oxygen (FiO2) at the 
oxygen blender and the desired FiO2 reaching the preterm infant during respiratory 
support at birth.
METHODS
This observational study was performed using a NeopuffTM T-piece Resuscitator 
attached to either a test lung (during initial bench tests) or a face mask during the 
stabilization of infants at birth. FiO2 was titrated following resuscitation guidelines. The 
duration for the desired FiO2 to reach either the test lung or face mask was recorded, 
both with and without leakage. A respiratory function monitor was used to record FiO2 
and amount of leak.
RESULTS
In bench tests, the median (IQR) time taken to achieve a desired FiO2 was 34.2 (21.8 
– 69.1) s. This duration was positively associated with the desired FiO2 difference, 
the direction of titration (upwards) and the occurrence of no leak (R2 0.863, F 65.016, 
p<0.001). During stabilization of infants (median (IQR) gestational age 29+0 (28+2 – 
30+0) weeks, birthweight 1290 (1240 – 1488) grams), the duration (19.0 (0.0 – 57.0) s) 
required to reach a desired FiO2 was less, but still evident. In 27/55 (49%) titrations, the 
desired FiO2 was not achieved before the FiO2 levels were again changed.  
CONCLUSION
There is a clear delay before a desired FiO2 is achieved at the distal end of the T-piece 
resuscitator. This delay is clinically relevant as this delay could easily lead to over- and 
under titration of oxygen, which might result in an increased risk for both hypoxia and 
hyperoxia. 




The transition to life after birth is hampered in preterm infants due to the immature 
respiratory system expressed by poor compliance of the lungs, weakness of the 
respiratory muscles and an immature respiratory center with a weak respiratory drive.
(1) Most preterm infants need respiratory support after birth to aerate their lungs and 
gain adequate oxygenation.(2) A T-piece ventilator that administers continuous positive 
airway pressure (CPAP) or positive pressure ventilation (PPV) via face mask is currently 
the method of first choice in order to minimize lung injury.(2-4) Additional oxygen is 
often used to reach and maintain adequate oxygenation.(5)
During stabilization after birth, additional oxygen needs to be titrated based on 
recommended oxygen saturations (SpO2) to decrease the risk of hypoxia and hyperoxia.
(3, 6) Hypoxia may lead to delayed cellular damage, as during hypoxia the production 
of free radicals will be provoked by an elevated level of hypoxanthine.(7, 8) On the 
other hand, free radical production (associated with both oxidative and nitrosative 
stress) also increases during hyperoxia, which can overwhelm the relatively immature 
antioxidant capacity of the preterm infant.(9-12) The excess of free radicals in turn may 
cause wide-spread damage to cells, enzymes, lipids, DNA and proteins.(9-12)
A time-dependent oxygen saturation range is targeted during stabilization, that is 
based on previously described international normograms.(6) To achieve oxygen 
saturations in this range, neonatal resuscitation guidelines recommend commencing 
resuscitation with a fraction of inspired oxygen (FiO2) of 0.21 - 0.3.(3) The desired 
oxygen concentration is achieved by mixing oxygen and room air using an oxygen 
blender, from which the gas mixture is administered to the neonate via the T-piece 
ventilator. During stabilization after birth, infants are evaluated every 30 s, which guides 
the amount of support and titration of additional oxygen.(3) The study of Goos et al.(5) 
showed that the FiO2 needed during stabilization at birth is highly variable between 
infants, with a reported range of 0.21 – 0.99, with 7 (3 – 10) adjustments of FiO2. 
While the adjustment of FiO2 is performed at the oxygen blender, this is located upstream 
of the T-piece resuscitation device and simply alters the concentration of oxygen 
entering the device. However, it is unknown how long it takes for the gas mixture with 
the desired oxygen concentration to reach the infant at the distal part of the circuit. As 
such, further titration could take place before the original desired FiO2 of gas entering 




The aim of this study was therefore to determine the time between adjustment of FiO2 at 
the oxygen blender and the desired FiO2 reaching the preterm infant during respiratory 
support at birth.
METHODS
An observational study was conducted at the Neonatal Intensive Care Unit of the Leiden 
University Medical Center. The study consisted of two parts: a bench test and clinical 
observations of neonatal stabilization at birth. 
The resuscitation of preterm infants at birth was replicated during a bench test, using 
a NeopuffTM T-piece Resuscitator (Fisher & Paykel Healthcare, Auckland, New Zealand) 
attached to a 50 mL test lung (Dräger, Lübeck, Germany). The circuit was set up with 
a flow of 8 L/minute, positive end expiratory pressure (PEEP) of 8 cm H2O, and a peak 
inspiratory pressure (PIP) of 20 cm H2O. FiO2 was measured at two distinct positions at 
the circuit, using oxygen analyzers (Teledyne, Analytical Instruments, USA): proximally 
- at the outlet of the NeopuffTM, and distally – between the T-piece of the NeopuffTM and 
the test lung (Figure 1). In the clinical part of the study, the same circuit was connected 
to a face mask (Fisher & Paykel Healthcare, Auckland, New Zealand) instead, which 
was placed over the mouth and nose of a preterm infant.
During the bench test, FiO2 was increased from 0.3 to 0.5 to 1.0, and decreased to 
0.8, 0.5, 0.3 and 0.21. The time needed to reach the desired FiO2 at the test lung was 
recorded, whereby a margin of 0.05 difference between FiO2 at the proximal and distal 
part of the circuit was accepted. Mask ventilation without any leakage is difficult to 
accomplish in clinical practice and leak percentages of 50% are not uncommon.(13) 
As the amount of flow passing the NeopuffTM circuit and reaching the test lung might 
be influenced by the amount of leak of the circuit, we performed the bench test both 
with a leakage of 50% and without any leakage. Leak was created by using a small 
tube through which some of oxygen/air mixture could flow away. This tube was placed 
between the NeopuffTM circuit and the test lung. The amount of leakage was ascertained 
by using a Respiratory Function Monitor (RFM). Both tests (with and without leak) were 
performed 6 times.
During stabilization of infants, local resuscitation guidelines were followed for increasing 
FiO2, using the same increments as those used during the bench test: FiO2 was started 
at 0.3, and increased to 0.5 and 1.0 if SpO2 remained below international normograms.
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(6) In addition, FiO2 was decreased whenever SpO2 exceeded 90% to 0.8, 0.5, 0.3 
and 0.21. Again, we analyzed the time delay between titration of FiO2 at the proximal 
part of the circuit and the desired FiO2 being achieved at the distal part, accepting a 
difference of 0.05 between those measurements. The amount of leakage was taken into 
consideration when analyzing the results.
Figure 1  |  Set-up bench test
In both parts of the study, a RFM was used for recording FiO2 at both positions within 
the circuit, as well as clinically relevant physiological parameters such as oxygen 
saturation and respiratory function. The RFM uses a small (dead space 1 mL) variable 
orifice flow sensor (Avea Varflex Flow Transducer, Carefusion, Yorba Linda, CA, USA) 
to measure gas flow in and out of a face mask, thereby calculating inflation pressures, 
flow and tidal volumes. The difference between inspired and expired tidal volume 
estimates leak from the face mask, which was also recorded. Oxygen saturations and 
heart rates were measured with a Masimo SET pulse oximeter (Masimo SET, Masimo 
Corporation, Irvine, California, USA). A pulse oximetry probe was placed around the 
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ulnar aspect of the infant’s right wrist. All signals measured were recorded at 200 
Hz using the NewLifeBox-R physiological recording system with Polybench software 
(Applied Biosignals, Weener, Germany). Oxygen analyzers were calibrated at the start 
of every test and clinical observation.
Data of both parts of the study was analyzed using Microsoft Excel (Microsoft Corporation, 
Washington, United States). During stabilization of infants, FiO2, SpO2 and respiratory 
function were recorded at 0.5 second intervals. Significant leak was accepted as being 
> 50% face mask leak. In the event that titration proceeded before the desired FiO2 
from the previous titration (set at the proximal part of the NeopuffTM circuit) had reached 
the infant (at the distal part of the circuit), the time between titrations was recorded as 
duration of achieving the desired FiO2. 
Statistical analysis was performed with SPSS version 23.0 (IBM software, NY, USA, 
2015). Data is presented as mean ± SD of parametric outcome parameters, non-
parametric outcome parameters are presented as median (IQR). Assessment of the 
relationship between duration of achievement of desired FiO2, with the difference in 
FiO2 that was aimed for during titration and the occurrence of leak, was determined 
using multiple regression. P-values <0.05 were considered statistically significant. 
Reported p-values are two-sided.
This was an observational study and as such under the Dutch law on Medical Research 
in Humans, no specific consent from an ethics committee was required. Nevertheless, 
the Research Ethics Committee of the Leiden University Medical Center issued a 
statement of no objection.
RESULTS
Bench test
When adjusting the FiO2, the oxygen analyzer at the proximal part of the circuit reached 
the desired oxygen concentration within 3 ± 1 seconds, independent of the amount of 
leakage in the circuit. There was a delay in time to achieve desired FiO2 at the distal part 
of the circuit (median (IQR) duration 34.2 (21.8 – 69.1) s). 
Without mask leak, the median (IQR) duration of the FiO2 to reach the desired 
concentration at the distal part of the NeopuffTM circuit during up-titration was 58.2 
(35.7 - 86.1) s. The largest delay in reaching the desired concentration during up-
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titration was found in the titration from FiO2 of 0.5 to 1.0 (Table 1). The median (IQR) 
duration of the FiO2 to reach the desired concentration at the distal part of the circuit 
during down-titration was 70.7 (39.9 – 88.8) s. The largest delay in reaching the desired 
concentration during down-titration was found in the titration from FiO2 0.8 to 0.5 (Table 
1).
With a leak of 50%, up-titration took a median (IQR) duration of 20.0 (17.8 – 28.6) s, with 
again the largest delay in titration of FiO2 from 0.5 to 1.0 (Table 1). Down-titration with 
50% mask leakage resulted in a median (IQR) duration of 22.1 (20.9 – 28.7) s for the 
FiO2 to reach the desired concentration at the distal part of the circuit. The largest delay 
was found during down-titration of FiO2 from 0.8 to 0.5 (Table 1).
Table 1  |  Duration to achieve desired FiO2 in bench test
Change in FiO2 Duration (s) 0% leak
n = 6
Duration (s) 50% leak
n = 21
Up titration
FiO2 0.3-0.5 40.9 ± 10.8 17.9 ± 0.2
FiO2 0.5-1.0 80.8 ± 17.0 26.6 ± 4.2
Down titration
FiO2 1.0-0.8 65.0 ± 19.6 21.1 ± 0.4
FiO2 0.8-0.5 100.6 ± 10.6 34.6 ± 6.0
FiO2 0.5-0.3 69.3 ± 2.4 24.5 ± 3.9
FiO2 0.3-0.21 32.6 ± 8.2 19.7 ± 2.4
Data are presented as mean ± SD
There was a positive association between the duration to achieve the desired FiO2 at 
the distal part of the NeopuffTM circuit and the desired FiO2 difference (longer duration 
when aiming for a larger FiO2 difference), the direction of titration (up instead of down) 
and the occurrence of no leak (R2 0.863, F 65.016, p<0.001, Table 2).
Table 2  |  Multiple linear regression analysis for the association between duration to achieve 
desired FiO2 and direction of titration, occurrence of leak and desired FiO2 difference
Variables Regression coefficient β (95% CI) Standardized β t P-value
Occurrence of leaka -38.317 (-44.973 – 31.662) -0.782 -11.743 < 0.001
Direction of titrationb -23.973 (-32.540 – 15.405) -0.464 -5.707 < 0.001
Desired FiO2 difference 1.220 (0.900 – 1.539) 0.634 7.789 < 0.001




Data was recorded from the stabilization of eight preterm infants. Included infants had 
a median (IQR) gestational age of 29+0 (28+2 – 30+0) weeks and birth weight of 1290 
(1240 – 1488) grams. All except one infant needed PPV during resuscitation. A total of 
55 FiO2 titrations occurred in these infants, with a median (IQR) of 7 (5 – 9) per infant. 
The median (IQR) desired FiO2 difference was 0.16 (0.09 – 0.21). Median (IQR) time 
between titration episodes was 52.5 (27.0 – 103.0) s. In 17/55 (31%) titration episodes, 
the time until the next titration was less than 30 s.
Overall, there was a variable delay in time to achieve desired FiO2 at the distal part 
of the circuit (median (IQR) duration 19.0 (0.0 – 57.0) s). FiO2 at the distal part of the 
NeopuffTM circuit changed during titration with a median (IQR) speed of 0.75% (0.42 – 
1.28) per s.
There were only four titration episodes in which the average amount of leak was > 50%. 
We observed a difference in median (IQR) speed with which FiO2 at the distal part of 
the NeopuffTM changed: 0.7(0.42 – 1.09) % per s with an average mask leak of 0 – 49 %, 
compared to 2.47 (0.26 – 3.57) % per s with an average mask leak of > 50 %.
The desired FiO2 was never reached before the titration of FiO2 proceeded in 27/55 
(49%) of titrations. This was not influenced by the occurrence of mask leakage (no leak: 
24/48 (50%) vs leak: 3/7 (43%), p=1.000).
DISCUSSION
This study shows a clear delay in obtaining the desired oxygen concentration at the 
distal part of the NeopuffTM circuit in both the bench test and during stabilization of 
preterm infants at birth. As the international resuscitation guideline prescribes evaluation 
periods of 30 s, the clinical evaluation of the infant and physiological parameters might 
precede the effect of the performed intervention (e.g. titration of oxygen).(3) This is 
demonstrated by the finding that in half of all titration episodes, the desired FiO2 was 
not yet reached at the distal part of the NeopuffTM circuit. In addition, the time between 
two titration episodes was less than 30 s in 31 % of titrations performed in this study. 
Our results confirm the findings of the study of Follett et al.(14) who observed that the 
achievement of desired oxygen concentration at a test lung was delayed. However, the 
titration of oxygen in their study was slightly different than our study, and it is not clear 
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what the time intervals between titration steps were. Follett et al.(14) also used different 
ventilators and different lengths of ventilation circuits, while we used the equipment that 
we use in the clinical setting. However, while both the current trial and the trial of Follett 
et al.(14) demonstrated that there appears to be a delay in achievement of desired FiO2, 
the exact duration of delay might be dependent on multiple variables, including type of 
ventilator and length of ventilation circuits. In addition, the rate with which the desired 
FiO2 is reached in the infant might also be dependent of the volume containing the 
FiO2 that needs to be replaced, which is influenced by the pressure administered (PIP 
and PEEP), respiratory rate and type of respiratory support (CPAP vs PPV vs sustained 
inflation).
We observed a higher duration to obtain the desired FiO2 in the bench test, compared 
to the clinical stabilization procedures. As the desired FiO2 was not reached in 49 % 
of all titrations, the duration to obtain the desired FiO2 was based on the time between 
titrations and represents an underestimation of the actual duration. Therefore, the delay 
in obtaining the desired FiO2 may be closer to the values seen in the bench test. 
In addition, the lower duration to reach the desired FiO2 during stabilization of preterm 
infants could also be due to the occurrence of leak, as the duration increases when there 
is no leak. In this study, only 4/55 titration episodes occurred during ventilation with an 
average of > 50 % leak. One should aim for a minimum level of leakage between the 
face mask and the face of the infant to achieve adequate ventilation, which, in clinical 
practice is shown to be difficult to accomplish with a high variability in percentage of 
leak.(13) These findings indicate that, when ventilating adequately (thus without mask 
leakage), following an adjustment in FiO2 there could be a delay in obtaining the desired 
oxygen concentration at the infant. Furthermore, it is likely that this delay will reduce 
as the amount of leak increases. However, when mask leakage is variable, it is unclear 
when the desired oxygen concentration will be reached, possibly leading to over- and 
under-titration and an increased risk of hypoxia and hyperoxia. 
The explanation of the delay in obtaining the desired oxygen concentration is still not 
clear. We have contacted the manufacturer of the NeopuffTM Infant Resuscitator (Fisher 
& Paykel Healthcare Auckland, New Zealand), and they acknowledge the results of 
the study, but the explanation for this delay still remains unclear. They recommend 
that clinicians should be aware of this when titrating oxygen to achieve target oxygen 
saturations and allow time for the system to equilibrate. We speculate that the delay 
might be influenced by not having a continuous flow through the circuit, particularly 
during inflations. Most T-piece resuscitators like the NeopuffTM have the PIP valve 
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located inside the box at the proximal end of the circuit and a PEEP valve located at the 
distal, infant end of the circuit. During an inflation, the PEEP valve is closed (by placing 
a finger on it) and the circuit, which includes the infants lungs, is pressurized by the flow 
of gas from the NeopuffTM down the circuit and into the infant. In the absence of leak, 
once the set PIP pressure is reached, the PIP valve opens and so gas stops flowing 
down the circuit and instead begins to flow out of the PIP valve, located upstream of the 
circuit, in the box. As such, during inflations, when the PIP pressure is reached, very 
little gas will flow down the circuit to the infant, thereby greatly increasing the time for 
the desired FiO2 to reach the infant. In case of leak, gas will continue to flow down the 
circuit, particularly if the set PIP is not reached, thereby reducing the duration to reach 
the desired FiO2. During lung deflation, lifting the finger from the PEEP valve allows 
expired gas from the infant to flow out through the PEEP-valve. In addition, the decrease 
in pressure allows the PIP valve to close which redirects gas flow down the circuit and 
out through the PEEP valve. Thus, at end-expiration all gas flowing into the NeopuffTM 
flows down the ventilation circuit and out the PEEP valve, allowing the set air-oxygen 
mixture to rapidly reach the distal (infant end) of the circuit.
However, if correct, the variability in time for the desired FiO2 to reach the infant end of 
the circuit may be explained by the degree of leak and the relative amount of time spent 
at either PIP or PEEP. 
CONCLUSION
In summary, there is a clear delay in set up of FiO2 at the proximal part of the T-piece 
ventilator and achievement of desired FiO2 at the distal part. This delay is clinically 
relevant when aiming for adequate mask ventilation, whereby over- and under titration 
of oxygen might result in an increased risk of hypoxia and hyperoxia. 
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CHAPTER 5
High versus low initial oxygen to improve the 
breathing effort of preterm infants at birth: 














Although most preterm infants breathe at birth, their respiratory drive is weak and 
supplemental oxygen is often needed to overcome hypoxia. This could in turn lead to 
hyperoxia. To reduce the risk of hyperoxia, currently an initial low fraction of inspired 
oxygen (FiO2) (0.21 – 0.3) is recommended during stabilization at birth, accepting the 
risk of a hypoxic period. However, hypoxia inhibits respiratory drive in preterm infants. 
Starting with a higher level of oxygen could lead to a shorter duration of hypoxia by 
stimulating breathing effort of preterm infants, and combined with subsequent titration 
based on oxygen saturation (SpO2), prolonged hyperoxia might be prevented.
METHODS
This multi-center randomized controlled trial will include 50 infants with a gestational 
age between 24 - 30 weeks. Eligible infants will be randomized to stabilization with an 
initial FiO2 of either 1.0 or 0.3 at birth. Hereafter, FiO2 will be titrated based on the oxygen 
saturation target range. In both groups, all other interventions during stabilization and 
thereafter will be similar. The primary outcome is respiratory effort in the first 5 minutes 
after birth expressed as average minute volume/kg. Secondary outcomes include 
inspired tidal volumes/kg, rate of rise to maximum tidal volume/kg, percentage of 
recruitment breaths with tidal volumes > 8mL/kg, duration of hypoxia and hyperoxia 
and plasma levels of markers of oxidative stress (8-iso-prostaglandin F2α). 
DISCUSSION
Current resuscitation guidelines recommend oxygen titration if infants fail to achieve the 
25th centile of the SpO2 reference ranges. It has become clear that, using this approach, 
most preterm infants are at risk for hypoxia in the first 5 minutes after birth, which could 
suppress the breathing effort. In addition, for compromised preterm infants who need 
respiratory support at birth, higher SpO2 reference ranges in the first minutes after 
birth might be needed to prevent prolonged hypoxia. Enhancing breathing effort by 
achieving an adequate level of oxygenation could potentially lead to a lower incidence 
of intubation and mechanical ventilation in the delivery room, contributing to a lower 
risk on lung injury in high-risk preterm infants. Measuring 8-iso-prostaglandin F2α could 
lead to a reflection of the true amount of oxygen exposure in both study groups.




Although most preterm infants breathe at birth, their respiratory drive is weak and often 
insufficient to aerate their lungs and establish gas exchange.(1-3) Historically, these 
infants were intubated and mechanically ventilated, which is associated with a higher 
risk of lung and brain injury.(4) To minimize injury, this approach is now avoided and 
the focus of respiratory care has shifted to support the mechanics of breathing by 
providing a continuous positive airway pressure (CPAP) by face mask.(5, 6) Despite 
this approach, there is still a high failure rate of CPAP in preterm infants in case of a 
weak respiratory drive, associated with higher mortality and major morbidities.(7) It has 
become clear that the best way to facilitate air entry into the lungs using non-invasive 
respiratory support is to stimulate spontaneous breathing(8, 9), which is also likely to be 
the most gentle and effective way of providing respiratory care without causing injury. 
Therefore, the focus of respiratory care should include both support of the mechanics of 
breathing and stimulation of spontaneous breathing. Currently, international guidelines 
recommend tactile stimulation and some local guidelines additionally advocate the use 
of caffeine in the delivery room to stimulate breathing in addition to the use of non-
invasive ventilation.(5, 10, 11)
Even with these techniques to support and stimulate spontaneous breathing, achieving 
adequate oxygenation with a low initial FiO2 during stabilization has been shown to 
be difficult.(12, 13) Most preterm infants born with a gestational age < 32 weeks are 
therefore at risk for hypoxia.(14) This, in turn leads to inhibition of respiratory drive 
because the inhibitory effect of hypoxia on fetal breathing movements persists well 
into newborn life.(2) Increasing the FiO2 can reduce the level of hypoxia leading 
to an increase of respiratory effort in preterm infants. This was demonstrated in an 
observational study where an increase in respiratory drive was observed after switching 
FiO2 from 0.21 to 1.0 at some point during stabilization at birth.(15) 
The optimal initial oxygen concentration for stabilizing infants after birth is still a 
subject of debate, as both hypoxia and hyperoxia can cause damage to multiple organ 
systems.(16, 17) Hypoxia may lead to delayed cellular damage(18), as during hypoxia 
the production of free radicals will be provoked, by an elevated level of hypoxanthine.
(19) On the other hand, high oxygen levels increase the biosynthesis of prostaglandins 
which are an additional mechanism inhibiting chemoreceptors in the respiratory center.
(20) In addition, free radical production (associated with both oxidative and nitrosative 
stress) increases during hyperoxia, which can overwhelm the relatively immature 
antioxidant capacity of the preterm infant. The resulting excess of free radicals cause 
wide-spread damage to cells, enzymes, lipids, DNA and proteins.(21-24) 
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The recent meta-analysis of Oei et al.(18) showed a higher mortality rate in the group 
of preterm infants (< 32 weeks of gestation) resuscitated with an initial FiO2 of 0.21 
compared to the group resuscitated with an initial FiO2 of 1.0. Furthermore, when 
stabilization of preterm infants after birth was started with low oxygen concentrations 
(FiO2 0.21-0.3), SpO2 and heart rates increased more slowly than the SpO2 references 
outlined in the international guidelines, despite the use of respiratory support. This 
indicates that when starting respiratory support with lower oxygen concentrations 
preterm infants are at a higher risk for hypoxia.(25) Indeed, this was shown in the study 
of Goos et al.(12) and White et al.(13).
Regardless of the initial FiO2 level, in all studies most infants ended up with a FiO2 
between 0.4 and 0.6 after 5 minutes to reach SpO2 target ranges. Currently, to prevent 
hyperoxia and achieve normoxia in newborns, international guidelines recommend to 
start stabilization after birth in preterm infants with low FiO2 (0.21 - 0.3)(26), after which 
FiO2 should be titrated based on SpO2 target ranges.(16, 17, 27) In this recommendation, 
a period of low oxygen saturation is accepted and the effect of hypoxia on respiratory 
effort seems to be disregarded.(28) 
We hypothesize that with an initial FiO2 of 1.0, infants will reach SpO2 target ranges 
more rapidly, leading to less hypoxia and an increase in respiratory effort. With careful 
titration of FiO2 based on SpO2 target ranges, we hypothesize that the occurrence of 
hyperoxia will be minimized.
The aim of this current study is to determine the effect of an initial FiO2 of 1.0 compared 
to standard management of an initial FiO2 of 0.3 on breathing effort of preterm infants 
immediately after birth. 
STUDY DESIGN AND POPULATION
Study design
The design of this multi-center study is a randomized clinical trial. Eligible infants 
between 24+0 - 29+6 weeks of gestation will be randomized to either start stabilization 
with an initial FiO2 of 1.0 or 0.3. 
Study population
The study will take place at the neonatal intensive care unit (NICU) of the Leiden 
University Medical Center (LUMC) and the NICU of the Amsterdam UMC (AUMC), both 
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located in the Netherlands. Infants with a gestational age between 24+0 - 29+6 weeks, 
born at the LUMC and the AUMC will be eligible for inclusion. Infants with a congenital 
abnormality or condition that might have an adverse effect on breathing or ventilation 
will be excluded, such as congenital diaphragmatic hernia, trachea-oesophageal 
fistula or cyanotic heart disease. 
Primary outcome
The primary outcome is respiratory effort, expressed as average minute volume 
normalized for body weight in the first 5 minutes after birth.
Secondary outcomes
Secondary outcomes include:
• Average tidal volumes in the first 5 minutes after birth
• Average rate of rise to maximum tidal volumes in the first 5 minutes after birth 
• Percentage of recruitment breaths with tidal volumes above 8 mL/kg in the first 5 
minutes after birth
• Duration of hypoxia (defined as oxygen saturation < 25th percentile of the target 
ranges defined by Dawson et al.(27)) in the first 10 minutes after birth
• Duration of hyperoxia (defined as oxygen saturation > 95%) in the first 10 minutes 
after birth
• Changes in diaphragmatic activity in the first 5 minutes after birth
• Incidence of intubation in the delivery room
• Concentration of 8-iso-prostaglandin F2α(29), an oxidative stress metabolite 
associated with hyperoxia in blood. 
Volumes measured will be normalized for body weight. In addition, the interaction 
between those primary and secondary outcomes and the time after birth will be 
assessed.
Other outcomes
Other outcomes that will be collected include:
• Percentage of time of face mask ventilation applied during stabilization at birth
• Average oxygen saturation and heart rate in the first 5 minutes after birth
• Oxygen saturation and heart rate per minute in the first 5 minutes after birth
• Percentage of spontaneous breaths with tidal volumes above 4 mL/kg




• Percentage of time that oxygen saturation is within 90-95% range between 5 and 10 
minutes after birth
• Percentage of time that oxygen saturation is within target ranges defined by Dawson 
et al.(27) in the first 10 minutes after birth
In addition, we will collect basic characteristics such as gestational age, birth 
weight, mode of delivery, incidence of complications in pregnancy, use of antenatal 
corticosteroids, maternal medication use, and Apgar score 1 and 5 minutes after birth.
This study is not designed to demonstrate any differences in clinical short- and long-
term outcomes. However, we will record study parameters focussing on short-term 
clinical outcomes, such as incidence of intubation in the delivery room and in the first 
24 hours after birth, pneumothorax, intraventricular hemorrhages grade 3 or more and 
neonatal death.
Sample size calculation
There is no data available on measurements of respiratory effort in the first 5 minutes 
after birth during stabilization with a FiO2 of 1.0 compared to 0.3. In a recent study, 
the average minute volume of preterm infants over the first 100 breaths was 150 ± 70 
mL/kg/min.(30) In a retrospective observational study, we observed an 80% relative 
increase in respiratory drive when FiO2 was switched from 0.21 to 1.0, in the first minute 
after FiO2 was increased (from 134 mL/kg/min to 240 mL/kg/min). Other parameters of 
respiratory effort increased as well: average expired tidal volumes (Vt) increased by 
37% (from 4.9 mL/kg to 6.7 mL/kg), and rate of rise to maximum tidal volumes increased 
by 32% (13.8 mL/kg/s to 18.2 mL/kg/s).(15) 
However, since we investigate a FiO2 of 0.3 instead of 0.21 in the lower oxygen arm, we 
expect half of the effect (40% relative increase) in respiratory drive than demonstrated in 
the study of van Vonderen et al.(15). Therefore, to detect an increase in average minute 
volume in the first 5 minutes after birth from 150 to 210 mL/kg/min, using a standard 
deviation of 70 mL/kg/min, with a power of 80% and an α error of 5% (two tailed test), 
22 infants are required for each arm. Given the fact that parents may withdraw their 
consent or decline deferred consent after the infant is included in the study, or that the 
recording of physiological measurements fails in 10% of all infants, a total of 50 infants 
will be recruited (25 in each arm).





Allocation will be stratified by gestational age. Infants of 24+0 - 26+6 weeks and 27+0 - 
29+6 weeks will be included using variable block (4-6) sizes. Concealment of allocation 
will be ensured by using the randomization process of Castor EDC (Amsterdam, The 
Netherlands), an electronic data capture system. The neonatal fellow or neonatal 
consultant in charge of the procedure will randomize using Castor EDC.
Study procedures
Infants will be randomized to start stabilization after birth with an initial FiO2 of either 1.0 
or 0.3, after which FiO2 will be titrated following target SpO2 recommended in our local 
guidelines on stabilization after birth, which are based on the target ranges described 
by Dawson et al.(27) In both groups, all other procedures in the delivery room and NICU 
will be performed according to the local and international guidelines, only the initial FiO2 
setting will be different. Cord clamping will be performed after 30 seconds in case of an 
apneic infant, and after 60 seconds if the infant is breathing at birth.
After the initial FiO2 setting, titration will be performed according to the local protocol: 
• When SpO2 is below target ranges defined by Dawson et al.(27), FiO2 will be titrated 
up to 0.5 and subsequently to 1.0, when the initial FiO2 setting was 0.3. In case of 
an initial FiO2 setting of 1.0, FiO2 will be maintained at 1.0.
• When SpO2 is above target ranges, FiO2 will be titrated down to 0.5 and subsequently 
to 0.3 and 0.21. If SpO2 is above target ranges when stabilization is initiated with 
FiO2 0.3, FiO2 will be titrated down to 0.21 directly.
Measurements
Measurement of respiratory function
In both groups, standard care will be provided in the delivery room and NICU and local 
guidelines on stabilization after birth will be followed, using a NeopuffTM infant T-piece 
resuscitator (Fisher & Paykel Healthcare, Auckland, New Zealand) or a Giraffe Star 
System (Anandic Medical Systems, Feuerthalen, Switzerland). Respiratory function 
monitoring at birth will be recorded during stabilization in the first 10 minutes of life, 
which is standard practice in our units. The respiratory function monitor will be used 
to measure inflation pressures, flow and tidal volumes. This can be used to measure 
average minute volume, average rate of rise to maximum tidal volumes, and the total 
time of ventilation given. It uses a small variable resistance anemometer to measure 
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gas flow in and out of a face mask or endotracheal tube. This signal is automatically 
integrated to provide inspired and expired tidal volumes. The difference equals the leak 
from the face mask or endotracheal tube.
Breathing effort will also be measured by activity of the diaphragm using 
electromyography (EMG) with the Dipha-16 (Demcon, Groningen, The Netherlands). 
The Dipha-16 is used to record spontaneous breathing (EMG of diaphragm) and heart 
rate (ECG). Both parameters are used for audit of stabilization, which is standard care 
in the NICU of the LUMC. Three EMG electrodes connected to the Dipha amplifier 
(similar to ECG electrodes) will be placed. Two are placed bilateral at costo-abdominal 
margin in the nipple line, and the common electrode will be placed on one of the legs.
 
To record SpO2 and heart rate, a Masimo SET pulse oximeter probe (Masimo Radical, 
Masimo Corporation, Irvine, California, USA) or NellcorTM pulse oximeter probe (Covidien, 
Dublin, Ireland) is placed around the right wrist or hand of the infant. The FiO2 is 
measured using a portable oxygen analyzer AX300-I (Teledyne Analytical Instruments, 
CA, USA), and the airway pressures are registered by a variable orifice flow sensor 
(Avea Varflex Flow Transducer, Carefusion, Yorba Linda, CA,USA) connected to the 
face mask measuring the flow in and out the infant. The signals are digitized at 200 Hz 
using the NewLifeBox-R physiological recording system (Advanced Life Diagnostics, 
Weener, Germany) and all signals are recorded by the NewLifeBox Neo-RSD computer 
system (Advanced Life Diagnostics, Weener, Germany) supported by Polybench 
physiological software (Applied Biosignals, Weener, Germany). Pulmochart software 
(Applied Biosignals, Weener, Germany) is used to analyze primary and secondary 
outcomes.
Measurement of metabolites of oxidative stress in blood
Chemical oxidation products of polyunsaturated fatty acids, formed by peroxidation 
initiated by free radicals, are shown to be the best biomarkers to assess oxidative 
stress in humans. Of oxidized fatty acids, the best indicator for oxidative stress is 8-iso-
prostaglandin F2α.(31) Cord blood 8-iso-prostaglandin F2α is a stable marker of lipid 
peroxidation at birth, and will therefore be analyzed as baseline value for oxidative 
stress obtained after birth.(32)
Measurement time points:
• Cord blood will be drawn directly after birth as a baseline value. 
• At approximately 1 hour after birth, a blood sample will be taken together with the 
sample normally taken for measuring standard analyses; this ensures that the infant 
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is not exposed to an extra venepuncture or capillary puncture. The total amount of 
inspired oxygen given from birth will be recorded from birth until the sample is taken. 
• At 24 hours after birth, again together with measurement of standard blood analyses.
For every sample, a total of 300 µL blood will be used to measure 8-iso-PGF2α. A 
preterm infant of 500 gram has ~40 mL of total blood volume, whereas an infant of 1000 
gram has ~80 mL. As only 2 samples will be taken from the preterm infants, only 600 µL 
of blood will be withdrawn, which accounts for 0.75-1.5% of total blood volume. 
PROCEDURES
Recruitment and consent
In addition to the initial FiO2 setting, standard care is provided in both groups. 
Respiratory data is collected as standard clinical care. As the starting FiO2 is randomly 
assigned, we will ask for parental consent. Antenatal consent will be obtained before 
birth if the mother is hospitalized in the LUMC or AUMC with imminent preterm labour 
before 30 weeks of gestation. Whenever antenatal consent is obtained, but the mother 
passes the term of 30 weeks of gestation, the infant will not be included in this study. 
In case the condition of the mother and/or fetus suddenly deteriorates, resulting in 
an emergency situation with immediate delivery, it may not be possible to ask for 
antenatal consent from either parent. Also, when the mother arrives in hospital in full 
labour and tocolysis is not an option, it may not be possible, or appropriate to ask 
for antenatal consent. Emergency situations after birth cannot always be predicted 
and the neonatologist may have to act upon the infant’s interest without being able 
to discuss the treatment plan with the parents, let alone ask for study consent. The 
worsening of the condition of these infants, who are often also not pre-treated with 
antenatal steroids, will increase the chances for respiratory insufficiency after birth and 
the need for respiratory support in the delivery room. Exclusion of this group of infants 
will therefore cause an important selection bias.
For the infants born in the following situations, retrospective consent will be used:
• In case of an emergency situation (e.g. the mother is in full labour or immediate 
delivery is necessary), when there is not enough time for antenatal consent.
• When obtaining antenatal consent is inappropriate (e.g. the condition of the 
mother does not allow for proper consideration of both parents on whether or not 
to participate in a trial). In this case there is enough time, though trying to obtain 
informed consent in this situation would be inappropriate.
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This study fulfils the criteria for a waiver of informed consent in Europe (Human Medicines 
Evaluation Unit 1995), Canada (Natural Sciences and Engineering Research Council 
of Canada 2006) and the United States (USA Food and Drug Administration 1999) 
and Australian NHMRC guidelines for studies in emergency medicine (National Health 
and Medical Research Council 2002). For these infants, retrospective consent will be 
sought from the parents to use data obtained. For this important study to be feasible, 
and enrol a representative sample, a waiver of informed consent is appropriate when 
consent cannot be obtained prior to delivery.
The parents will be informed as soon as possible after the study and asked to consent 
to data being collected on their infant. There are many precedents of randomized trials 
conducted with such a consent waiver in emergency situations in neonatal stabilization 
after birth and adult resuscitation.
While undertaking research studies without prior informed consent needs careful 
consideration, studies of emergency medical interventions, such as neonatal 
stabilization after birth, are exceptionally difficult if prior consent is required. Arguably, 
it is more unethical to use treatments that have not been studied than to evaluate them 
in a carefully controlled manner.(23, 33)
Withdrawal of individual subjects
Parents can withdraw their consent at any time for any reason if they wish to do so 
without any consequences. When parents want to withdraw their infant for any reason, 
this infant will be handled as drop-out. As we included an additional 10% of infants in 
the sample size calculation, this will not influence the power calculation.
(Serious) adverse events
Adverse events are defined as any undesirable experience occurring to a subject 
during the study, considered related to the initial FiO2 setting of 1.0. All adverse events 
observed by the investigator or the staff will be recorded and noted to the medical 
ethical committee of the LUMC.
This study population (preterm infants) has a high risk of serious complications, which 
are inherent to their vulnerable condition and unrelated to the intervention that is 
under evaluation in this trial. These complications (pneumothorax, bronchopulmonary 
dysplasia (BPD), retinopathy of prematurity (ROP), intraventricular hemorrhage (IVH) 
grade 3 or more, cystic periventricular leukomalacia (PVL), necrotizing enterocolitis 
(NEC) grade 2 or more, death) are not expected to be related to the intervention 
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(starting stabilization after birth with a FiO2 of 1.0 versus 0.3) as the intervention will 
be performed only at the start of stabilization, after which in both groups titration will 
be performed. In light of the above, immediate and individual reporting of all these 
conditions related complications will not enhance the safety of the study, and therefore 
these complications will be handled as adverse events.
Statistical analysis
Data will be presented as median (interquartile range (IQR)), mean ± standard deviation 
(SD) or number (percentage) where appropriate. Data will be checked for meeting the 
assumption of normality first by making a frequency distribution per minute. Outliers 
will be identified and handled according to the data (outliers will be deleted if there are 
arguments to do so, or transformed if not). Intention-to-treat will be employed. Statistical 
analysis will be performed with SPSS software version 23.0 (SPSS, Chicago, Illinois, 
2012).
Differences in average respiratory minute volume in the first 5 minutes after birth 
between the study groups will be tested with a Student’s t-test if the data are found to 
be parametric, or with Mann-Whitney U test when the data are non-parametric. 
The interaction of respiratory minute volume, tidal volumes, rate of rise to maximum 
tidal volumes and diaphragm activity in the first 5 minutes after birth with time will be 
analyzed with a linear mixed model, in which both study group (treatment) and time 
will be taken in consideration. Differences in average tidal volumes, average rate of 
rise to maximum tidal volumes, and percentage of recruitment breaths will be tested 
with a Student’s t-test if the data is found to be parametric, or with Mann-Whitney U test 
when the data is non-parametric. The concentration of 8-iso-prostaglandin F2α will be 
analyzed with a linear mixed model, in which both study group (initial FiO2 0.3 vs 1.0) 
and time will be taken in consideration.
Other study parameters and basic characteristics will only be explored to test for 
differences between the study groups. If there are found to be significant differences 
with clinical relevance for the primary outcome, this will be taken into account when 
analyzing the data by incorporating these differences in the linear mixed model.
Ethical considerations
The study will be conducted according to the principles of the Declaration of Helsinki 
and in accordance with the Medical Research Involving Human Subjects Act (WMO). 
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The study protocol is approved by the ethical committee of the LUMC and AUMC.
Dissemination of results
Results of the study will contribute to a manuscript, which will be submitted for 
publication to a peer-reviewed international medical journal, and will be presented at 
national and international conferences. 
DISCUSSION
Most preterm infants need additional oxygen during stabilization at birth to achieve 
appropriate SpO2 target ranges.(34) Results of a recent meta-analysis demonstrated 
that persisting hypoxia at 5 minutes after birth is associated with a higher risk of 
mortality and the development of an intraventricular hemorrhage, which we should try 
to avoid.(14) Although a recent systematic review showed no differences in percentage 
of infants achieving SpO2 target ranges between infants initiating stabilization with high 
or low FiO2, the level of evidence of these results is low.(35) It is therefore still unclear 
whether the initial FiO2 level influences breathing effort, thereby influencing the capacity 
of preterm infants to reach the target range. However, it has recently became clear that 
oxygenation can only be influenced in infants supported by non-invasive ventilation 
in case of presence of spontaneous breathing, as then the larynx opens and an open 
airway is achieved.(9) Before focussing on achievement of SpO2 target ranges, we 
should look at the effect of initiation stabilization with a high FiO2 on breathing effort. 
The current SpO2 target ranges used during stabilization at birth are based on the 
reference values described by Dawson et al.(27) While these target ranges have been 
based on data from healthy term and preterm infants, those values might not apply 
to infants requiring more respiratory assistance at birth. In the current resuscitation 
guidelines, oxygen titration is recommended if infants fail to achieve the 25th centile of 
the SpO2 reference ranges and are thus hypoxemic in the first minutes after birth.(14, 
36) Because hypoxia is known to provide inhibitory input into the respiratory center, this 
effect on respiratory effort has been overlooked with regard to the importance of oxygen 
titration. It is possible that the compromised preterm infant requiring respiratory support 
during transition would benefit by higher SpO2 reference ranges during stabilization at 
birth. By initiating stabilization at birth with a FiO2 of 1.0, we hypothesize that infants 
will achieve higher SpO2 values in the first minutes after birth, leading to an increase in 
respiratory effort at birth.
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A FiO2 of 1.0 should be administered with caution to avoid the detrimental effects of 
hyperoxia.(21, 23, 24) However, in this study the amount of time that infants receive 
pure oxygen is very limited since FiO2 will be titrated according to SpO2 values. To 
evaluate pure oxygen exposure, both the amount of time that infants spent above SpO2 
target range and the level of 8-iso-prostaglandin F2α indicating oxidative stress will be 
measured. 
While low SpO2 values reflect a low oxygenation level in arterial blood, known as 
hypoxaemia, this does not necessarily represent low oxygen uptake and usage by 
tissues, particularly cerebral tissues. While pO2 gradients drive oxygen diffusion into 
tissues and pO2 levels in blood are related to blood SpO2 levels, there are many factors 
that determine oxygen uptake and usage by tissues. For instance, organs can increase 
blood flow to maintain oxygen delivery and/or increase oxygen extraction when 
blood oxygen content decreases. As such, SpO2 alone provides limited information 
on oxygen consumption by tissues at high or low blood oxygen levels. In addition, 
individual patients might differ from one another in their ability to cope with free radicals 
released in response to inflammation, hyperoxia and hypoxia before or after birth.(21) 
Although the study is not powered to detect a difference in oxidative stress, we decided 
to objectively measure this using 8-iso-prostaglandin F2α as marker of oxidative stress, 
which indicates the true amount of oxygen exposure. 
The reported trials comparing high versus low levels of oxygen did not report on how 
oxygenation levels influence respiratory effort. Although the level of respiratory support 
during stabilization at birth was reported in most trials and shown to be not significantly 
different, the effectiveness of spontaneous breathing in both infants receiving higher or 
lower FiO2 was not evaluated.(18, 37-39, 43) Gaining an adequate level of spontaneous 
breathing during stabilization at birth to improve the success of non-invasive respiratory 
support could potentially lead to a lower incidence of intubation and mechanical 
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CHAPTER 6
The effect of initial high versus low FiO2 on 
breathing effort in preterm infants at birth: 
















Non-invasive ventilation in preterm infants at birth is hampered by closure of the glottis 
between breaths when breathing is intermittent. Infants are currently stabilized with 
initial low fraction of inspired oxygen (FiO2) (0.21 - 0.3) which increases the risk of 
hypoxia and suppression of breathing in the first minutes after birth. We hypothesized 
that stabilization of preterm infants at birth with an initial high FiO2 (1.0), followed by 
titration, would improve breathing effort when compared to an initial low FiO2.
METHODS
In a bi-center randomized controlled trial, infants < 30 weeks gestation were stabilized 
at birth with an initial FiO2 of 0.3 or 1.0, after which oxygen was titrated using the 
reference ranges described by Dawson et al.(12). Primary outcome was minute volume 
of spontaneous breathing. We also assessed tidal volumes, rate of rise to maximum tidal 
volumes (RoR) and respiratory rate with a respiratory function monitor. Pulse oximetry 
was used to measure heart rate and oxygen saturation (SpO2). Hypoxia was defined 
as SpO2 < 25
th percentile and hyperoxia as SpO2 > 95%. Differences in breathing effort 
and oxygenation parameters were tested with a Student’s t-test or Mann-Whitney U test, 
depending on the distribution. The interaction of breathing effort parameters with time 
was analyzed with a linear mixed model.
RESULTS
52 infants were randomized (26 in 100% O2-group, 26 in 30% O2-group) and recordings 
were obtained in 44 infants (20 infants in 100% O2-group, 24 infants in 30% O2-group). 
Minute volumes were significantly higher in the 100% O2-group (146.34 ± 112.68 mL/
kg/min) compared to 30% O2-group (74.43 ± 52.19 mL/kg/min) (p=0.014). Average 
tidal volumes and RoR in the first 5 minutes after birth were significantly higher in the 
100% group, while the duration of mask ventilation given was significantly shorter. 
Oxygenation was significantly higher in infants in the 100% O2-group (85 (64 – 93) %) 
compared to the 30% O2-group (58 (46 – 67) %) (p<0.001) in the first 5 minutes after 
birth. The duration of hypoxia was significantly shorter in the 100% O2-group, while the 
duration of hyperoxia was not different between groups.  
CONCLUSION
Initiating stabilization of preterm infants at birth with 100 % oxygen led to a higher 
breathing effort, improved oxygenation, and a shorter duration of mask ventilation as 
compared to 30 % oxygen, without increasing the risk for hyperoxia.




Spontaneous breathing movements are present even before birth, enabling small volumes 
of liquid to move in and out of the airways. During apnea, the glottis is predominantly 
closed, restraining the efflux of lung liquid.(1-3) This process is essential in allowing the 
lung to grow and develop. After birth, the purpose of breathing movements changes to 
gas exchange, which necessitates the lungs to fill with air instead of liquid. However, 
the function of the larynx present in the fetal situation appears to persist in newborn 
life. During apnea after birth, is has been shown that the glottis remains predominantly 
closed and opens only briefly in case of spontaneous breathing.(4-6) 
While most preterm infants need respiratory support at birth because of their low muscle 
strength and structural and biochemical immaturity of the lungs, this is now provided 
non-invasively instead of invasively to reduce the risk for lung and brain injury. However, 
applying non-invasive respiratory support necessitates an open airway in order to 
aerate the lungs and support the infant in transitioning. A closed glottis during apnea 
hampers the effectiveness of non-invasive ventilation, demonstrated in the study of van 
Vonderen et al.(5) in which a non-invasively applied sustained inflation to preterm infants 
at birth was only effective in case of concurrent spontaneous breathing. Interventions 
aimed at improving effectiveness of non-invasive ventilation should therefore focus on 
stimulation of spontaneous breathing in order to open the glottis.
One of the factors influencing breathing activity is oxygenation. Hypoxia leads to 
suppression of fetal breathing movements before birth, and it is now well established 
that this inhibitory effect of hypoxia on breathing persists for days-weeks after birth.(7) 
Avoiding persisting hypoxia at birth might result in enhancing spontaneous breathing 
and opening of the glottis, allowing non-invasive respiratory support to be effective. 
This, in turn, might reduce the need for intubation and mechanical ventilation and 
thereby reduces the risk of lung and brain injury. 
Oxygenation is largely defined by the surface area available for gas exchange and the 
diffusion distance as well as the partial pressure gradient for oxygen between the alveoli 
and adjacent capillaries. It has become clear that in most very preterm infants, clinicians 
fail to create adequate lung aeration and thus have to use a higher FiO2 to compensate 
for the suboptimal surface area created for gas exchange. However, the 2015 versions 
of the international resuscitation guidelines recommend to start resuscitation with a low 
FiO2 in order to reduce the risk of hyperoxia, which is associated with an increased 
production of oxygen free radicals leading to tissue damage in infants with an immature 
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antioxidant capacity.(8-11) After this initial FiO2, oxygen is recommended to be titrated 
based on the 25th percentile of the oxygen saturation target ranges defined by Dawson 
et al.(12), which has been based on data of healthy term and preterm infants. Using 
this approach, we accept that infants will be at risk for hypoxia, thereby overlooking the 
subsequent effect on breathing effort. A number of trials have recently been performed 
to assess the effect of initiating stabilization of preterm infants at birth with either a 
high or low FiO2. In the largest randomized controlled trial so far, recruitment had to 
be ceased because of a higher incidence of neonatal mortality in the low FiO2-group.
(13) However, results of the meta-analysis performed by Welsford et al.(14) were 
inconclusive about the ideal initial FiO2 in relationship with clinical outcomes, due to a 
very low overall level of evidence. Still, it has been shown that persisting hypoxia at 5 
minutes after birth is associated with a higher risk of mortality and the development of 
intraventricular hemorrhage.(15) This might be caused by hypoxia-induced respiratory 
depression, leading to a higher risk on intubation and mechanical ventilation. So far, 
the effect of high versus low initial FiO2 at birth on breathing effort and oxygenation of 
preterm infants has not been evaluated.
We aimed to evaluate the effect of reducing hypoxia by using an initial high vs low FiO2 
(1.0 vs 0.3) on breathing effort of preterm infants at birth. We thereby hypothesize that 
initiating resuscitation of preterm infants at birth with a high FiO2 will increase breathing 
effort.
METHODS
A single blinded randomized controlled trial was conducted at the Leiden University 
Medical Center (LUMC) and the Amsterdam University Medical Center (AUMC), both 
located in the Netherlands. Preterm infants with a gestational age between 24+0 - 29+6 
weeks were included. Infants with congenital abnormalities or conditions that might 
have an adverse effect on breathing effort of ventilation were excluded. Infants were 
randomized for resuscitation with an initial FiO2 of 0.3 (30% O2-group) or 1.0 (100% 
O2-group) using Castor EDC (Amsterdam, the Netherlands), an electronic data capture 
system. Allocation was stratified by gestational age (24+0 – 26+6 weeks and 27+0 – 29+6 
weeks), using variable block sizes (4-6).
After the initial FiO2 setting, FiO2 was titrated following SpO2 target ranges recommended 
in our local guidelines on stabilization after birth, which are based on the target ranges 
described by Dawson et al.(12) Cord clamping was performed after 30 seconds in 
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case of an apneic infant, and after 60 seconds if the infant was breathing at birth. 
In both groups, respiratory support was provided using a NeopuffTM infant T-piece 
resuscitator (Fisher & Paykel Healthcare, Auckland, New Zealand) or a Giraffe Star 
System (Anandic Medical Systems, Feuerthalen, Switzerland). Respiratory function 
monitoring at birth was recorded during stabilization in the first 10 minutes of life, which 
is standard practice in our units. 
The respiratory function monitor was used to measure inflation pressures, flow and 
tidal volumes. The measurements were used to calculate average minute volume, RoR, 
and the total time of ventilation given. It uses a small variable resistance anemometer 
to measure gas flow in and out of a face mask or endotracheal tube. This signal is 
automatically integrated to provide inspired and expired tidal volumes. The difference 
equals the leak from the face mask or endotracheal tube. To record SpO2 and heart 
rate a Masimo SET pulse oximeter probe (Masimo Radical, Masimo Corporation, Irvine, 
California, USA) or NellcorTM pulse oximeter probe (Covidien, Dublin, Ireland) was 
placed around the right wrist or hand of the infant. The FiO2 was measured using a 
portable oxygen analyzer AX300-I (Teledyne Analytical Instruments, CA, USA), and 
the airway pressures were registered by a variable orifice flow sensor (Avea Varflex 
Flow Transducer, Carefusion, Yorba Linda, CA,USA) connected to the face mask 
measuring the flow in and out the infant. The signals were digitized at 200 Hz using the 
NewLifeBox-R physiological recording system (Advanced Life Diagnostics, Weener, 
Germany) and all signals were recorded by the NewLifeBox Neo-RSD computer system 
(Advanced Life Diagnostics, Weener, Germany) supported by Polybench physiological 
software (Applied Biosignals, Weener, Germany). Pulmochart software (Applied 
Biosignals, Weener, Germany) was used to analyze primary and secondary outcomes.
The main study parameter was breathing effort, expressed as average minute volume 
normalized for body weight in the first 5 minutes after birth. Other parameters of 
breathing effort that were assessed, are: breathing rate, tidal volumes and RoR in the 
first 5 minutes after birth as well as the duration of ventilation given via face mask in 
the first 10 minutes after birth. Since Apgar scores are composed by the neonatologist 
often retrospectively after stabilization at birth has been completed, these could have 
been influenced by the received intervention. Therefore, both Apgar scores at 1 and 
5 minutes after birth are considered outcomes. In addition, oxygenation of the infants 
was assessed by measuring SpO2 values in the first 10 minutes and determining the 
amount of time that infants were considered to be hypoxic (SpO2 < 25
th percentile of the 
target ranges defined by Dawson et al.(12)) or hyperoxic (SpO2 > 95%). The following 
demographic data were collected: gestational age, birth weight, gender, antenatal use 
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of corticosteroids, mode of delivery and maternal medication use. Short-term clinical 
outcomes were noted: intraventricular hemorrhage ≥ grade III, intubation during 
resuscitation or within 24 hours after birth and neonatal mortality.
In a recent study, the average minute volume of preterm infants over the first 100 breaths 
was 150 ± 70 mL/kg/min.(16) The study of van Vonderen et al.(17) shows an 80% 
relative increase in respiratory drive when FiO2 was switched from 0.21 to 1.0, in the 
first minute after FiO2 was increased (from 134 mL/kg/min to 240 mL/kg/min). However, 
since we investigate a FiO2 of 0.3 instead of 0.21 in the lower oxygen arm, we expected 
half of the effect (40% relative increase) in respiratory drive than demonstrated in the 
study of Van Vonderen et al.(17) For this, a sample size of 44 infants would be needed 
(α of 0.05 and power (1 – β) of 0.8, 2-sided). To anticipate a 10% fail of recording 
of physiological measurements, and an additional risk for withdrawment or decline of 
consent after inclusion of an infant, 52 infants were recruited.
The ethical committees of the LUMC and AUMC approved the study protocol. Informed 
parental consent was obtained antenatally when possible. In case of an emergency 
situation (e.g. mother in full labour or when immediate delivery was necessary) or when 
obtaining antenatal consent was inappropriate (e.g. if the condition of the mother did 
not allow for proper consideration on participation), consent was asked retrospectively. 
This study was registered in www.trialregister.nl, with registration number NTR6878. 
The study protocol is published in Frontiers in Pediatrics: https://doi.org/10.3389/
fped.2019.00179.
Statistical analysis was performed with SPSS software version 23.0 (SPSS, Chicago, 
Illinois, 2012). Differences in parameters of breathing effort in the first 5 minutes after 
birth between the study groups were tested with a Student’s t-test if the data are found 
to be parametric, or with Mann-Whitney U test when the data are non-parametric. The 
interaction of respiratory minute volume, tidal volumes, RoR in the first 5 minutes after 
birth with time were analyzed with a linear mixed model, in which both study group 
(treatment) and time were taken in consideration. Other study parameters and basic 
characteristics were explored to test for differences between the study groups. If there 
were found to be significant differences with clinical relevance for the primary outcome, 
these parameters were incorporated in the linear mixed model.




A total of 109 eligible infants were born in the LUMC and AUMC during the study 
enrolment period between January 2018 and March 2019. 58 infants could not 
be included in this study because antenatal parental consent was refused, it was 
inappropriate to approach parents for considering enrolment in the study, the study was 
conflicting with other trials or due to practical reasons. Therefore, a total of 52 infants 
were randomized for initiation of resuscitation with either 100% or 30% O2. 6 of these 
infants were excluded from analysis for outcomes on breathing effort and oxygenation 
due to failure to record physiological parameters with the RFM and pulse oximetry, 1 
infant was excluded from complete analysis because he did not receive any respiratory 
support and 1 infant because deferred consent was not obtained (Figure 1). 
Figure 1  |  CONSORT 2010 Flow chart
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There are no significant differences between the 100% and the 30% O2-group with 
regard to gestational age, gender, birth weight, percentage of infants that received a 
full course of antenatal steroids or mode of delivery in both the total group and the group 
where physiological parameters were recorded (Table 1, Table 2). Neither were there 
any differences regarding maternal medication use or complications during pregnancy 
that could have had an effect on respiration of the infant at birth (Table 1, Table 2). 
The average FiO2 received in the first 5 minutes after birth was significantly higher in 
the 100% O2-group (100% O2-group: FiO2 0.91 (0.67 – 0.98) vs 30% O2-group: FiO2 0.48 
(0.33 – 0.53), p<0.001), as was the average FiO2 in the first 10 minutes after birth (100% 
O2-group: FiO2 0.69 (0.41 – 0.88) vs 30% O2-group: FiO2 0.45 (0.33 – 0.64), p=0.020).






Gestational age (weeks)a 27 2/7 ± 1 6/7 27 1/7 ± 1 4/7 0.746
Birth weight (grams)a 1000 ± 291 934 ± 258 0.405
Gender (% male)c 13/24 (54%) 9/26 (35%) 0.565
Mode of delivery (% caesarean section)c 14/24 (58%) 11/26 (42%) 0.396
Antenatal corticosteroids (% full course)c 11/24 (46%) 14/26 (54%) 0.606
Maternal medication use influencing respiration of the 
infantc
0/24 (0%) 0/26 (0%) 1.000
Complications during pregnancyc 7/24 (29%) 12/26 (46%) 0.255
Data are presented as mean ± SD for parametric data (a), median (IQR) for non-parametric data (b) and n (%) for 
categorical data (c). 






Gestational age (weeks)b 27 6/7 (25 2/7 – 28 6/7) 27 2/7 (25 4/7 – 28 3/7) 0.671
Birth weight (grams)a 992 ±309 931 ± 256 0.481
Gender (% male)c 11/20 (55%) 17/24 (71%) 0.352
Mode of delivery (% caesarean section)c 12/20 (60%) 10/24 (42%) 0.364
Antenatal corticosteroids (% full course)c 9/20 (45%) 14/24 (58%) 0.628
Maternal medication use influencing 
respiration of the infantc
0/20 (0%) 0/24 (0%) 1.000
Complications during pregnancyc 6/20 (30%) 12/24 (50%) 0.227
Data are presented as mean ± SD for parametric data (a), median (IQR) for non-parametric data (b) and n (%) for 
categorical data (c).




The average minute volume/kg was significantly higher in the 100% O2-group: (146.34 
± 112.68 mL/kg/min vs 74.43 ± 52.19 mL/kg/min, p=0.014). The minute volume in the 
first 5 minutes following birth was significantly higher in infants in whom resuscitation 
was initiated with 100% O2 (area under the curve (AUC) 498.18 ± 390.10 vs 244.63 ± 
168.42, p=0.014) (Figure 2), which represents a higher respiratory effort.
The average tidal volume and rate of rise to maximum tidal volumes in the first 5 minutes 
after birth were significantly higher in the 100% O2-group (Table 3, Figure 3). There was 
a trend towards a higher breathing rate in the 100% O2-group, although this difference 
did not reach statistical significance (Table 3, Figure 3). Although there was a trend 
towards a higher incidence of breaths with a tidal volume > 4 mL/kg (49 ± 25% vs 35 ± 
24%, p=0.056), the incidence of recruitment breaths (> 8 mL/kg) did not differ between 
the study groups (Table 3).






Average tidal volumes in first 5 minutesa 4.8 ± 3.8 3.8 ± 3.7 0.006
Average rate of rise to maximum tidal volume in first 5 
minutesa
12.7 (5.7 – 18.0) 7.8 (3.3 – 13.3) 0.014
Breathing rateb 33 (14 – 52) 26 (11 – 36) 0.099
Time of mask ventilation in the first 10 minutes (s)b 23.6 (0.0 – 122.2) 108.3 (46.4 – 205.1) 0.021
Incidence of breaths with tidal volume > 4 mL/kga 50 ± 24 35 ± 24 0.056
Incidence of recruitment breaths  
(> 8mL/kg)b
6 (1 – 24) 5 (0 – 18) 0.873
Data are presented as mean ± SD (a) and median (IQR) for non-parametric data (b).
The duration of mask ventilation was significantly shorter in the 100% O2-group (23.6 
(0.0 – 122.2) s vs 108.3 (46.4 – 205.1) s, p=0.021). While Apgar scores at 1 minute after 
birth were not significantly different between the study groups (6 (3 – 8) vs 5 (3 – 7), 
p=0.149), infants in the 100% O2-group showed significantly higher Apgar score at 5 
minutes after birth (8 (8 – 9) vs 8 (7 – 8), p=0.028). 
Oxygenation
The average oxygen saturation in the first 5 minutes after birth was significantly higher 
in infants in the 100% O2-group (85 (64 – 93) % vs 58 (46 – 67) %, p<0.001). In addition, 
there was a trend towards a higher heart rate in the 100% O2-group (Table 4). Infants 
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in the 100% O2-group had SpO2 values between 90 - 95% for a significantly higher 
percentage of time in the first 5 minutes after birth, while at 5 - 10 minutes after birth 
this was not significantly different between the groups (Figure 4). A SpO2 of 80 % was 
reached significantly earlier in the 100% O2-group (57 (2 – 130) s after birth vs 133 (80 
– 186) s after birth, p=0.013). In addition, the duration of hypoxia (SpO2 < 25
th percentile 
of reference ranges described by Dawson et al.(12)) was significantly shorter in the 
100% O2-group (Table 4). However, the duration of hyperoxia (SpO2 > 95%) did not 
significantly differ between the study groups. 
 






Average SpO2 in first 5 minutes
b 85 (64 – 93) 58 (46 – 67) < 0.001
Average heart rate in first 5 minutesa 134 ± 24 120 ± 28 0.086
Duration of hypoxia (< 25th percentile of Dawson target 
ranges) in first 10 minutes (s)b
73 (0 – 189) 158 (116 – 184) 0.018
Duration of hyperoxia in first 10 minutes (s)b 99 (24 – 215) 79 (15 – 152) 0.394
Percentage of time of SpO2 90-95% in first 5 minutes
b 15 (2 – 38) 1 (0 – 9) 0.002
Percentage of time of SpO2 90-95% in 5-10 minutes
b 30 (21 – 41) 35 (19 – 58) 0.556
Incidence of intubation in delivery roomc 0/20 (0%) 2/24 (8%) 0.493
Data are presented as mean ± SD for parametric data (a), median (IQR) for non-parametric data (b) and n (%) for 
categorical data (c). 
Short-term clinical outcomes
Only 2 infants of the total study population needed intubation in the delivery room, both 
infants were randomized to the 30% O2-group. There were no differences between the 
study groups with regard to intubation, incidence of IVH ≥ grade III or neonatal mortality 
(Table 5).






Incidence of intubation in the delivery room 0/24 (0%) 2/26 (8%) 0.491
Incidence of intubation < 24 hours after birth 8/24 (33%) 7/26 (27%) 0.760
Incidence of IVH ≥ grade III 0/24 (0%) 4/26 (15%) 0.111
Incidence of neonatal mortality 2/24 (8%) 5/26 (19%) 0.420
Data are presented as n (%). 




In this bi-center single blinded randomized controlled trial, the effect of initiating 
resuscitation with an FiO2 of either 0.3 or 1.0 on breathing effort was evaluated. We 
demonstrated that breathing effort was significantly higher in preterm infants who 
started initially with 100% O2 during stabilization as compared to infants initiating with 
30% O2, with minute volumes that were almost twice as high in the 100% O2-group. 
Infants in the 100% O2-group were significantly better oxygenated in the first 5 minutes 
after birth, with a shorter duration of hypoxia without an increase in hyperoxia. The 
better oxygenation and breathing effort are also reflected by a shorter duration in mask 
ventilation given in the 100% O2-group. These results indicate that initiating with a high 
level of oxygen followed by careful titration to avoid hyperoxia, is a better option for 
stimulating breathing and decreasing the need for positive pressure ventilation.
The effectiveness of non-invasive ventilation is hampered in case of a closed glottis 
during apnea, preventing air from entering the lung. While non-invasive respiratory 
support is universally adopted as primary respiratory support for preterm infants 
at birth, the closure of the glottis between breaths underscores that stimulating 
spontaneous breathing is important for the success of this non-invasive approach. 
Evaluating the effect of interventions used in the delivery room on breathing effort of 
preterm infants is therefore important to guide clinicians in prioritizing interventions 
to increase the effectiveness of non-invasive respiratory support. Although there are 
multiple randomized trials performed on comparing the effect of a high versus low initial 
FiO2 during stabilization of preterm infants at birth, none of these trials has evaluated 
breathing effort.(13, 18-22) The effect of oxygenation on breathing effort has so far only 
been demonstrated in an observational study where an increase in breathing effort was 
observed after switching FiO2 from 0.21 to 1.0.(17) However, we recently demonstrated 
the effect of the use of 100% oxygen at birth on breathing effort in a spontaneously 
breathing preterm rabbit model (unpublished data). When compared to stabilization 
with room air, 100% oxygen led to a more stable breathing pattern with a lower variability 
in inter-breath interval, higher respiratory rate and less apnea. We now observed similar 
results in the current clinical study in preterm infants, even when oxygen was titrated 
instead of a continuous FiO2 of 1.0 used in the preterm rabbit model.  
The effect of other interventions used in the delivery room on breathing effort has been 
described previously.(23, 24) Applying a strict protocol of repetitive tactile stimulation 
to preterm infants at birth showed a non-significant but clinically relevant increase 
of breathing effort, as compared to stimulation on discretion of the caregiver.(23) In 
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addition, infants who have been administered caffeine in the delivery room showed a 
significantly higher breathing effort.(24) However, the magnitude of the difference in MV 
that is shown between the 100% O2-group and the 30% O2-group in the current study 
was not demonstrated before in any other trial on breathing effort of preterm infants at 
birth. This indicates that oxygen might be the major contributor to improving breathing 
effort at birth.
Oxygenation was significantly higher in infants in the 100% O2-group, who showed 
significantly higher SpO2 values, with a shorter duration of hypoxia, as compared 
with infants in the 30% O2-group. Next to the initial FiO2, all infants in this study were 
managed with the same respiratory support strategy. Additionally, the duration of mask 
ventilation needed by infants in the 100% O2-group was significantly shorter compared 
to the 30% O2-group. Therefore, the partial pressure gradient for oxygen is likely to be 
the major contributor to the improved oxygenation in the 100% O2-group. Other trials 
on comparing high versus low initial oxygen concentrations for resuscitation of preterm 
infants at birth show conflicting results: SpO2 values of infants initiating resuscitation 
with a low FiO2 (<0.3) were significantly lower when compared to a high FiO2 (>0.9),(13, 
18, 20) whereas other trials detected no significant differences in oxygenation.(19, 21, 
22) However, differences in titration protocols might have influenced these results, and 
there is heterogeneity in timepoints at which these outcomes have been assessed. 
Probably just as important is the prevention of hyperoxia, known to cause damage 
to tissues as well by an increased free oxygen radical production. However, there 
were no significant differences in the duration of hyperoxia between infants initiating 
resuscitation with either 30% or 100% O2.
Improving oxygenation in the first 5 minutes after birth has gained increased attention, 
as it has become clear that persistent hypoxia after 5 minutes after birth is associated 
with an increased risk for IVH and mortality.(15) As hypoxia inhibits breathing both in 
the fetal situation as well as after birth, persistent hypoxia could reduce the effect of 
non-invasive ventilation resulting in an increased need for intubation and mechanical 
ventilation.(7) Our trial was not designed to detect significant differences in clinical 
outcomes. However, it should be noted that IVH and mortality occurred non-significantly 
more often in the 30% O2-group. 
The recent systematic review including trials on high versus low FiO2 during resuscitation 
of preterm infants at birth showed no difference in clinical outcomes. However, the level 
of evidence of included studies was assessed to be very low. In our study we aimed 
to provide knowledge on one of the factors that could contribute to improve breathing 
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effort at birth. It was shown that oxygen is a major contributing factor, next to other 
factors that have previously been shown to increase breathing effort, such as tactile 
stimulation and caffeine administration in the delivery room.(23, 24) Incorporating these 
factors in the resuscitation guidelines on delivery room management might result in 
an increase in effectively supporting preterm infants non-invasively, leading to less 
intubation and mechanical ventilation and better clinical outcomes.
CONCLUSION
In this randomized controlled trial, we have demonstrated significantly higher breathing 
effort when resuscitation was initiated with 100% O2 compared to 30% O2. In addition, 
infants in the 100% O2-group were significantly better oxygenated with a shorter duration 
of hypoxia without increasing the duration of hyperoxia. These results suggest that 
oxygenation might be a primary determinant in stimulating breathing and decreasing 
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Caffeine promotes spontaneous breathing by antagonizing adenosine. We assessed 
the direct effect of caffeine on respiratory effort in preterm infants at birth.
METHODS
30 infants of 24 – 30 weeks of gestation were randomized for receiving caffeine directly 
after birth in the delivery room (caffeine DR-group) or later in the neonatal intensive 
care unit (control-group). Primary outcome was respiratory effort, expressed as minute 
volume, tidal volumes, respiratory rate, rate of rise to maximum tidal volume (RoR) and 
recruitment breaths at 7 - 9 minutes after birth.
RESULTS
After correction for gestational age, minute volumes ((mean ± SD) 189 ± 74 mL/kg/min 
vs 162 ± 70 mL/kg/min, p<0.05) and tidal volumes ((median (IQR) 5.2 (3.9 – 6.4) vs 4.4 
(3.0 – 5.6) mL/kg, p<0.001) were significantly greater in caffeine DR-group. Although 
respiratory rates were similar ((mean ± SD) 35 ± 10 breaths/minute vs 33 ± 10 breaths/
minute), RoR increased significantly ((median (IQR) 14.3 (11.2 - 19.8) mL/kg/s vs 11.2 
(7.9 – 15.2) mL/kg/s, p<0.001) and more recruitment breaths were observed (13% vs 
9%, p=0.001). 
CONCLUSION
Caffeine increases respiratory effort in preterm infants at birth, but the effect on clinical 
outcomes needs further investigation.




During the transition after birth, lung aeration is pivotal for the changes in respiratory 
and cardiovascular function that are required for survival.(1, 2) Although most preterm 
infants breathe at birth, their respiratory drive is weak and often insufficient to aerate their 
lungs and establish gas exchange.(3-7) To minimize injury, intubation and mechanical 
ventilation is now avoided, and the focus of respiratory care has shifted to non-invasive 
ventilation, involving positive pressure support of breathing and/or ventilation via face 
mask.(6, 8)
Recent studies have demonstrated that intermittent positive pressure ventilation (IPPV) 
applied via mask in infants with insufficient respiratory effort, was often ineffective unless 
the infant took breaths during IPPV.(3) Mask ventilation is often hampered not only by 
leak, but also by obstruction caused by active larynx adduction.(3, 4, 9) Antenatally, 
active larynx adduction during apnea is needed for lung expansion and lung growth(9), 
and this pattern of activity might temporarily persist at birth. Logically, the best way 
to open the larynx is to stimulate spontaneous breathing, which is also likely to be 
the most gentle and effective way of providing respiratory care without causing injury. 
Currently, only tactile stimulation is recommended to stimulate breathing.(10-12)
Caffeine promotes breathing in infants by antagonizing the suppressive effects of 
adenosine and is a safe and effective treatment for apnea of prematurity.(13, 14) When 
caffeine is given in the first hours after birth, diaphragmatic activity increased at 5 
minutes after caffeine administration, which correlates with an increased tidal volume 
(Vt).(15) Also, the need for vasopressors and the incidence of intubation are lower 
when caffeine is given in the first few hours after birth, compared with that given after 
12 hours.(16) In addition, the incidence of bronchopulmonary dysplasia was lower 
when caffeine was given in the first 2 days of life.(17, 18)  Although these studies 
demonstrated the effects of caffeine in the first days after birth, there is little data on the 
direct effect of caffeine on respiratory effort or whether gestational age (GA) influences 
the effect of caffeine. Bairam et al.(19) showed in 2 – 5 day-old term lambs that Vti 
increased after a loading dose of caffeine. Kraaijenga et al. confirmed this in 1 – 4 day-
old preterm infants by measuring diaphragmatic activity after caffeine administration.
(15, 19) Within 5 minutes after administration, diaphragmatic activity increases, resulting 
in a 30% increase in tidal volumes.(15) Higher tidal volumes could potentially lead to 
greater lung recruitment and improved oxygenation, which can result in an increased 
respiratory drive.(20) We hypothesized that this effect of caffeine can be duplicated 
when caffeine is administered directly after birth. 
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We aimed to evaluate the respiratory effort of preterm infants at birth when caffeine was 
either administered directly after birth in the delivery room or after admittance to the 
neonatal intensive care unit (NICU). 
METHODS
An unblinded randomized controlled trial was conducted at the Leiden University 
Medical Center. Preterm infants born between 24+0 - 29+6 weeks of gestation were 
included. We excluded infants with congenital abnormalities or conditions that might 
have an adverse effect on breathing or ventilation, including congenital diaphragmatic 
hernia, tracheoesophageal fistula, or cyanotic heart disease. Infants participating in 
other trials on respiratory effort were also excluded. Infants were randomized using 
sequentially numbered sealed envelopes to either receive a loading dose of caffeine 
base (10 mg/kg, based on estimated or measured birth weight) at birth in the delivery 
room (caffeine DR-group) or later after arrival in the NICU (caffeine NICU-group). 
Consecutive caffeine base therapy was given in both groups according to the local 
protocol (5 mg/kg, 24 h after loading dose). Allocation was stratified by GA (24+0 – 26+6 
or 27+0 – 29+6 weeks) using blocks of 4. When randomized for caffeine administration in 
the delivery room, a butterfly needle (21G) that was prefilled with saline and attached to 
a saline-filled 5 mL syringe was inserted in the umbilical vein just above the umbilicus 
after a chlorhexidine swap. Endovascular location of the needle tip was confirmed by 
flushing in saline and withdrawing blood. A bolus of caffeine was administered within 
the first 7 minutes after birth. After the administration of caffeine, a further 2 mL flush of 
saline was given. 
None of the mothers received general anesthesia or iv narcotics close to delivery. In 
both groups, standard care was provided in both the delivery room and after arrival 
in the NICU. A NeopuffTM infant T-piece resuscitator (Fisher & Paykel Healthcare LTD, 
Auckland, New Zealand) was used for respiratory resuscitation. For stabilization at birth, 
local resuscitation guidelines were followed, including delayed cord clamping and early 
start of continuous positive airway pressure (CPAP) for all infants with a GA < 32 weeks. 
In addition, a sustained inflation of 15 s with a pressure of 20 cm H2O was given to 
apneic and bradycardic infants. A second sustained inflation of 15 s with a pressure of 
25 cm H2O was given when infants remained apneic and bradycardic, after which IPPV 
was started. Intubation was considered when effectiveness of mask ventilation could 
not be guaranteed or prolonged mask ventilation was needed. Respiratory function 
monitoring (RFM) was recorded at birth, which is also standard clinical care in our 
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centre to have a direct feedback device for respiratory support. This monitor was used 
to measure inflation pressures, gas flow, Vt, average minute volume (MV), and average 
rate of rise to maximum tidal volume (RoR). The monitor utilizes a small (dead space 
1 mL) variable orifice anemometer to measure gas flow in and out of a face mask. 
This signal was automatically integrated to provide inspired and expired tidal volume. 
RFM measurements were collected during the first 10 minutes after birth. All signals 
measured were digitized and recorded at 200 Hz using the New Life Box physiological 
recording system with Polybench software (Advanced Life Diagnostics, Weener, 
Germany). Pulmochart software (Advanced Life Diagnositcs, Weener, Germany) was 
used for analyzing recorded data. Oxygenation and heart rates were measured with a 
Masimo SET pulse oximeter (Masimo corporation, Irvine, CA, USA). The pulse oximetry 
probe was placed around the ulnar aspect of the infant’s right wrist. Fraction of inspired 
oxygen (FiO2) was measured with a Teledyne oxygen analyzer (Teledyne Analytical 
Instruments, City of Industry, CA, USA) inserted into the inspiratory limb of the Neopuff 
circuit.
The primary outcome was respiratory effort, expressed as MV of spontaneous breathing 
at 7 - 9 minutes after birth. Also, the Vt, respiratory rate, the RoR and recruitment 
breaths (% of Vt > 8 mL/kg) were used as parameters of respiratory effort. Maximum 
FiO2, oxygen saturation (SpO2), and heart rate at 7 - 9 minutes after birth were also 
measured. Analyses were performed on these outcomes at 7 - 9 minutes after birth; as 
we assumed that caffeine could be administered within the first 7 minutes after birth, 
most infants would be respiratory stable at 7 minutes, and were transported to the NICU 
10 minutes after birth.
To observe the direct effect of caffeine we compared the MV in the minute before (period 
0) with the minute after (period 1) caffeine administration in the caffeine DR-group. The 
frequency of expiratory holds and panting were also compared, using the definitions 
previously described by te Pas et al.(21) Basic characteristics of all included infants 
were collected: GA, birth weight, gender, Apgar score, antenatal use of corticosteroids, 
mode of delivery, the need for a sustained inflation and cord pH and BE. Data were also 
collected on short-term clinical outcomes as intraventricular hemorrhage, intubation, 
and need for surfactant administration during the admission on the NICU.
Based on the previous studies of Bairam et al. and Kraaijenga et al.(15, 19) that 
examined the direct effect of caffeine, we calculated that with an α of 0.05 and β of 0.8, 
26 infants were needed to detect a 150 mL/kg/min increase in MV with a SEM of 60. 
The ethical committee of the Leiden University Medical Center approved the study 
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protocol. Parental informed consent was obtained prior to randomization, and 
in emergency situations with immediate delivery required or when approaching 
parents for antenatal consent was not considered appropriate, consent was obtained 
retrospectively as soon as possible after birth.
This study was registered in www.trialregister.nl, with registration number NTR4896.
Statistical analysis was performed with SPSS software version 23.0 (SPSS, Chicago, 
Illinois). The parameters of both groups were tested for normality using the Kolmogorov-
Smirnov and Shapiro-Wilkinson test. The caffeine DR-group and caffeine NICU-group 
were compared using Student’s t-test for parametric and the Mann-Whitney U test for 
non-parametric comparisons for continuous variables, and the χ2 test for categorical 
variables. Results are presented as mean ± SD for normally distributed values or 
median (IQR) for non-normally distributed values. P-values <0.05 were considered 
statistically significant. Reported p-values are two-sided. MV was calculated using only 
tidal volumes recorded without mask leakage, and dividing it by the number of seconds 
for which data were present. Of all other study parameters, calculations were made 
based on available data. Despite randomization of infants, a significant and clinically 
important baseline imbalance in GA between the two groups was discovered. As a 
result, we performed a post-hoc analysis to adjust the outcome parameters for the GA 
and examined the relationship between GA and MV together and separately in both 
groups using PRISM software (Irvine, CA, USA). Reported results are corrected for GA. 
RESULTS
Between November 2014 and August 2015, 76 eligible infants were born in the Leiden 
University Medical Center with a GA of 24 - 30 weeks. In total, 23 infants were not 
included because the study was conflicting with other trials, the monitor was not 
available or consent was not given. Also, 23 infants of 27-30 weeks’ gestation were not 
included as we reached full recruitment for that stratification group. 
Therefore, 30 infants were randomized. Of these, 4 infants were excluded because of 
failure to obtain recordings (1 infant in caffeine DR-group, 3 infants in caffeine NICU-
group), and 1 infant was excluded because the timing of administration of caffeine 
exceeded the time stated in the protocol. Two infants (one infant in each group) 
remained apneic at 7 - 9 minutes after birth, and outcome parameters could not be 
obtained from these infants. Therefore, 23 infants were analyzed - 13 in the caffeine 
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DR-group and 10 in the caffeine NICU-group (Figure 1). A total of 1840 spontaneous 
breaths were analyzed - 1061 in the caffeine DR-group and 779 in the caffeine NICU-
group. Of 23 infants included in analysis, 16/23 (70%) of parents gave informed consent 
retrospectively.
Infants included in the caffeine DR-group had a significantly lower GA, despite 
randomization (Table 1). There were no differences in birth weight, gender, Apgar score 
at 5 minutes, use of antenatal corticosteroids, mode of delivery, need for sustained 
inflation, cord pH or Base Excess at birth. Caffeine was given at a median (IQR) time 
of 4.4 (3.6 – 5.5) minutes after birth in the caffeine DR-group, and at 48 (32.8 – 107.3) 
minutes after birth in the caffeine NICU-group.
Respiratory effort at 7 – 9 minutes after birth
At 7 - 9 minutes after birth, MV was significantly (p=0.006) related to GA (Figure 2). 
When corrected for GA, MV was significantly greater in the caffeine DR-group than in 
the caffeine NICU-group (189 ± 74 mL/kg/min vs 162 ± 70 mL/kg/min, p<0.05, OR (95% 
Figure 1  |  CONSORT flow diagram
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CI) 53.1 (18.0 – 88.3)). When analyzed within each group (Figure 2), the relationship 
between MV and GA was significant in the caffeine DR-group (p=0.0008; slope = 4.1 
mL/min/kg/day), but not in the caffeine NICU-group (p=0.09; slope = 2.3 mL/min/kg/
day). 
Vt, RoR, percentage of recruitment breaths and heart rate were significantly higher (all 
p<0.001) in the caffeine DR-group as compared to the caffeine NICU-group (Table 2). 
There were no differences in respiratory rate, maximum FiO2 and SpO2 (Table 2).
Table 1  |  Demographical data
Caffeine DR-group Caffeine NICU-group p-value
Gestational age (weeks)b 27 (26 – 28) 28.5 (27 – 29) 0.049
Birth weight (grams)b 870 (767 – 1198) 960 (731 – 1450) ns
Gender (% male)c 7/13 (54%) 6/10 (60%) ns
Apgar score at 5 minutesb 9 (7 – 9) 8 (7 – 9) ns
Antenatal use of corticosteroidsc 13/13 (100%) 10/10 (100%) ns
Mode of delivery (% caesarean section)c 5/12 (42%) 6/10 (60%) ns
Sustained inflationc 9/13 (69%) 9/10 (90%) ns
Cord pH after birthb 7.33 (7.22 – 7.36) 7.26 (7.20 – 7.29) ns
Cord BE after birtha -4.6 ± 3.1 -5.2 ± 2.6 ns
Intubation during NICU admissionc 7/13 (54%) 4/10 (40%) ns
Surfactant administrationc 9/13 (69%) 5/10 (50%) ns
Endotracheally 5/13 (39%) 2/10 (20%) ns
Minimal invasively 4/13 (31%) 3/10 (30%) ns
IVH (all grades)c 3/13 (23%) 3/10 (30%) ns
Data are presented as mean ± SD for parametric data (a), median (IQR) for non-parametric data (b) and n (%) for 
categorical data (c).
Direct effect of caffeine
In the caffeine DR-group, both the spontaneous breathing MV ((mean ± SD) 236.8 ± 
106.6 mL/kg vs 134.8 ± 103.9 mL/kg, p<0.05, OR (95% CI) 39.2 (-1.5 – 79.9)) and 
inspired tidal volumes ((median (IQR)) 5.3 (3.8 – 8.2) mL/kg vs 4.1 (2.4 – 7.2) mL/kg, 
p<0.001, OR (95% CI) 1.4 (0.9 – 1.9)) were significantly greater in the minute after 
caffeine administration compared with that in the minute before caffeine administration. 
There were no significant differences in breathing pattern (percentage of time panting, 
percentage of expiratory holds) between the minutes before and after caffeine 
administration for infants receiving caffeine directly after birth (Table 3). 




There were no differences between the groups in short-term clinical outcomes. Intubation 
rates following NICU admission, surfactant administration, either by endotracheal tube 
or by minimal invasive surfactant therapy, and all grades of intraventricular hemorrhage 
were similar in the caffeine DR-group and caffeine NICU-group, respectively (Table 1). 
Figure 2  |  Minute volume in relation to gestational age
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p-value OR (95% 
confidence 
interval)
Minute volume (mL/kg)a 189 ± 74 162 ± 70 < 0.05 53.1 (18.0 – 88.3)
Average rate of rise to maximum 
tidal volumes (mL/kg/s)b
14.3 (11.2 – 19.8) 11.2 (7.9 – 15.2) < 0.001 5.5 (4.8 – 6.3)
Average inspired tidal volume 
(mL/kg)b
5.2 (3.9 – 6.4) 4.4 (3.0 – 5.6) < 0.001 0.8 (0.5 – 1.0)
Recruitment (number of breaths 
with inspired tidal volume/kg > 
8 mL)c
142/1061 (13%) 67/779 (9%) 0.001 1.6 (1.2 – 2.2)
Respiratory rate/minutea 35 ± 10 33 ± 10 ns 4.7 (-0.5 – 9.9)
Heart rate (bpm)b 157 (141 – 170) 146 (135 – 160) < 0.001 9.7 (8.2 – 11.2)
Maximum FiO2
a 0.55 ± 0.21 0.63 ± 0.27 ns 10.0 (-15.7 – 
35.7)
FiO2 when leaving the delivery 
roomb
0.35 (0.31 – 0.40) 0.39 (0.32 – 0.63) ns 7.8 (-12.2 – 27.7)
SpO2 (%)
b 91 (87 – 94) 91 (88 – 94) ns -0.2 (-0.7 – 0.4)
Data are presented as mean ± SD for parametric data (a), median (IQR) for non-parametric data (b) and n (%) for 
categorical data (c).
Table 3  |  Difference in breathing pattern
Minute before  
caffeine
Minute after  
caffeine
p-value OR (95% 
confidence 
interval)
Percentage of expiratory holdsa 43.5 ± 16.8 43.1 ± 28.7 ns 8.0 (-9.5 – 25.5)
Percentage of time pantingb 0 (0 – 18) 0 (0 – 6) ns -0.8 (-7.8 – 6.1)
Data are presented as mean ± SD for parametric data (a) and median (IQR) for non-parametric data (b).
DISCUSSION
In this randomized controlled trial, we found that MV at 7 – 9 minutes after birth was 
significantly greater in the caffeine DR-group than in the caffeine NICU-group, after 
correction for GA. Although respiratory rate did not increase, all other parameters 
assessing respiratory effort increased significantly by caffeine administration, including 
Vt, RoR and the percentage of recruitment breaths. We also observed an immediate 
increase in respiratory effort in the minute after caffeine administration in caffeine-
treated infants. There was a moderate but significant increase in heart rate, but oxygen 
need and SpO2 did not differ between the groups. These results indicate that caffeine 
at birth could play a role in stimulating breathing during transition at birth. 
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Studies have reported the effect of caffeine in preterm infants with apnea of 
prematurity(13, 14), whereas the focus of more recent studies has shifted towards the 
timing of the caffeine administration and its effect on breathing and ventilation.(15) 
Our study confirmed the increase in Vti observed in the study of Kraaijenga et al.(15), 
although they did not report the immediate effect of caffeine and the infants were 1 - 4 
days old. They observed increased diaphragmatic activity at 5 minutes after caffeine 
administration and increased Vti, measured using inductive plethysmography, in the 
first hour after administration. 
Bairam et al.(19) observed a large increase in MV when caffeine was administered 
to 2 - 5 day-old term lambs with well-established respiratory rhythms. Based on this 
stimulatory effect in lambs, we expected caffeine to stimulate MV and other respiratory 
parameters directly after birth in preterm infants. In our study, the stimulatory effect 
of caffeine was clear with regard to increasing RoR, Vti and frequency of recruitment 
breaths. We also found a significant (p=0.006) relationship between MV and GA in 
all infants at 7 - 9 minutes after birth (Figure 2). As the GA was different between the 
groups, despite randomization, we adjusted MV for GA. Adjusted for GA, MVs were 
significantly greater in caffeine treated infants than control infants. Furthermore, in 
caffeine treated infants, we found that the relationship between MV and GA was highly 
significant (p=0.0008), with MV increasing at a rate of 4.1 mL/min/kg/day. In contrast, 
in control infants the relationship between MV and GA just failed to reach statistical 
significance (p=0.09), because of the small number of observations, with MV tending to 
increase at only 2.3 mL/min/kg/day. These findings indicate that caffeine enhances the 
GA-related increase in MV and that the stimulatory effect of caffeine on MV increases 
with GA.
Te Pas et al.(21) described that braked expirations occur often in preterm and term 
infants, but expiratory holds occurred significantly more often in preterm infants. In this 
situation, the glottis closure combined with abdominal muscle contraction and increase 
in intrathoracic pressure helps to maintain functional residual capacity. In our study, 
the percentage of expiratory holds in the minute after caffeine administration did not 
differ from the minute before caffeine, but at 7 – 9 minutes after birth the percentage 
of expiratory holds was significantly greater in the caffeine DR-group. The increase in 
respiratory effort observed at 7 – 9 minutes after birth might be explained by a change 
in breathing pattern. 
Caffeine antagonizes adenosine at its receptor, and thereby stimulates the respiratory 
center in the medulla, and increases skeletal muscle tone, diaphragmatic contractility 
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and the sensitivity to carbon dioxide.(22, 23) The levels of adenosine, however, may 
vary considerably in infants under different conditions, such as the mode of delivery and 
the presence of hypoxemia.(24) Irestedt et al.(24) showed higher plasma adenosine 
concentrations in infants born vaginally compared to infants born with caesarean 
section, possibly due to hypoxemia caused by uterine contractions. Indeed, in piglets 
in the first 3 days after birth, hypoxemia can increase adenosine levels and reduce 
MVs.(25) However, administration of aminophylline, a xanthine-derivative, counteracted 
the effect of adenosine and increased MVs by 43.5 %, an effect that persisted for at 
least 6 minutes despite persisting hypoxemia.(25) Therefore, the effect of caffeine may 
also differ at birth because of different levels of hypoxemia. It is possible that different 
dosages of caffeine are needed to compete with the level of adenosine present at birth 
or to overcome other variables. 
In this study, a bolus of 1 mL/kg of caffeine, followed by a 2 mL flush of saline, was 
administered in the caffeine DR-group. The effect of the administration of a volume 
bolus on cerebral perfusion is a well-discussed subject. In the study by Kooi et al.(26), 
cerebral perfusion did not improve after the volume expansion (15 mL/kg) in the first 
day of life in infants with a GA of 25 - 28 weeks, although this might be caused by 
the presence of an adequate cerebral autoregulation. In the present study, it is not 
clear how the administration of the small bolus of caffeine and saline might have 
influenced cerebral outcomes. There are additional factors influencing these outcomes, 
as mentioned by Rajani et al.(27) in their review on delivery room management. The 
use of positive pressure ventilation and rapid PaCO2 changes influence cerebral blood 
flow, thereby increasing the risk of intraventricular hemorrhage. However, in our study 
there were no differences between the caffeine DR-group and caffeine NICU-group by 
means of any grade of intraventricular hemorrhage or periventricular leucomalacia. 
This study is limited by the lack of a placebo-controlled group. It is theoretically 
possible that the flush of saline given, before caffeine was administered, could have a 
positive effect on the breathing effort. When reviewing the monitor recordings, we did 
not observe any effect when a flush of saline was given before the administration of 
caffeine; however, the caregivers were not blinded for the allocated intervention when 
reviewing the monitor recordings. 
This study is also methodologically limited by excluding study participants and thereby 
not reaching the proposed sample size. Infants were excluded because of failure of the 
recordings, which was only visible during analysis. Therefore, no additional infants could 
be included. Another methodologic limitation is the sample size calculation, which was 
based on experimental data from 2 – 5 day-old lambs, and data from preterm infants 
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multiple days after birth. The proposed change in MV of 150 mL/kg appears to be too 
optimistic, as the overall mean ± SD MV in this study was 152 ± 74 mL/kg in preterm 
infants during the first minutes after birth.
In addition, infants in the caffeine DR-group had a significantly lower GA. Our finding of 
a significant relationship between MV and GA indicates that older infants have a more 
developed respiratory control system. As this could have influenced the outcomes, 
resulting in an underestimation of the effect size, we corrected analyses for GA using 
multiple regression.
CONCLUSION
In this small randomized trial, we observed a direct positive effect of administering 
caffeine on the respiratory effort in preterm infants at birth. The results of this study 
provide evidence, indicating that caffeine could play a role in stimulating breathing in 
preterm infants during the transition. Further studies are needed to explore whether 
the use of caffeine in the delivery room might contribute to a decrease in delivery room 
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Sedation during minimal invasive surfactant 












There is no data available whether sedation should be given during minimally invasive 
surfactant therapy (MIST). The aim of this study was to compare the level of comfort of 
preterm infants receiving sedation vs no sedation for MIST.
METHODS
A retrospective study of preterm infants receiving MIST was performed in the Leiden 
University Medical Center in 2014. Sedation (propofol 1 mg/kg) was optional and left 
to the discretion of the caregiver. Standardized COMFORTneo scores were compared 
and COMFORTneo < 14 was considered comfortable. Basic characteristics and 
complications were noted. 
RESULTS
In 38 infants receiving MIST, 23 received propofol and 15 were not sedated. Mean ± SD 
gestational age (29 ± 2 weeks vs 29 ± 3 weeks) and birth weight (1312 ± 483 grams 
vs 1469 ± 588 grams) were not different. Median (IQR) COMFORTneo was not different 
between the groups before (11 (9 - 15) vs 10 (8 - 12)) and after MIST (10 (8 - 12) vs 
9 (8 - 10)), but lower in the sedated group during MIST (12 (9 - 17) vs 20 (15 - 23), 
p=0.002) with more often COMFORTneo < 14 (56% vs 11%, p=0.04). Duration of MIST 
(2 (2 - 4) minutes vs 3 (2 - 7) minutes) and occurrence of bradycardia (13% vs 33%) 
and hypotension (21% vs 18%) were not different. Although not significant, intubation 
occurred more often in the sedated group (during MIST: 9% vs 0%, < 24 hours after 
MIST: 26% vs 13%). During MIST, oxygen saturation < 80% lasted longer in the sedated 
group (3 (2 - 4) minutes vs 1 (0 - 2) minutes, p=0.001) and nasal intermittent positive 
pressure ventilation (nIPPV) was applied more (100% vs 33%, p<0.001).
CONCLUSION
Preterm infants receiving MIST were more comfortable when sedation was given, but 
needed ventilation more often. A randomized controlled trial is warranted to test whether 
the benefit of sedation outweighs the risks of complications. 




Many preterm infants need surfactant therapy to diminish alveolar surface tension 
and work of breathing caused by respiratory distress syndrome (RDS), so as to 
avoid the occurrence of atelectasis.(1) While intubation and mechanical ventilation is 
increasingly being avoided(2, 3),  infants are still being intubated and mechanically 
ventilated for surfactant therapy.(4) Mechanical ventilation can, however, lead to lung 
injury and ultimately to bronchopulmonary dysplasia (BPD).(5) The incidence of BPD 
decreases when non-invasive ventilation increases.(6) In this context, minimal invasive 
surfactant therapy (MIST) techniques are promising, in which surfactant is administered 
to a spontaneously breathing infant who then remains on continuous positive airway 
pressure (CPAP).(7, 8) During MIST, the vocal cords are visualized by the use of a 
laryngoscope and the trachea is catheterized using a semirigid catheter, and then the 
surfactant is instilled.(4) To date, most Neonatal Intensive Care Unit (NICU) centers in 
the Netherlands have adopted this procedure. 
There is consensus that an endotracheal intubation procedure should be performed 
while the infant is adequately sedated.(9, 10) However, there is an ongoing debate 
whether or not sedation should be used during MIST as the presence of spontaneous 
breathing is a pre-requisite for the procedure. So far, there are no studies concerning 
sedation during this procedure. In the recent published studies and current trials on 
MIST, no sedation is given before MIST.(4) 
By using a laryngoscope during MIST, pharyngeal stretching triggers sympathic and 
parasympathic reflexes, which could lead to cardiovascular responses.(10) Also, when 
the infant is not sedated, efforts to resist the laryngoscope and attempts to cry can 
cause an increase in intracranial pressure, which could result in impairment of the 
venous return of the brain and intracranial venous hypertension.(9, 11, 12) This can 
then contribute to the risk of intraventricular hemorrhage.(9) In addition, laryngoscopy 
is associated with apnea, increased blood pressure, decreased heart rate and 
decreased transcutaneous PO2.(13-15) These differences in vital signs were greater in 
infants who did not receive any premedication.(15) However, many analgesic agents 
used for neonatal intubation have been studied, and side effects such as respiratory 
depression, hypotension, muscle rigidity, increased intracranial blood pressure and 
decreased cerebral blood flow have been reported.(16, 17) 
Propofol is routinely used as premedication for endotracheal intubation at our center. 
Although the maintenance of spontaneous breathing is described as an advantage of 
propofol, hypotension and respiratory depression have been reported.(17) 
Chapter 8
140
The use of propofol during MIST is currently left to the discretion of the attending 
neonatologist when discomfort is anticipated. Propofol may then contribute to 
more comfort and less resistance from the infant during the procedure, which can 
increase the success of the procedure. However, administering propofol could also 
cause respiratory depression and increase the chance for non-invasive intermittent 
positive pressure ventilation or, when respiratory depression persists, intubation and 
mechanical ventilation. There is no data available whether the use of propofol for more 
comfort during MIST outweighs the risk for failure of the procedure and the occurrence 
of complications.
We performed a cohort study to compare the level of comfort and the occurrence of 
complications of infants receiving sedation with infants receiving no premedication 
during MIST. 
METHODS
A retrospective cohort study was conducted at the neonatal department of the Leiden 
University Medical Center. All admitted infants receiving surfactant by MIST in the year 
2014 were included in this study. We only included the first MIST, repeated surfactant 
doses by MIST were excluded. The criteria receiving surfactant by MIST were: GA 25+6 
– 36+6 weeks of gestation, no need for imminent intubation, adequate respiratory drive, 
CPAP level ≥ 8 cm H2O and FiO2 > 0.3.
According to the local protocol the decision whether to give sedation for MIST was 
left to the discretion of the attending neonatologist. For endotracheal intubation, 
intravenous propofol 2.5 mg/kg is standardly used for sedation in our unit. However, to 
maintain spontaneous breathing and reduce the risk of side effects, a reduced dose 
of intravenous propofol (1 mg/kg) was administered before MIST. In each infant, non-
pharmacological techniques for comfort were also performed, which consisted of the 
administration of oral sucrose 24% in the cheek pouch of the infant along with a pacifier 
at least 2 minutes before the procedure, and swaddling the infant in a swaddling cloth 
to keep the infant contained. 
MIST was performed using the method as described earlier by Dargaville et al.(8), in 
which the vocal cords are visualized using a laryngoscope, where after a semi-rigid 
angiocatheter is orally introduced to catheterize the trachea. 
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The infants receiving propofol (sedated group) were compared with the infants without 
premedication (non-sedated group). Nurses in our unit routinely score the comfort of 
the infants using the COMFORTneo score, which is validated for measuring objectively 
the (dis)comfort of a preterm infant.(18) Interrater reliability was assessed by Caljouw 
et al.(18), who found that the COMFORTneo score is reliable to measure distress in 
preterm infants. With a score < 14, the infant’s comfort is considered to be acceptable. 
The COMFORTneo score before, during and after MIST of both groups were retrieved 
and noted. In our unit, interrater reliability between nurses of the COMFORTneo 
research group (Caljouw et al.(18)) and other NICU nurses was assessed in ten clinical 
situations, and nurses could measure comfort using the COMFORTneo score if they 
had achieved a Cohen’s κ > 0.6. Cohen’s κ measures the interrater agreement, where 0 
means no agreement and 1 means total agreement.(19) 
Both COMFORTneo scores and basic characteristics (gestational age, gender and 
birth weight) were gathered, as well as complications of MIST and the administration of 
propofol. These complications included the need for nIPPV, intubation, the occurrence 
of desaturation (oxygen saturation < 80 %), hypotension (mean mmHg < gestational 
age) or bradycardia (heart rate < 80 bpm). The differences in heart rate between the 
interval before the MIST and during the MIST were also compared for the sedated and 
the non-sedated groups. 
All study data were retrieved from the digital medical charts (PDMS, MetaVision iMD-
soft, Leiden, The Netherlands), a clinical information system designed especially for 
use in NICUs. In this system, each parameter is noted every minute. 
This was a retrospective study and did not need to comply with the Dutch law on 
Medical Research in Humans; the Research Ethics Committee issued a statement of 
no objection.
Statistical analysis
Because of the retrospective nature of this study, a convenience sample was used. 
No power calculation was performed because there was no data regarding sedation 
during MIST. Statistical analysis was performed using SPSS 22 (IBM SPSS Statistics). 
The parameters of both groups were tested for normality using Kolmogorov-Smirnov 
and Shapiro-Wilkinson. The groups were compared using Student’s t-test for parametric 
variables and the Mann-Whitney U test for non-parametric comparisons for continuous 
variables, and the X2 test for categorical variables. Results are presented as mean ± SD 
for normally distributed values or median (IQR) for non-normally distributed values. P 




During the one-year period, 310 infants with a gestational age between 26+0 and 
36+6 weeks were admitted to the NICU. In 38 infants, surfactant was given by MIST, 
of which 23 infants received propofol (supplemental video 1; www.karger.com/
doi/10.1159/000443823) and 15 infants were not sedated (supplemental video 2) 
based on the discretion of the attending neonatologist. Reasons given for prescribing 
propofol were expected discomfort. There were no significant differences in mean ± SD 
gestational age (sedation vs no sedation: 29 ± 2 weeks vs 29 ± 3 weeks), birth weight 
(1312 ± 483 grams vs 1469 ± 588 grams) and the percentage of males (61% (14/23) 
vs 73% (11/15)). The median (IQR) duration of the procedure did not significantly differ 
between the groups (2 (2 - 4) minutes vs 3 (2 - 7) minutes). 
Comfort
Surfactant was administered by MIST 38 times, in which comfort was scored before, 
during and after the procedure in 76% (29/38), 71% (27/38) and 71% (27/38) of the 
procedures, respectively. Both before and after MIST the median (IQR) COMFORTneo 
score did not differ between the study groups, but the COMFORTneo score during the 
procedure was significantly lower in the sedated group when compared to the non-
sedated group (Table 1). The COMFORTneo score was significantly more often < 14 in 
the sedated group during MIST (56% vs 11%, p<0.05). There was a significant positive 
correlation between both gestational age (r=0.419, p<0.05) as postnatal age (r=0.435, 
p<0.05) and COMFORTneo score during the procedure. However, as previously 
mentioned the gestational age did not differ between the sedated and the not sedated 
group.






COMFORTneo score before MIST 11 (9 – 15) 
n = 18
10 (8 – 12) 
n = 11
ns
COMFORTneo score during MIST 12 (9 – 17) 
n = 17
20 (15 – 23) 
n = 10
0.002
% COMFORTneo score < 14 during MIST 9/16 (56%) 1/9 (11%) 0.04
COMFORTneo score after MIST 10 (8 – 12) 
n = 23
9 (8 – 10) 
n = 9
ns
Data is presented as median (IQR) for non-parametric data, and n (%) for categorical data.




The occurrence of complications could be retrieved from the digital medical chart for 
all patients. Bradycardia and hypotension occurred in a few infants, but these were not 
significantly different between the groups (Table 2). There was no significant increase or 
decrease in heart rate during the procedure in both groups. The median (IQR) duration 
of oxygen desaturation of all infants (< 80 %) was longer in the sedated group (3 (2 - 4) 
minutes vs 1 (0 - 2) minutes, p <0.01). All patients in the sedated group needed nIPPV 
temporarily due to apnea and saturation < 80 % during MIST as compared to 33 % in 
the non-sedated group (p<0.001) (Table 2). 2 infants (8%) in the sedated group were 
intubated during MIST due to failure of the procedure because the trachea could not 
be catheterized, while this did not occur in the non-sedated group (ns). There was 
no significant difference in occurrence of intubations in the first 24 hours after MIST 
between the two groups (Table 2). The intubated infants had a mean ± SD gestational 
age of 28 ± 2 weeks and a birth weight of 1109 ± 454 grams. Reasons to intubate in 
the first 24 hours after MIST were apneas in 3 cases, no improvement or an increase 
in FiO2 need in 3 cases, and no adequate respiratory drive before the procedure with 
persistent apnea after the procedure in 2 cases (Table 3). 






nIPPV during MISTa 23/23 (100%) 5/15 (33%) < 0.001
Intubation in the first 24 hours after MISTa 6/23 (26%) 2/15 (13%) ns
Intubation during MISTa 2/23 (9%) 0/15 (0%) ns
Duration of SpO2 < 80% during MIST (minutes)
b 3 (2 – 4) 1 (0 – 2) 0.001
Hypotension during MISTa 3/14 (21%) 2/11 (18%) ns
Bradycardia during MISTa 3/23 (13%) 5/15 (33%) ns
Heartrate before – during MIST (bpm)b -4 (-10 - -1) -2 (-7 – 3) ns
Data is presented as n (%) for categorical data (a) and median (IQR) for non-parametric data (b).






Trachea could not be catheterized 2/8 (25%) 0/2 (0%) ns
Infant did not meet MIST criteria before procedure 2/8 (25%) 0/2 (0%) ns
Apnea 2/8 (25%) 1/2 (50%) ns
No improvement/increase FiO2 needed 2/8 (25%) 1/2 (50%) ns




In this retrospective cohort study, we observed that infants receiving propofol had a 
higher level of comfort compared to the infants receiving no sedation before MIST. 
However, infants receiving propofol desaturated for a longer period, needed temporarily 
nIPPV more frequently during the procedure and, although this did not reach 
significance, more often infants were intubated during or within 24 hours after MIST. 
All other complications (hypotension and bradycardia) were not different between the 
groups. 
Administration of surfactant without intubation and mechanical ventilation, using 
procedures such as MIST, has recently received increased attention and many neonatal 
units have adopted the method.(4, 7, 20, 21) There is however no consensus on whether 
the procedure should be performed with or without the use of premedication, which has 
been a hot topic for debate. This is the first study describing the comfort of preterm 
infants receiving MIST using objective measurements and the effect of sedation vs 
no sedation. It is argued by Dargaville et al(4) that MIST can generally be performed 
without creating discomfort in the infants, however, this was not objectively evaluated. 
There is consensus that an intubation procedure should be performed while the infant is 
adequately sedated.(9, 10) Laryngoscopy can be painful and is associated with crying 
and increased changes in intracranial pressure when infants are awake.(9, 11, 12) It 
could be reasoned that this also accounts for MIST as laryngoscopy is also performed. 
Although propofol has been used for the intubation-surfactant-extubation (INSURE) 
method, its usage for MIST has not been described before.(17) Propofol is used 
because of its short acting character and it is also used in our unit as sedation for 
endotracheal intubation. We have chosen to use a low dose of propofol for MIST to 
minimize the risk of apnea and hypotension. Propofol has an anxiolytic effect in low 
dosages, but it is not known whether propofol has analgesic effects or not.(22) Propofol 
is effective for obtaining hypnosis and muscle relaxation in endotracheal intubation.(16, 
17) One of the complications of propofol is respiratory depression.(17) This study has 
shown that all infants receiving propofol needed nIPPV temporarily, compared to 33 % 
of infants receiving no propofol. However, respiratory drive might be depressed by the 
use of propofol; of all sedated infants, 2/23 infants (9 %) needed to be intubated during 
the procedure due to other reasons than respiratory depression, as the trachea could 
not be catheterized. To make solid conclusions about respiratory depression caused by 
propofol for MIST, a randomized controlled trial is warranted.
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When high doses of propofol were used (3 and 6 mg/kg), hypotension was considered 
a significant complication during and within 1 hour after intubation.(23, 24) In contrast, 
other studies reported that hypotension did not occur when propofol 2.5 mg/kg was 
used.(16, 25) Interestingly, Welzing et al.(17) also noted a high incidence of hypotension 
even when a dosage of 1 mg/kg was used. However, our study does not confirm this 
as we did not observe more hypotension when we used this low dose compared to no 
sedation. 
The MIST procedure has been recently introduced in our unit and it is possible that infants 
would be more comfortable in a center with extensive experience in the procedure. 
However, the MIST procedures in our study were performed by neonatologists who 
were well trained in endotracheal intubation and laryngoscopy. Also, there were no 
significant differences in duration of the procedure and the frequency of complications 
in the non-sedated group appeared to be low.  
The decision for the use of propofol as premedication for MIST was left to the discretion 
of the attending neonatologist, and a selection bias could have occurred. The reason 
given by the caregivers for the decision to use propofol was expected discomfort. 
However, gestational age, birth weight and COMFORT score before the procedure were 
not different between the groups, which makes it less likely that these items influenced 
the decision of the caregiver to give sedation or not.
This was a small retrospective cohort study with a convenience sample. We already 
reached a large difference in COMFORTneo score in this small group, but it is possible 
that differences in complications would have reached significance in a larger group. 
Although we could not retrieve the COMFORTneo score in all infants, this was equally 
distributed among the study groups. In addition, comfort was scored by nurses who 
were not blinded to the treatment given, which could influence the COMFORTneo 
scores and cause observer bias.
CONCLUSION
In summary, we observed more comfort in preterm infants when they received a low 
dose of propofol (1 mg/kg) as premedication for MIST, but an increase in respiratory 
complications and non-significantly more intubations. However, we do not consider this 
study to be conclusive and a randomized controlled trial is warranted to determine 
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Although sedation for endotracheal intubation of infants is widely adopted, there is no 
consensus whether sedation should be used for minimal invasive surfactant therapy 
(MIST). We compared, in a randomized controlled setting, the level of stress and 
comfort of preterm infants during MIST with and without receiving low dose sedation.
METHODS
Infants between 26 - 36 weeks gestational age were randomized to receive either 
low dose sedation (1 mg/kg propofol iv) or no premedication during MIST procedure. 
Standard comfort care was given in both groups, which consisted of administering 
sucrose in the cheek pouch of the infant and containment. Primary endpoint was the 
percentage of infants assessed to be comfortable during the procedure (COMFORTneo 
score < 14). Secondary parameters included complications of both the MIST procedure 
and low dose sedation administration. 
RESULTS
In total 78 infants were randomized and analyzed, with a median (IQR) gestational age 
of 29+0 (28+0 – 32+0) weeks. The percentage of infants with a COMFORTneo score < 14 
during MIST was significantly higher in the sedated group (32/42 (76 %) vs 8/36 (22 
%), p<0.001). The incidence of desaturation (SpO2 < 85 %) during the procedure was 
significantly higher in the sedated group (38/42 (91 %) vs 25/36 (69 %), p=0.023), and 
infants needed more often nasal intermittent mandatory ventilation during the procedure 
(39/42 (93 %) vs 17/36 (47 %), p<0.001). There were no differences in incidence of 
hypotension, bradycardia, intubation or pneumothoraxes. 
CONCLUSION
Low dose sedation increased comfort during MIST procedure in preterm infants, but the 
need for transient non-invasive ventilation was increased. 




Many preterm infants have respiratory distress syndrome due to surfactant deficiency.
(1) Although nasal continuous positive airway pressure (CPAP) is effective as the initial 
means of respiratory support in most premature infants, a proportion of infants require 
surfactant therapy in order to succeed on CPAP.(2, 3) However, this has traditionally 
involved intubation followed by mechanical ventilation. Avoiding mechanical 
ventilation has the potential to decrease the risk for intraventricular hemorrhage (IVH), 
bronchopulmonary dysplasia (BPD) and death.(4, 5) This can be achieved with MIST, 
where surfactant is administered to a spontaneously breathing infant who then remains 
on CPAP.(6, 7) The most common method for this approach involves visualising the 
vocal cords with a laryngoscope and catheterising the trachea using a semi-rigid 
catheter, after which the surfactant is instilled.(8) Currently, many Neonatal Intensive 
Care Unit (NICU) centers, including in the Netherlands, have adopted this procedure. 
There is general consensus that an infant should be adequately sedated when an 
endotracheal intubation procedure is performed.(9-12) Although it is known that 
visualising the vocal cords with a laryngoscope is highly uncomfortable(13), there is 
still no consensus on whether or not to use sedation during MIST, particularly when 
a laryngoscope is used. The use of a laryngoscope can lead to cardiovascular 
responses and attempts to resist the laryngoscope might result in an increased risk of 
intraventricular hemorrhage by impairing cerebral venous return.(14-17) While sedation 
might also increase the chance for an uneventful, smooth and successful procedure, 
sedation might compromise the infant’s respiratory drive which is a prerequisite for 
MIST. Reported experience from feasibility studies suggests that the MIST procedure 
is generally well tolerated without any premedication.(1, 6, 8) However, Klotz et al.(18) 
reported in a European survey that almost half of the neonatologists use premedication 
during MIST procedures, including sedatives. 
We have performed a randomized controlled trial where we hypothesized that low dose 
sedation would increase the comfort of preterm infants during the MIST procedure 
with minimal side-effects. The aim of this study was to compare the level of comfort of 




A randomized controlled trial was conducted at the Leiden University Medical Center, 
including all preterm infants with a gestational age between 26 - 37 weeks needing 
surfactant therapy for respiratory distress syndrome according to the local criteria 
(FiO2 > 0.3 and PEEP ≥ 8 cm H2O). Opaque sealed envelopes were used to determine 
randomization: low dose sedation or no premedication. We excluded infants who had an 
imminent need for intubation because of respiratory insufficiency, expressed by apnea 
and/or persistent acidosis. Infants with a pneumothorax or pulmonary hemorrhage were 
also excluded. All infants < 30 weeks gestational age (GA) received caffeine in the 
delivery room or at admission to the NICU. Infants > 30 weeks GA received caffeine 
in case of recurrent apnea. Allocation was stratified by GA (26+0 – 31+6 and 32+0 – 36+6 
weeks) using variable block sizes (4-8). 
The intervention consisted of the use of administering intravenous propofol (1 mg/kg) for 
sedation during the MIST procedure. This is a reduced dose compared to the standard 
dose of 2.5 mg/kg used for neonatal intubation, to prevent side effects as respiratory 
depression. Propofol was administered intravenously, either by peripheral or central 
vein dependent on the iv access point of the infant. The administration was performed 
slowly directly before MIST, to refrain from thoracic rigidity and pain at administration 
point. Both groups received standard comfort care, which consisted of administering 
sucrose 24% in the cheek pouch of the infant and containing the infant during the MIST 
by swaddling the infant or gently placing the hands of a caregiver on the infant’s body.
The main study parameter was the COMFORTneo score; the primary endpoint was 
the percentage of infants with a COMFORTneo score < 14 during the procedure. 
The COMFORTneo score is a validated instrument for measuring objectively the (dis)
comfort of a preterm infant,(19) and is used by trained NICU nurses as standard of 
care to assess the comfort of a preterm infant every shift at the NICU of the LUMC. The 
procedure was video recorded, where both the face of the infant and the motions of 
one of the extremities could be observed, while the other extremities were contained. 
The recordings were coded and edited so that the administration of sedation was not 
visible, and two independent NICU nurses, blinded for the allocation, reviewed the 
recordings and measured the level of comfort using the COMFORTneo scale. Both 
nurses assessed comfort in 10 MIST procedures, after which interrater reliability between 
these nurses was assessed. Cohen’s κ was used to assess interrater reliability, where 0 
means no agreement and 1 means total agreement. A Cohen’s κ > 0.4 was considered 
reasonable. When interrater reliability appeared to be < 0.4, an additional NICU nurse 
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assessed the same 10 MIST procedures, to find reasonable reliability between two 
NICU nurses. When reasonable Cohen’s κ was achieved within two NICU nurses, the 
remaining MIST procedures were subdivided into those two nurses for assessment.
Secondary study parameters were: the occurrence of nasal intermittent mandatory 
ventilation (nIMV) during and immediately after the procedure, intubation need during 
the procedure and within 24 hours, number of attempts of insertion of the angio-catheter, 
duration of the procedure, complications occurring during the procedure (desaturation 
< 85 %, hypotension with mean < GA, bradycardia < 80 bpm, nasal hemorrhage), other 
complications (pneumothorax, pulmonary hemorrhage, resuscitation, intraventricular 
hemorrhage ≥ grade 3, death), and heart rate and blood pressure before, during and 
after the procedure. Oxygenation and heart rate were measured with the Masimo SET 
pulse oximeter. Arterial blood pressure was measured using an IntelliVue MP30 Philips 
Monitor. If an arterial line was not present, blood pressure was measured non-invasively 
using an appropriately sized neonatal cuff (Philips). All clinical parameters were stored 
every minute in the local Patient Data Management System (Metavision, IMDSoft, Tel 
Aviv, Israel).
As there was no data available on comfort during MIST to base the sample size on, 
we based our sample size calculation on a study that compared intubation during 
sevoflurane anaesthesia with awake intubation in preterm infants.(20) In this trial, the 
incidence of hypertension, which is a sign of discomfort, was 25% in the anaesthetized 
infants as compared to 56% in awake infants. To detect a comparable decrease in the 
incidence of COMFORTneo score > 14 when using propofol, with a power of 80% and 
an α error of 5% (two-tailed test), we required 39 infants for each arm. 
The ethical committee of the LUMC approved the study protocol. Informed parental 
consent was obtained if time permitted to do so before MIST. However, when MIST 
was imminent and there was no time to approach parents for consent or this was 
considered inappropriate, deferred consent was asked at a more appropriate time 
after the procedure. This study was registered in www.trialregister.nl, with registration 
number NTR5010.
Statistical analysis was performed with SPSS software version 23.0 (SPSS, Chicago, 
Illinois). Demographics of the sedated and the non-sedated group were compared by 
α2 test, Student’s t-test and Mann-Whitney U test based on normality of the data. Linear 
study parameters that were assessed once per infant were compared by a two-way 
factorial ANOVA or a linear mixed-effect regression model in multiple assessments, 
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including both the randomization and stratification group. Categorical outcomes were 
assessed by Fisher’s exact test. Two-sided p-values <0.05 were considered statistically 
significant. 
RESULTS
A total of 110 eligible infants were admitted to the NICU between January 2015 and 
July 2017, of which 22 infants were not randomized (Figure 1). However, 4 infants in the 
sedated group and 6 infants in the non-sedated group were excluded from analysis. A 
total of 78 infants were analyzed, of which 42 in the sedated group and 36 in the non-
sedated group. There were no differences between the groups in GA, birth weight or 
gender (Table 1). 
Figure 1  |  CONSORT flow diagram
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Gestational agea 29+0 (27+5 – 32+0) 29+0 (28+0 – 31+0) 0.731
Birth weight (grams)b 1475 ± 575 1502 ± 606 0.837
Gender (% males)c 26/42 (62%) 20/36 (56%) 0.647
Data are presented as median (IQR) for non-parametric data (a), mean ± SD for parametric data (b) and n (%) for 
categorical data (c).
MIST procedure
Time point after birth when MIST procedure was performed was not different (sedated 
vs non-sedated group: median (IQR) 5.5 (3 – 15) hours vs 6.5 (3 – 14) hours, p=0.7). 
The number of attempts needed to insert the angio-catheter in the trachea was not 
different (1 (1 – 2) attempts vs 1 (1 – 2) attempts, p=0.982). There was no difference 
in total duration of the MIST procedure (246.1 ± 174.8 s vs 246.1 ± 178.4 s, p=0.641).
COMFORTneo score
The percentage of infants with a COMFORTneo score < 14 during MIST was significantly 
higher in the sedated group when compared to the non-sedated group (32/42 (76%) vs 
8/36 (22%), p<0.001). 
The mean ± SD COMFORTneo score during MIST was significantly lower in the sedated 
group compared with the non-sedated group (12 ± 3 vs 17 ± 4, p<0.001). 
Complications
The incidence of desaturation was significantly higher in the sedated group (38/42 
(91%) vs 25/36 (69%), p=0.023). There was no difference in mean blood pressure in the 
30 minutes before MIST, during MIST and 30 minutes after MIST (Table 2). The incidence 
of hypotension was not significantly different between the groups (p=0.282), as was 
volume expansion as treatment of hypotension (p=1.000) (Table 2). In both groups, heart 
rate was significantly lower during and after the procedure when compared to before 
the MIST procedure. In the sedated group, the difference in heart rate was significantly 
greater between the periods before, during and after MIST when compared to the non-
sedated group (p=0.002). There was no difference in the occurrence of bradycardia 
(heart rate < 100 bpm, p=0.556) (Table 2). 
More infants in the sedated group needed nIMV during MIST (39/42 (93%) vs 17/36 
(47%), p<0.001), but there was no difference in duration of nIMV given (median 
(IQR) time 7 (3 – 21) minutes vs 6 (3 – 12) minutes, p=0.274). Applying nIMV was not 
influenced by the different GA strata (Figure 2).
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Incidence of desaturationa 38/42 (91%) 25/36 (69%) 0.023
Incidence of hypotensiona 9/30 (30%) 2/17 (12%) 0.282
Treatment for hypotensiona 3/9 (33%) 0/2 (0%) 1.000
Blood pressure (mean mmHg)b 0.145
Before MIST 37 ± 8 38 ± 7
During MIST 35 ± 7 39 ± 5
After MIST 35 ± 7 38 ± 4
Incidence of bradycardiaa 9/42 (21%) 5/35 (14%) 0.556
Heart rate (beats per minute)b 0.002
Before MIST 151 ± 16 148 ± 13
During MIST 143 ± 14 147 ± 13
After MIST 141 ± 13 146 ± 14
Need for nIMVa 39/42 (93%) 17/36 (47%) < 0.001
Duration of needed nIMV (minutes)c 7 (3 – 21) 6 (3 – 12) 0.274
Intubation during MISTa 1/42 (2%) 4/36 (11%) 0.175
Intubation < 24 h after MISTa 10/42 (24%) 6/36 (17%) 0.576
Incidence of pneumothoraxa 3/42 (7%) 1/36 (3%) 0.620
Incidence of pulmonary hemorrhagea 1/42 (2%) 0/36 (0%) 1.000
Intraventricular hemorrhage ≥ grade IIIa 2/42 (5%) 0/36 (0%) 0.497
Deatha 1/42 (2%) 1/36 (3%) 1.000






































Figure 2  |  Need for nasal intermittent mandatory ventilation (nIMV) during minimal invasive 
surfactant therapy
Only 1 infant in the sedated group was intubated during MIST, while 4 infants were 
intubated in the non-sedated group (1/42 (2%) vs 4/36 (11%), p=0.175). Overall, the 
rate of intubation in the first 24 hours after MIST was similar in the two groups (10/42 
(24%) vs 6/36 (17%), p=0.576). GA stratum did not influence intubation rate.
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The incidence of pneumothorax (3/42 (7%) vs 1/36 (3%); p=0.620) and pulmonary 
hemorrhage (1/42 (2%) vs 0/36 (0%), p=1.000) was not different. There were no 
differences in rates of intraventricular hemorrhage ≥ grade 3 or mortality. None of the 
included infants needed resuscitation during the MIST procedure. 
DISCUSSION
In this randomized study we observed that during the MIST procedure more infants were 
comfortable and the average COMFORTneo score was lower when low-dose sedation 
was given. However, infants that received sedation were more likely to desaturate and 
receive nIMV. There were no differences in other complications of the procedure or the 
use of sedation. This implies that when accepting a temporary need for nIMV, low-dose 
sedation could be used to increase the comfort of preterm infants during the MIST 
procedure, without major clinical implications.
Resistance of the infant during laryngoscopy can lead to an increased risk of 
intraventricular hemorrhage by impairing cerebral venous return.(14-17) Therefore, 
more comfort during the procedure might be beneficial. The results of the meta-analyses 
of studies where no sedation is used, are conflicting.(21,22) While Kribs et al.(2007) 
and Klebermass-Schrehof et al.(2013) described a decrease in IVH, Aldana-Aguirre et 
al.(2016) reported no reduction in IVH. We have reported no differences in rate of IVH 
between the randomization groups, yet this trial was not powered on this outcome.
Cruz et al.(21) reported that infants in the NICU experience many invasive procedures 
each day, with the highest frequency in the vulnerable first week of life. Thereby, infants 
with the lowest GA and at the highest risk for neurological impairment received the lowest 
amount of analgesic interventions.(21) Procedural pain can affect neurodevelopment, 
as the exposure to multiple painful procedures can lead to on-going stress.(22) There 
is evidence that these adverse events can be prevented or minimized by using both 
analgesic and non-pharmacological interventions during painful procedures.(23, 24) 
On the other hand, the use of analgesia can lead to adverse effects in the brain as 
well.(25) A high level of analgesia correlates strongly with reduced cerebellar volume 
and poorer cognitive and motor outcomes in infancy.(26-28) However, in our study we 
used a single low dose of propofol, which reduced the stress of a painful stimulus 




While this is the first trial focussing on sedation during MIST, the use of sedation for 
administrating surfactant by intubation-surfactant-extubation (INSURE) has previously 
been studied.(29) In both the INSURE and the MIST procedure, the sedative agent 
should have a rapid distribution and redistribution.(29, 30) Remifentanil is described 
to have these characteristics, and is therefore used in many clinical applications in 
neonates.(31) However, remifentanil was found to be unsuitable as premedication 
for INSURE, as it did not provide adequate sedation.(30) In addition, remifentanil is a 
potent respiratory depressant, which makes it unsuitable as a sedative for MIST.(31) 
Propofol however, has been widely used as well during intubation and other procedures 
for sedation and anaesthesia.(32-34) Thereby, the level of sedation achieved by the 
use of propofol was considered satisfactory during surgery in the study of Piersigilli et 
al.(33), but this was not evaluated objectively. 
One of the most noted side effects of propofol is the occurrence of hypotension, although 
the incidence varies in studies. Hypotension was not reported in the study which used 
a dose of 2 mg/kg propofol iv(35), while hypotension was reported in studies with an 
even lower dose of propofol.(36, 37) In our study, the observed rate of hypotension is 
similar to our previous observational report.(38) In most infants, hypotension was mild 
and transient and only 3/9 infants (33 %) needed a fluid bolus as treatment.
Only 44 % of infants receiving MIST in the study of Dargaville et al.(8) needed positive 
pressure ventilation, which we confirm in our non-sedated group (47 % needed nIMV). 
However, we report a significantly higher incidence of need for nIMV in the sedation 
group (93 %). This is due to a higher incidence of desaturation, which was comparable 
to the study of Descamps et al.(39) However, the incidence of need for intubation during 
or within 24 hours after the procedure, did not differ between the randomization groups, 
thereby indicating that the need for nIMV was transient.
Intermittent hypoxemia is associated with an impaired neurodevelopmental outcome.
(40) However, infants born preterm are intrinsically at risk for intermittent hypoxic 
episodes during the first 6 - 8 weeks after birth due to immaturity and many other 
factors, with a mean of 100 - 800 hypoxic episodes occurring each week.(40) It is 
therefore difficult or even impossible to differentiate the effect of the single hypoxic 
episode during MIST procedure on outcome. 
The neonatologists performing MIST in this trial were not blinded for the allocated 
treatment. Although there was clinical equipoise, awareness of the treatment allocation 
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could have influenced the use of nIMV. In contrast, the NICU nurses who analyzed 
the primary outcome were blinded, therefore this parameter was not influenced by the 
study design.  
Another limitation of this study is the insufficient sample size to perform sub-analyses 
based on different GA strata. However, as we have included GA strata in the models for 
statistical analyses, our results are corrected for GA.
CONCLUSION
In this randomized controlled trial, we observed that preterm infants were more often 
comfortable during the MIST procedure while more often desaturation occurred and 
nIMV was given. The low dose sedation could help increase comfort during MIST and 
might reduce the risk for neurodevelopmental complications due to stress of a painful 
stimulus. However, only a large and adequately powered randomized trial on this 
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Compared to term infants, the respiratory system of preterm infants is structurally 
and biochemically immature, with a highly compliant chest wall, a large gas diffusion 
barrier and stiff lungs due to structural immaturity and surfactant deficiency.(1) 
Although most preterm infants breathe at birth, respiratory support is often needed to 
ensure adequate gas exchange.(2, 3) While traditionally infants were intubated and 
mechanically ventilated, there is considerable evidence that this approach increases 
the risk of lung and brain injury with subsequent long-term impairment of lung function 
and neurodevelopment.(4, 5) To avoid injury, the focus of respiratory support has 
therefore shifted towards more non-invasive approaches, such as applying positive 
pressure support or ventilation via face mask.(6-10) In addition, immediate cord 
clamping is necessary when stabilizing preterm infants in order to transfer the baby to 
the resuscitation table. However, the interventions that are currently recommended for 
stabilization/resuscitation of the preterm infant are largely based on long held beliefs 
or scientific knowledge coming from fetal or fully transitioned animal models. We know 
very little about how mask ventilation strategies interact and integrate with the infant’s 
physiology as it transitions a from a fetal into a neonatal phenotype. 
The effectiveness of non-invasive ventilation might be hampered by a number of reasons. 
For instance, mask leak is often not recognized by the caregiver and represents one of 
the major causes of ineffective ventilation, as it reduces the administered tidal volumes.
(11-13). Ventilating non-invasively by face mask without leakage requires training and 
experience.(12-15) In addition, commercially available face masks are commonly not 
of an appropriate size for the infant’s face, particularly in preterm infants, making it 
difficult to avoid placing the rim over the chin or eyes.(16-18) As a result, efforts have 
been made to implementing extra training(19), improving ventilation devices(20) and 
designing different masks(21). Another complication is that, in an effort to minimize 
mask leak during ventilation, caregivers may also inadvertently further reduce the 
effectiveness of ventilation by pressing too hard and obstructing the upper airways.
(13, 22, 23)
The adducted larynx at birth has so far been overlooked as a possible cause for 
obstruction. Lung aeration can only take place in case of an open airway – including the 
larynx.(2, 24, 25) However, during fetal life the larynx is chronically adducted to promote 
lung expansion and thereby lung growth and it is unknown when and how the larynx 
adapts to the new function after birth.(25, 26) There is now evidence that immediately 




closed, making ventilation strategies inadequate when applied non-invasively.(24) This 
was recently demonstrated in a preterm rabbit model showing that at birth, the larynx 
is predominantly closed during apnea, and opens only briefly when a breath is taken. 
This pattern changes and the larynx remains mainly open once a stable breathing 
pattern has been established.(24) This explains the distention of the upper airway that 
can occur during mask ventilation, as has been demonstrated in preterm lambs and 
infants by van Vonderen et al.(27) This should be taken into account when targeting 
ventilation, because tidal volumes could be interpreted as ‘appropriate’ during mask 
ventilation, while the closed larynx prevents lung aeration and gas exchange which 
results in inadequate ventilation. This finding could completely change the perspective 
of applying non-invasive ventilation at birth. The mechanisms controlling how the larynx 
functions is still unclear, but preliminary results suggest that it is closely linked to the 
stimulation/suppression of breathing; when breathing is stimulated the larynx is open, 
but when breathing is inhibited the larynx closes. As such oxygenation and aeration of 
the lung play an important role in this. This almost sounds like a catch 22: for a patent 
larynx you need lung aeration and oxygenation, but for lung aeration and oxygenation 
you need a patent larynx. However, spontaneous breathing seems to be able to break 
through this impasse. The larynx will open during a spontaneous breath, allowing air 
to enter the lung. Stimulating spontaneous breathing of preterm infants at birth could 
therefore enhance the success of non-invasive ventilation at birth.
Maintaining spontaneous breathing is also an important goal in the first hours after 
admission to the Neonatal Intensive Care Unit (NICU). While the majority of preterm 
infants leave the delivery room supported by non-invasive ventilation, a proportion of 
them will suffer from severe respiratory distress syndrome, for which administration of 
exogenous surfactant might be needed.(28) Traditionally, intubation and subsequently 
mechanical ventilation was required to administer surfactant, increasing the risk for 
ventilation-induced-lung-injury.(29) However, recent trials have demonstrated the 
feasibility and efficacy of surfactant administration in a minimal invasive way, thereby 
omitting intubation.(30, 31) A stable respiratory drive is a prerequisite to make this 
procedure successful in avoiding intubation and mechanical ventilation. 
We will discuss the interventions to stimulate and maintain spontaneous breathing of 
preterm infants at birth and in the first hours after admission in the NICU, which was the 
aim of this thesis. 
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STIMULATING SPONTANEOUS BREATHING AT BIRTH
Tactile stimulation
The incidence, methods and effect of tactile stimulation in preterm infants at birth is 
described in Chapter 1 & 2. 
Chapter 1 describes a large variability in practice with regard to tactile stimulation. 
The primary method of stimulation varied from rubbing the soles of the feet to rubbing 
the chest and/or back. A similar variety in stimulation methods was described by Baik-
Schneditz et al.(32-34) This wide variety of practices might be due to the international 
resuscitation guidelines not being very specific on timing and methods of recommended 
tactile stimulation.(35, 36) 
Figure 1  |  Pathways involved by different methods of stimulation.
By using different methods of tactile stimulation, activation of different sensory pathways 
could be involved (Figure 1). Stimulation of proprioceptors activated by changing 
the position of the feet and legs by rubbing the soles of the feet has been shown 
to reduce breathing pauses and increase respiratory rate.(37, 38) Rubbing the chest 
or back, thereby activating the somatic or visceral mechanoreceptors in the thoracic 
region might affect the respiratory center as well.(39, 40) Activating a larger number of 
receptors by applying stimulation to a larger cutaneous surface area might increase the 




The true effect of tactile stimulation on respiratory effort is difficult to determine in human 
preterm infants. Clinical equipoise for omitting stimulation is not possible as tactile 
stimulation has been common practice for many years and has become a fundamental 
intervention of resuscitation, even though recent studies described that one third to 
even two thirds of infants do not receive any stimulation.(33, 34) Therefore, the effect 
of standard stimulation (stimulation at the discretion of the caregiver) was compared 
to a strict protocol of repetitive stimulation in our randomized controlled trial in preterm 
infants at birth (chapter 2). It was hypothesized that repetitive stimulation, consisting 
of stimulation episodes of 10 seconds alternated with pauses of 10 seconds, would 
improve breathing effort. Pauses in stimulation were included in an attempt to avoid 
habituation of the reflex.(41) Respiratory effort was shown to be higher in the repetitive 
stimulation group, but these differences did not reach statistical significance. However, 
while infants in the repetitive stimulation group had significantly better oxygenation, 
despite requiring a significantly lower fraction of inspired oxygen (FiO2), the findings 
of an increased respiratory effort were clinically relevant and indicate that applying 
repetitive stimulation may facilitate the respiratory transition of preterm infants at birth.
(42) 
The incidence of stimulation has been studied retrospectively in many studies, and was 
shown to vary between centers: from 35 % in the study of Baik-Schneditz et al. to 90 
% in the study of van Henten et al.(32-34, 43) Lower percentages of stimulation were 
reported in infants < 30 weeks of gestation, which are wrapped in a polyethylene bag.
(32, 34) The polyethylene bag might form a physical barrier and thereby contributes 
to the omission of stimulation.(44, 45) However, these infants usually need more 
(respiratory) support and could benefit from receiving tactile stimulation.
It is important to note that, while we have described an incidence of stimulation of 67 
% during our retrospective study (Chapter 1), the incidence increased when a clinical 
trial was performed, as described in Chapter 2. Despite the fact that infants in the 
standard stimulation group were supposedly stimulated based on clinical indication, 
the incidence of stimulation appeared to be 96 %.(32-34, 42) It is likely that performing 
a study on a maneuver like tactile stimulation produced a Hawthorne effect, leading 
to an increase in applying stimulation in the control group.(42) This could explain 
the smaller than expected difference between the intervention and control groups in 
respiratory effort, resulting in an underestimation of the effect. Although further larger 
trials are needed to test the effect of repetitive stimulation on clinical outcomes, the 





We reported the effect of oxygenation on respiratory effort at birth in a spontaneously 
breathing preterm rabbit model in chapter 3 and in preterm infants in chapter 5&6.
In the model described in chapter 3, preterm rabbit kittens were breathing spontaneously 
while being supported non-invasively after birth. Kittens showed a more stable breathing 
pattern when FiO2 1.0 was given when compared to FiO2 0.21. Kittens receiving a FiO2 
of 0.21 suffered from apnea, and the breathing pattern was restored more stable after 
rescue ventilation was given with a FiO2 of 1.0 compared to 0.21. 
It is well established that, in utero, when oxygenation levels are reduced below normal 
(PaO2 < 25 - 30 mmHg), fetal breathing movements are greatly reduced or even abolished.
(46-50) On the other hand, hyperoxia can stimulate fetal breathing movements, but the 
stimulatory effect is not sustained.(51-53) After birth, it is now well established that the 
inhibitory effect of hypoxia (PaO2 below 20 - 25 mmHg) on breathing persists for days 
- weeks, it diminishes with time and eventually switches to a stimulation of respiratory 
drive which persists for the remainder of our lives.(54) In addition, intermittent hypoxia 
during uterine contractions might elevate fetal plasma adenosine concentrations, 
which also could inhibit peripheral and central chemoreceptors and cause respiratory 
depression.(55)
Oxygenation is largely defined by the surface area available for gas exchange and 
the diffusion distance as well as the partial pressure gradient for oxygen between the 
alveoli and adjacent capillaries. It has become clear that in most very preterm infants, 
clinicians fail to create adequate lung aeration and thus have to use a higher FiO2 to 
compensate for the suboptimal surface area created for gas exchange. Using the latest 
resuscitation guidelines, most preterm infants fail to reach the 25th percentile of the 
oxygen saturation (SpO2) reference values in the first minutes after birth, despite the 
use of SpO2-based titration.(56-62) Caregivers thereby appear to accept hypoxia and 
disregard the effect on respiratory effort. As increasing the FiO2 can reduce the level 
of hypoxia, this would be expected to increase the respiratory effort in preterm infants. 
However, this has so far only been demonstrated in an observational study where an 
increase in respiratory drive was observed after switching fraction of inspired oxygen 
from 0.21 to 1.0.(63) Nevertheless, it is important to recognize that when hypoxia 
persists for longer than the first 5 minutes after birth, it is associated with a higher risk 
of mortality before hospital discharge and development of intraventricular hemorrhage.
(64) Caregivers should aim for an optimal level of oxygenation in preterm infants directly 




Resuscitation with FiO2 1.0 was shown to increase pulmonary blood flow in a preterm 
lamb model, equal to the increase occurring in term lambs, permitting optimal gas 
exchange, while this increase was not observed in lambs resuscitated with FiO2 0.21.
(65) Up until 2005, guidelines recommended that resuscitation of preterm infants 
commenced with a FiO2 of 1.0 in order to improve oxygenation at birth. However, SpO2 
were not monitored consistently, which resulted in an increased risk for hyperoxia.(66) 
Excessive oxygen exposure should be avoided in infants during stabilization at birth, 
as hyperoxia increases free radical production thereby overwhelming the immature 
antioxidant capacity of the preterm infant, which might lead to damage to cells, enzymes, 
lipids, DNA and proteins.(67-69) Meta-analyses have found that resuscitation of term 
infants at birth with FiO2 0.21 significantly reduced mortality compared with infants 
resuscitated with FiO2 1.0.(70-72) Less data is available in preterm infants, although 
hyperoxia at birth likely increases the risk of bronchopulmonary dysplasia (BPD).(73, 
74) For this reason, international resuscitation guidelines now recommend to initiate 
resuscitation with low FiO2 levels, which should thereafter be titrated based on SpO2 
target ranges.(36) However, the SpO2 target ranges are based on data from healthy 
term and preterm infants, who did not need extensive resuscitation.(75) As such, the 
optimal SpO2 target ranges for compromised preterm infants are not clear, although it 
is possible that better oxygenation is needed for optimal stimulation of spontaneous 
breathing. 
High versus low FiO2 was compared in recent multi-center trials in human preterm 
infants.(58, 59, 61, 62, 76-79) Although a recent systematic review showed no 
differences in percentage of infants achieving SpO2 target ranges between infants 
initiating stabilization with high or low FiO2, the level of evidence of these results is 
low.(80) So far, the studies comparing different initial FiO2 levels did not evaluate the 
effect on respiratory effort. We have conducted a trial to test the effect of initial high 
FiO2 versus low FiO2 with subsequent titration based on SpO2, on respiratory effort 
in the first minutes after birth (Chapter 5 & 6). Respiratory effort was assessed by 
using a respiratory function monitor calculating minute volume and electromyography 
recordings of the diaphragm. In this trial, FiO2 was titrated up from 0.3 to 0.5 and 1.0 
when SpO2 values are below reference ranges, and down from FiO2 1.0 to 0.5, 0.3 and 
0.21 if SpO2 values are above reference ranges. Breathing effort was significantly higher 
in preterm infants who started initially with FiO2 1.0 during stabilization as compared 
to infants initiating with FiO2 0.3, with minute volumes that were almost twice as high in 
the FiO2 1.0-group. Although other interventions described in this thesis had a positive 
effect on increasing breathing effort as well, the magnitude of the difference in MV that 
is shown between the FiO2 1.0-group and the FiO2 0.3-group in the trial described in 
General Discussion
172
Chapter 6 was not demonstrated before in any other trial on breathing effort of preterm 
infants at birth. This indicates that oxygen might be the major contributor to improving 
breathing effort at birth. In addition, infants in the FiO2 1.0-group were significantly 
better oxygenated in the first 5 minutes after birth, with a shorter duration of hypoxia 
without an increase in hyperoxia. The better oxygenation and breathing effort are also 
reflected by a shorter duration in mask ventilation given in the FiO2 1.0-group. These 
results indicate that initiating with a high level of oxygen followed by careful titration to 
avoid hyperoxia, is a better option for stimulating breathing and decreases the need for 
positive pressure ventilation. Although not significantly different, intubation rates in the 
delivery room or within 24 hours after birth, as well as the incidence of intraventricular 
hemorrhage (IVH) and mortality, were higher in the FiO2 0.3-group compared to the FiO2 
1.0-group. However, the current trial was not designed to detect significant differences 
in clinical outcomes. Because of the magnitude of the difference in breathing effort that 
was demonstrated, using this intervention in an appropriately sized clinical trial might 
result in significant differences in clinical outcomes.
It is important to note that, as we have described in Chapter 4, there appears to be 
a clear delay in obtaining the desired oxygen concentration when using a T-piece 
resuscitator in both a bench test and during stabilization of preterm infants at birth. 
As the international resuscitation guideline prescribes evaluation periods of 30 s, the 
clinical evaluation of the infant and physiological parameters might precede the effect 
of the performed intervention (e.g. titration of oxygen).(36) This delay was also present 
in the study by Follett et al.(81) who used different ventilators and different lengths of 
ventilation circuits, while we used the equipment that we use in the clinical setting. 
However, while both the current trial and the trial of Follett et al.(81) demonstrated that 
there appears to be a delay in achievement of desired FiO2, the exact duration of delay 
might be dependent on multiple variables, including type of ventilator and length of 
ventilation circuits. In addition, the rate with which the desired FiO2 is reached in the 
infant might also be dependent of the volume containing the different FiO2 that needs 
to be replaced, which is influenced by the pressure administered (peak inspiratory 
pressure and positive end expiratory pressure), respiratory rate and type of respiratory 
support (CPAP vs positive pressure ventilation (PPV) vs sustained inflation).
Caffeine
In the study described in Chapter 7 we evaluated the effect of administration of caffeine 
base (10 mg/kg, administered by the use of a butterfly needle (21 G) inserted in the 
umbilical vein) in the delivery room on respiratory effort of preterm infants in a small 




a greater respiratory effort, with higher minute volumes, inspired tidal volumes and 
recruitment breaths (with a tidal volume > 8 mL/kg), as compared with infants receiving 
caffeine after admission to the NICU.(82) Although this trial consisted of a small number 
of infants with a gestational age of 24 - 30 weeks, the trial was able to demonstrate a 
significant positive correlation between minute volume and gestational age. The minute 
volume increased by 2.4 mL/min/kg with each day of gestational age. This association 
was even more pronounced when caffeine was administered in the first minutes after 
birth with an increase in minute volume of 4.1 mL/min/kg with each day of gestational 
age.(82) These results indicate that the stimulatory effect of caffeine is gestational age 
dependent, and different caffeine dosages per gestational age would be needed to 
gain the optimal effect on breathing effort.(82) 
Caffeine is a methylxanthine that has a molecular structure similar to adenosine and 
works as an adenosine-receptor antagonist to reduce adenosine-induced respiratory 
depression.(83) The required dosage of caffeine might therefore be influenced by the 
level of adenosine. Inflammation leads to an increase in adenosine levels, and also 
the presence of hypoxia leads to an imbalance between adenosine synthesis and its 
breakdown.(84, 85) 
Although the safety and effectivity of caffeine to prevent apnea of prematurity has 
been demonstrated in a large randomized trial, the optimal timing and dosage is still 
unclear.(86, 87) A systematic review comparing the effects of high versus low doses of 
caffeine in the first days after birth demonstrated that a high dose of caffeine led to a 
decrease in BPD, the combined outcome BPD or death and extubation failure, although 
the level of evidence was reported to be low.(88) However, these findings endorse the 
possible advantages of a higher dose of caffeine, which should be confirmed in a large 
randomized controlled trial. When caffeine is administered even earlier, within the first 
2 days of life , it decreases the risk of developing BPD and improves both short- and 
long-term neurodevelopmental outcomes.(86, 89-92) When administered as soon as 
within 2 hours after birth, it decreases the incidence of CPAP failure, which in turn could 
lead to further improvement in outcome.(93) One possible explanation is increased 
diaphragm activity, which occurs after administration of a loading dose of caffeine, 
leading to higher tidal volumes that are indicative of an increase in respiratory effort.
(94) Since we have described that caffeine administration in the first minutes after birth 
increases respiratory effort which might lead to better outcomes as well, the presence 
of the stimulatory effect of caffeine seems desirable as soon as the infant is born.
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Because caffeine can freely pass the placenta by passive diffusion, administration to 
the mother before or during delivery could potentially lead to a direct stimulating effect 
on respiratory drive of the preterm infant at the time of birth.(95) This was demonstrated 
in the lamb-model of Binder-Heschl et al.(96), which showed that a loading dose of 
caffeine base administered to the ewe resulted in similar plasma caffeine concentration 
in the mother and the lamb, obtained immediately following infusion. In addition, the 
study of Binder-Heschl et al.(96) showed a significant decrease in SpO2 after cord 
clamping in the lambs not receiving caffeine, while this was absent in the caffeine 
treated lambs. It is possible that when antenatal administration of caffeine leads to 
better aeration of the lung, this could decrease the occurrence of hypoxia after early 
clamping of the cord. 
Delayed cord clamping
Before birth, the placental circulation contains approximately 30 – 50 % of the blood 
volume of the combined fetal/placental unit. While the lungs remain unaerated and the 
pulmonary circulation remains vasoconstricted, cardiac output is largely dependent 
on venous return from the placenta. Clamping the umbilical cord before lung aeration, 
therefore, causes umbilical venous return to cease which can lead to a sudden 
decrease in cardiac output. However, when the lungs aerate before cord clamping, the 
associated increase in pulmonary blood flow can replace umbilical venous return as the 
primary source of ventricular preload and as such cardiac output remains unchanged. 
As such, clamping the cord after ventilation onset has less impact on cardiac output 
and avoids the cardiovascular instability at the time of clamping.(97, 98) This has been 
demonstrated in a preterm lamb model showing a more stable heart rate and arterial 
pressure when the cord is clamped after lung aeration compared to clamping before 
lung aeration.(99) In addition, ventilation before clamping of the umbilical cord has 
shown to increase arterial and cerebral oxygenation.(100) Increasing the pulmonary 
blood flow also leads to a better ventilation/perfusion ratio, thereby optimizing the 
uptake of oxygen leading to better oxygenation. This will enhance respiratory effort 
even more.
It is currently unclear how delaying cord clamping affects the respiratory transition after 
birth. Keeping the cord intact should provide the newborn with a baseline PaO2 that is 
no lower than that which occurred before birth, assuming that placental gas exchange 
is still functional. Delaying cord clamping could thereby help in the establishment 
of a continuous breathing pattern after birth, as severe breathing-inhibitory hypoxia 
due to cord clamping would be avoided. On the other hand, the placenta releases 




to inhibit breathing.(101) As such, cutting the cord might be beneficial for breathing 
activity as it would reduce circulating prostaglandin (and adenosine) levels and thereby 
reduce any inhibitory effect on breathing.(102) However, as circulating prostaglandins 
are completely metabolized by circulation through the lung, the inhibitory effect of 
the prostaglandins may only be an issue in apneic infants.(103, 104) This makes it 
only more important that lung aeration occurs while delaying cord clamping. Also, it is 
possible that for those apneic infants, prostaglandin synthesis inhibitors might result in 
an increase in respiratory activity.(105) 
So far, there are no studies assessing respiratory effort of infants receiving delayed 
cord clamping. However, Katheria et al.(106) showed that infants who did not receive 
respiratory support during delayed cord clamping needed significantly more stimulation 
to initiate breathing, and the duration of stimulation was longer to maintain spontaneous 
breathing. During delayed cord clamping, respiratory support could enhance 
spontaneous breathing by improving lung aeration, leading to better oxygenation 
and reducing hypoxia.(100, 107) Although timing of the first breath is a measure of 
respiratory effort, effectivity of spontaneous breathing was not objectively evaluated by 
using respiratory function parameters. By objectively evaluating respiratory effort during 
delayed cord clamping, one could determine to what extent circulating prostaglandin 
affects spontaneous breathing, and thus if there appears to be an indication for the use 
of prostaglandin synthesis inhibitors. 
MAINTAINING SPONTANEOUS BREATHING IN THE FIRST 
HOURS AFTER BIRTH
CPAP
Applying CPAP can be used to facilitate respiratory transition at birth by increasing 
the pressure gradient which promotes alveolar fluid reabsorption and prevents end-
expiratory alveolar collapse. This in turn increases the surface area available for gas 
exchange(108), leading to improved oxygen exchange and a decreased risk of hypoxia.
(109) Also, functional residual capacity will increase by maintaining alveolar aeration 
during both inspiration and expiration, leading to a reduction in work of breathing.(110) 
In infants who breathe spontaneously at birth, CPAP is therefore recommended for use 
as the initial mode of respiratory support.(30, 36) Studies showed that the use of CPAP 
after the initial stabilization at birth led to decreased BPD rates when compared to 
elective intubation and positive pressure ventilation.(4, 111) 
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While the beneficial effects of CPAP use in the delivery room have been shown, the 
optimal CPAP level and strategy remain unclear. A recent review has shown that there 
is a wide variety of CPAP practices across different units, varying in pressure levels and 
titration strategies.(112) Although the international guidelines recommend the use of 
CPAP levels between 5 - 8 cm H2O, experimental studies have shown that higher CPAP 
levels lead to better lung aeration.(24, 113) Instead of using a fixed CPAP level, we 
might need to adjust the level according to the phase of respiratory transition. It is likely 
that higher CPAP levels are initially needed to assist airway liquid clearance during lung 
aeration, whereas during the subsequent phase, the primary role of CPAP is to minimize 
airway liquid re-entry when the lung is at functional residual capacity (FRC).(112) On 
the other hand, sustained high CPAP levels might delay stiffening of the chest wall by 
opposing lung recoil. Therefore, CPAP levels should be weaned down after respiratory 
transition at birth and clearance of lung liquid from the interstitial space. However, more 
data are needed to define the optimal CPAP strategy for facilitating and maintaining 
lung aeration at birth in order to improve oxygenation without causing overdistension 
of the lung.(114)
Surfactant
After transition has been successfully established, respiratory distress syndrome (RDS) 
can cause difficulties in obtaining an appropriate level of oxygenation, which might lead 
to CPAP failure.(8, 10, 115) In this stage, oxygenation can be improved by treating RDS 
with exogenous surfactant, as this results in improved lung compliance and less work of 
breathing.(116) Recently, minimal or less invasive surfactant administration techniques 
have gained increasing favor.(31, 117) This involves administering surfactant via 
nasogastric tubes, angio-catheters or specially designed catheters positioned in the 
trachea, while the infant is spontaneously breathing on CPAP. These techniques have 
shown to be effective, resulting in increased breathing effort.(118-123) However, the 
terminology less or minimally invasive (MIST) is potentially misleading as the procedure 
still involves placement of a catheter in the trachea using a laryngoscope to visualize 
the vocal cords.(31, 117, 124) It is known that laryngoscopy is highly uncomfortable, 
and while this is performed in an awake infant, his/her attempts to resist this procedure 
might lead to negative cardiovascular responses.(125-127) As experiencing pain 
during procedures might affect neurodevelopment of preterm infants, efforts should 
be taken to reduce pain or discomfort during a procedure.(128) In addition, the use of 
sedation to enhance the comfort of the infant during MIST could increase the chance of 
an uneventful procedure. On the other hand, caution is needed as the use of sedation 




We assessed the effect of low-dose propofol as premedication for MIST in an observational 
study and a randomized controlled trial (Chapter 8 & 9).(129, 130) The number of 
infants who were comfortable (COMFORTneo score < 14) was significantly higher in 
the group who received low-dose propofol compared to no premedication. However, 
propofol led to significantly more desaturations and the need for nasal intermittent 
mandatory ventilation (nIMV) also increased, although temporarily.(129) This indicates 
a decrease in respiratory drive or respiratory effort, which might be counterproductive 
as the maintenance of spontaneous breathing is essential for successful administration 
of surfactant in a minimal invasive way. However, this effect was transient and did not 
lead to an increased need for intubation. In addition, the maturity of the respiratory 
center evolves during gestation, which might influence the response to premedication 
as well. Indeed, most infants with a gestational age < 32 weeks receiving propofol 
needed nIMV.(129) It might be because of this, that those infants with a low gestational 
age receive the lowest amount of analgesic interventions, while those infants undergo 
the largest amount of (painful) procedures.(131) Administration of low-dose propofol 
could therefore be considered in obtaining a better level of comfort during MIST. 
The choice of sedative during MIST is dependent of the level of sedation/analgesia 
that can be achieved, counterbalanced by the negative effect it may have on 
respiratory drive. Remifentanil was thought to be promising sedative for procedures 
such as intubation-surfactant-extubation (INSURE) due to its rapid distribution and 
redistribution.(132) However, remifentanil is a potent respiratory depressant and the 
level of sedation during INSURE was not shown to be effective.(133) Recent trials have 
shown an adequate level of sedation when propofol is used and it is now widely used for 
intubation and other procedures.(134-136) However, side effects such as hypotension 
have been described.(137) There is much controversy whether propofol provides 
analgesia next to sedation.(138) Nevertheless, the sedative effect of propofol might 
result in better comfort and thus less stress, thereby avoiding possible negative effects 
of MIST on neurodevelopment.(129) An additional benefit of propofol is its short acting 
anesthetic properties which, in animals, minimizing the swallowing reflex allowing the 
larynx to relax and providing easier access to the upper trachea.
Taken altogether, available data indicate that sedatives can be used to decrease 
discomfort of infant receiving surfactant non-invasively, but dose finding and alternative 




In Chapter 1 & 2 the results of the studies on tactile stimulation are described. While 
the occurrence of tactile stimulation was evaluated by use of a respiratory function 
monitor, motivation to perform tactile stimulation could not be deduced. In addition, the 
incidence of stimulation appeared to increase during the conduction of the randomized 
trial. Therefore, the differences in treatment between the groups were likely smaller than 
expected, leading to smaller-than-expected differences in outcomes. However, although 
the majority of results were statistically not significant, we were able to demonstrate a 
significant difference in oxygenation – representing a clinically relevant effect.
In Chapter 3 the positive effect of the use of 100% oxygen on respiratory effort was 
explicated. This study was limited as oxygenation of the preterm rabbits could not be 
confirmed. We administered 21% O2 or 100% O2, although we do not know what PaO2 
and oxygen saturation levels were achieved and, therefore, to what extent oxygenation 
of the kittens influenced the results. However, the optimal oxygen saturation range that 
we should aim for is not clear in those extreme preterm infants, as the internationally 
recommended target ranges are based on healthy term and preterm infants not 
requiring any resuscitation.
While the randomized trials described in part II of this thesis are limited by a small 
sample size, it is impossible to make clinically relevant treatment recommendations 
on the interventions studied. However, the aim of performing these trials was mainly to 
assess the direct effect of the interventions on respiratory effort, to guide a future larger 
trial focused on an important clinical outcome. 
In part III of this thesis (chapters 8 & 9), the use of propofol as premedication for MIST 
was evaluated, but in both studies the control groups lacked the administration of a 
placebo. This might have influenced the results in terms of applied interventions for 
respiratory support. In case the infant received a low dose of propofol as premedication 
for MIST, the caregivers might have started to increase the level of respiratory support 
sooner, leading to a higher incidence of the use of nIMV. However, during analysis of 
the primary outcome of the randomized trial (level of comfort during the procedure), 
the researchers were blinded for the allocated treatment. Therefore, the conclusions 
made on this outcome are considered valid. However, in Chapter 9, the relatively small 






While we described different ways to stimulate breathing at birth, it is also important to 
recognize that these attempts should not take away the focus on applying adequate 
respiratory support (Figure 2). A possible solution could be to automate some of the 
described interventions to stimulate breathing. We described that tactile stimulation is 
often omitted. The development and use of a device for automated stimulation based 
on respiratory effort of the infant might assist the caregiver during resuscitation. Hereby, 
the caregiver can fully focus on applying optimal non-invasive ventilation by face-mask 
which might lead to less leakage or obstruction. 
Normoxia is also an important determinant of respiratory drive. Ideally, both hypoxia and 
hyperoxia should be avoided. Automated oxygen titration used during resuscitation of 
preterm lambs led to similar time spent below and within SpO2 target range compared 
to manual FiO2 control, but the time spent above target range was significantly shorter 
when using automated control.(139) Optimizing automated oxygen titration in the 
delivery room by using narrower target ranges or devices with better algorithms could 
potentially lead to more time spent within the SpO2 target range, resulting in improved 
respiratory effort.
We have shown in Chapter 7 that the effect of caffeine is significantly related to GA 
of the infant. However, optimal caffeine dosages for infants in different GA ranges are 
not yet defined. In addition, those dosages might need to be defined based on other 
determinants of adenosine levels at birth as well, such as presence of inflammation 
or hypoxia. In addition, the stimulatory effect of caffeine on respiratory effort might be 
present as soon as the infant is born when caffeine would be administered antenatally. 
It has been shown that, using this approach, the required dose is reached immediately 
after birth. Thereby, less interventions might be required after birth focused on 
stimulation of spontaneous breathing. This, in turn, enables the caregiver to focus on 
applying non-invasive respiratory support. Altogether, respiratory transition might occur 
more smoothly, possibly leading to better outcomes.
In case of signs of RDS after admittance to the NICU, surfactant should be administered 
in a way that preserves respiratory drive and prevents discomfort. When we are able to 
determine the optimal dose of propofol in different gestational age ranges during this 
procedure, we might avoid adverse effects on neurodevelopmental outcome due to 
stress during the procedure.
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For each of these interventions, large trials are needed to test these newly acquired 
hypotheses. However, since the subjects of these trials are infants born at the limit 
of viability which are considered most vulnerable, performing multiple trials on the 
same aim seems undesirable. Incorporating all interventions focused on stimulation 
of spontaneous breathing at birth into a bundle of care might reduce the number of 
patients needed to test the effect of our hypotheses. Using experimental studies to 
provide us with knowledge on the physiological basis of each intervention, a bundle 
of care might be composed comprising the optimized version of all interventions. 
Herewith, recommendations can be made on improving respiratory support during 
stabilization at birth.
Figure 2 | Interventions focused on stimulation of spontaneous breathing during 
stabilization at birth. A: Application of continuous positive airway pressure, supplemented 
with inflations if indicated. B: Tactile stimulation. C: Administration of supplemental oxygen. 





The success of non-invasive ventilation depends on the effectiveness of spontaneous 
breathing both during transition and on the NICU. At birth, the importance of larynx 
function has been overlooked in the story of a successful transition of preterm infants. 
Thus, interventions which aide laryngeal patency could be a game changer when non-
invasive ventilation for stabilization of preterm infants is desired. Therefore, the focus 
of the caregiver needs to shift towards stimulation instead of trying to take over the 
spontaneous breathing efforts of the infant with positive pressure ventilation. While 
different ways for supporting and stimulating breathing effort have been investigated 
separately, it is likely that combining these interventions in a bundle of care will increase 
the success in maintaining effective breathing of the preterm infant.
After admission to the NICU, maintaining spontaneous breathing leads to a reduction 
in mortality and morbidity.(111) The success of non-invasively administered surfactant 
has been shown before, and the focus has now shifted to the reduction of side-effects 
accompanied by this procedure. While the effect of non/less-invasive surfactant 
administration on morbidity and mortality still needs to be demonstrated, this procedure 
has already been adopted by many centers world-wide. Most would argue that the 
benefit has already been shown by decreasing the need for mechanical ventilation. In 
this thesis we demonstrated that using a low-dose sedation increases comfort of the 
infant, which has the potential to reduce the risk for neurodevelopmental complications 
due to stress of the procedure. Dose finding and comparison with different agents 
is still needed to find the right balance between comfort and effect on respiratory 
drive. Nevertheless, maintaining spontaneous breathing while avoiding stress during 
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Most preterm infants breathe at birth, but need additional respiratory support due to 
immaturity of the lung and respiratory control mechanisms. To avoid lung injury, the 
focus of respiratory support has shifted from invasive towards non-invasive ventilation. 
However, applying effective non-invasive ventilation is difficult due to mask leak and 
airway obstruction. The larynx has been overlooked as one of the causes for obstruction, 
preventing face mask ventilation from inflating the lung. The larynx remains mostly closed 
at birth, only opening briefly during a spontaneous breath. Stimulating and supporting 
spontaneous breathing could enhance the success of non-invasive ventilation by 
ensuring that the larynx remains open. Maintaining adequate spontaneous breathing 
and thereby reducing the need for invasive ventilation is not only important directly 
after birth, but also in the first hours after admission to the Neonatal Intensive Care 
Unit (NICU). Respiratory distress syndrome (RDS) is an important cause of respiratory 
failure. Traditionally, treatment of RDS required intubation and mechanical ventilation 
to administer exogenous surfactant. However, new ways have been implemented to 
administer surfactant and preserve spontaneous breathing while maintaining non-
invasive support. 
The general aim of this thesis was to evaluate the effect of interventions on the respiratory 
effort of preterm infants performed directly after birth in the delivery room and shortly 
after arrival on the neonatal intensive care unit. The interventions evaluated in this thesis 
are targeted on stimulating and maintainaning spontaneous breathing. This thesis 
comprises experimental studies, observational clinical studies and randomized clinical 
trials. 
STIMULATING SPONTANEOUS BREATHING AT BIRTH
Tactile stimulation
We evaluated the use and effect of tactile stimulation on respiratory effort at birth.
In chapter 1, we evaluated the incidence and methods of tactile stimulation during 
stabilization of preterm infants at birth. In total 245 recordings of video and physiological 
parameters of the stabilization at birth of preterm infants with a gestational age < 32 
weeks were retrospectively analyzed, and details of tactile stimulation during the first 
7 minutes after birth were noted. We observed that tactile stimulation was applied in 
164/245 (67%) of infants during stabilization at birth. Stimulation was clinically indicated 
in 67% of stimulation episodes, but a proportion of infants did not receive stimulation 
while this was indicated. In addition, the starting time, duration and method of tactile 
Summary
193
stimulation varied between infants. The observed variation in practice warrants further 
studies to investigate the most optimal duration and type of tactile stimulation, which 
will then lead to a more specific recommendation of the use of tactile stimulation in 
resuscitation guidelines. 
In chapter 2, we evaluated the direct effect of repetitive tactile stimulation on breathing 
effort of preterm infants at birth in a randomized controlled trial. Preterm infants with a 
gestational age < 32 weeks were randomized to receive repetitive stimulation, defined 
as gently rubbing the back or the soles of the feet during 10 s, alternated with 10 s 
of rest, or standard stimulation, defined as gently rubbing the back or the soles of 
the feet when clinicians considered the breathing to be insufficient or absent. In both 
groups, physiological parameters, including respiratory function monitoring (RFM) 
were recorded during stabilization at birth and analyzed to evaluate respiratory effort. 
Although not significantly different, all respiratory effort values (minute volume (MV), 
tidal volumes (Vt) and rate of rise to maximum tidal volume (RoR)) were higher in the 
repetitive stimulation group. Considering that all measured parameters point to the 
same direction, the findings are likely to be clinically relevant. The study created more 
awareness for tactile stimulation as infants in the standard stimulation group were much 
more frequently stimulated when compared to a cohort in our previous observational 
study (96% vs 67%). Infants in the standard group were often stimulated without a 
clear clinical indication (37%). This could have resulted in reducing the difference in 
outcomes between the two groups. Nevertheless, we observed better oxygenation 
(SpO2 values 87.6 ± 3.3% vs 81.7 ± 8.7%, p=0.01) while less extra oxygen was needed 
at the end of resuscitation (28.2 (22.8 – 35.0) % vs 33.6 (29.4 – 44.1) %, p=0.04) 
in the repetitive stimulation group when compared to the standard group, indicating 
that the non-statistical differences in respiratory function between the two groups were 
biologically significant.
Oxygen
To evaluate the effect of the administration of oxygen on hypoxia-induced breathing 
inhibition at birth, we have performed an experimental study and subsequently a 
randomized controlled trial. To inform the resuscitation guidelines also in a more practical 
way, we evaluated the duration of achievement of desired oxygen concentration at the 
infant while using a T-piece ventilator during stabilization at birth. 
The experimental study comparing using initially 100% O2 with 21% O2 for the stabilization 
of preterm rabbits at birth is described in chapter 3. This experiment consisted of 
two phases. Rabbit kittens who were spontaneously breathing on continuous positive 
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airway pressure (CPAP) were divided into two groups and were initially breathing 
in either 21% O2 or 100% O2, while their breathing pattern was analyzed (phase 
1). All kittens started on CPAP as means of respiratory support, commencing with 
a pressure of 15 cmH2O, which was titrated down to 8 cmH2O, with a rate of 2 cm 
H2O/30 seconds. If kittens became apneic, a rescue intervention was performed with 
positive pressure ventilation (PPV) using a ventilation rate of 60 breaths per minute, 
peak inflation pressure (PIP) of 25 cm H2O and positive end-expiratory pressure (PEEP) 
of 8 cm H2O. The oxygen concentration during the rescue ventilation depended on 
the group. Kittens that commenced in 21% O2 were randomized to receive either 21% 
O2 or 100% O2, whereas kittens that commenced in 100% O2 remained in 100% O2. 
Whenever ventilation alone was not sufficient for regaining a stable breathing pattern, 
physical stimulation was applied. After rescue intervention, breathing pattern was again 
analyzed (phase 2). In both phases, functional residual capacity (FRC) was measured 
using high resolution phase-contrast X-ray imaging as a parameter of lung aeration. 
We observed that initiating resuscitation of preterm kittens with 21% O2 resulted in a 
more unstable breathing pattern (higher variability in inter-breath interval: 68.5 ± 11.9 
% vs 40.1 ± 4.2 %, p=0.042), a lower respiratory rate (29 ± 4 breaths/minute vs 42 
± 3 breaths/minute, p=0.038) and a higher incidence of apnea (11/12 (92%) vs 1/8 
(13%), p=0.001) compared to kittens starting resuscitation in 100% O2. Furthermore, 
the kittens who were rescued with 21% O2 after apnea, also had a higher inter-breath 
variability (83.6 ± 32.2 % vs 9.5 ± 1.3 %, p=0.014) and lower respiratory rate (27 (18 
– 31) vs 45 (39 – 50) breaths/minute, p=0.007) than kittens rescued with 100% O2. 
The degree of lung aeration, as assessed by measuring FRC, was not affected by 
the O2 concentration used for stabilization or rescue from apnea. The degree of lung 
aeration was similar between the two groups, despite a much higher respiratory activity, 
which could be influenced by the moment of start of resuscitation. As the kittens are 
very fragile, providing them with medication, an oesophageal tube, a face mask and 
attaching them to the ventilator is a delicate process, which can vary the delay between 
birth and imaging onset. However, while this delay is not well defined in our study, 
human preterm infants likely experience similar variations in the delay between birth 
and resuscitation onset. However, these data indicate that avoidance of apnea and 
stability of breathing are predominantly determined by oxygenation in the newborn 
immediately after birth.
During stabilization of human preterm infants at birth, oxygen is titrated based on 
oxygen saturation reference ranges described by Dawson et al.(2010) to reduce the 
risk for hypoxia and hyperoxia. During stabilization after birth, infants are evaluated 
every 30 s, which guides the amount of support and titration of additional oxygen. In 
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chapter 4, we described an observational study consisting of a bench test and clinical 
observations of stabilization of preterm infants, which aimed to determine the time 
between adjustment of FiO2 at the oxygen blender and the desired FiO2 reaching the 
preterm infant. A NeopuffTM T-piece Resuscitator attached to a 50 mL test lung or a face 
mask was used to administer CPAP or PPV. The circuit was set up with a flow of 8 L/min, 
PEEP of 8 cm H2O, and a PIP of 20 cm H2O in case of PPV. FiO2 was measured at two 
distinct positions at the circuit, using oxygen analyzers: proximally - at the outlet of the 
NeopuffTM, and distally – between the T-piece of the NeopuffTM and the test lung or face 
mask. This study shows a clear delay in obtaining the desired oxygen concentration at 
the distal part of the NeopuffTM circuit in both the bench test (34.2 (21.8 – 69.1) s) and 
during stabilization of preterm infants at birth (19.0 (0.0 – 57.0) s). As the international 
resuscitation guideline prescribes evaluation periods of 30 s, the clinical evaluation 
of the infant and physiological parameters might precede the effect of the performed 
intervention (e.g. titration of oxygen). This is demonstrated by the finding that in half 
of all titration episodes, the desired FiO2 was not yet reached at the distal part of the 
NeopuffTM circuit. In addition, the time between two titration episodes was less than 30 s 
in 31% of titrations performed in this study. This delay is clinically relevant when aiming 
for adequate mask ventilation, whereby over- and under titration of oxygen might result 
in an increased risk for hypoxia and hyperoxia. Caregivers should be aware of this 
delay when proceeding titration if the effect is not forthcoming. With this delay in mind, 
trials should focus on determining the optimal titration steps to achieve normoxia. 
In Chapter 5 we described the study protocol of our randomized controlled trial on 
initiation stabilization with a FiO2 of 0.3 or 1.0, with subsequent titration of FiO2 based 
on oxygen saturation. Previously reported trials comparing high versus low levels of 
oxygen did not report on how oxygenation levels influence respiratory effort. Although 
the level of respiratory support during stabilization at birth was reported in most trials 
and shown to be not significantly different, the effectiveness of spontaneous breathing 
in both infants receiving higher or lower FiO2 was not evaluated. Gaining an adequate 
level of spontaneous breathing during stabilization at birth to improve the success 
of non-invasive respiratory support could potentially lead to a lower incidence of 
intubation and mechanical ventilation in the delivery room, contributing to a lower risk 
of lung injury in high-risk preterm infants. Therefore, our study protocol aims to evaluate 
respiratory effort during stabilization at birth.
In chapter 6, the results of our randomized trial on stabilization with an initial FiO2 of 0.3 
or 1.0 are shown. In total 52 infants were randomized, and physiological parameters on 
breathing effort and oxygenation could be recorded of 44 infants (20 infants in 100% 
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O2-group, 24 infants in 30% O2-group). Average minute volume/kg was significantly 
higher in the 100% O2-group (146.34 ± 112.68 mL/kg/min vs 74.43 ± 52.19 mL/kg/min, 
p=0.014). Average tidal volumes and rate of rise to maximum tidal volumes in the first 
5 minutes after birth were significantly higher in the 100% group, while the duration of 
mask ventilation given was significantly shorter. Oxygenation was significantly higher 
in infants in the 100% O2-group (85 (64 – 93) % vs 58 (46 – 67) %, p<0.001). The 
duration of hypoxia was significantly shorter in the 100% O2-group, while the duration 
of hyperoxia (SpO2 > 95%) was not different between groups. These results indicate 
that initiating with a high level of oxygen followed by careful titration to avoid hyperoxia, 
is a favourable option for stimulating breathing and decreasing the need for positive 
pressure ventilation. 
Caffeine
In chapter 7 we evaluated the effect of administration of caffeine base (10 mg/kg, 
administered by the use of a butterfly needle (21 G) inserted in the umbilical vein) in the 
delivery room on respiratory effort of preterm infants. We randomized 30 infants with 
a gestational age < 30 weeks to receive caffeine in the delivery room or after arrival 
at the NICU. To evaluate the effect on respiratory effort, we used the RFM to measure 
MV, Vt, RoR, respiratory rate and recruitment breaths. We observed that MV at 7 – 
9 minutes after birth was significantly greater when caffeine was administered in the 
delivery room, after correction for gestational age (189 ± 74 mL/kg/min vs 162 ± 70 mL/
kg/min, p<0.05). While respiratory rate did not increase, all other parameters assessing 
respiratory effort increased significantly by caffeine administration, including Vti, RoR 
and the percentage of recruitment breaths. Furthermore, in caffeine treated infants, 
we found that the relationship between MV and gestational age was highly significant 
(p=0.0008), with MV increasing at a rate of 4.1 mL/min/kg/day. In contrast, in control 
infants the relationship between MV and gestational age just failed to reach statistical 
significance (p=0.09), due to the small number of observations, with MV tending to 
increase at only 2.3 mL/min/kg/day. These findings indicate that caffeine enhances the 
gestational age-related increase in MV and that the stimulatory effect of caffeine on MV 
increases with gestational age. These results indicate that caffeine at birth could play a 
role in stimulating breathing during transition at birth. 
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MAINTAINING SPONTANEOUS BREATHING AFTER BIRTH
While the majority of very preterm infants leave the delivery room supported by 
non-invasive ventilation, in a large proportion their spontaneous breathing will be 
compromised by development of respiratory distress syndrome, for which administration 
of exogenous surfactant might be needed. Traditionally, intubation and subsequently 
mechanical ventilation was required to administer surfactant, increasing the risk for 
ventilation-induced-lung-injury. However, recent trials have demonstrated the feasibility 
and efficacy of surfactant administration in a minimal invasive way, thereby maintaining 
spontaneous breathing and avoiding intubation. A stable respiratory drive is a 
prerequisite to make this procedure successful in avoiding intubation and mechanical 
ventilation. 
In Chapter 8 we described our retrospective study on the effect of sedation during 
minimal invasive surfactant therapy (MIST) in preterm infants. MIST was performed in 
38 infants with a gestational age of 26 - 37 weeks, using the method as described earlier 
by Dargaville et al.(2011), in which the vocal cords are visualized using a laryngoscope 
where after a semi-rigid angiocatheter was orally introduced to catheterize the trachea. 
Sedation (propofol 1 mg/kg) was optional and left to the discretion of the caregiver. 
Standardized COMFORTneo scores were compared and COMFORTneo < 14 was 
considered comfortable. We observed that preterm infants were more comfortable 
when they received a low dose of propofol as premedication for MIST (COMFORTneo 
score sedated group 12 (9 – 17) vs non-sedated group 20 (15 – 23), p=0.002), but 
the occurrence of respiratory complications was increased (incidence of nasal 
intermittent mandatory ventilation (nIMV) 23/23 (100%) vs 5/15 (33%), p<0.001) and 
non-significantly more intubations took place (8/23 (35%) vs 2/15 (13%), ns). These 
results needed to be confirmed in a randomized controlled trial to determine whether 
the benefit of sedation in comfort outweighs the risks for complications. 
We therefore conducted a randomized trial on the use of sedation during MIST, which is 
described in chapter 9. In this randomized controlled trial, 78 infants with a gestational 
age between 26 - 37 weeks were randomized to receive either low dose sedation (1 mg/
kg propofol iv) or no premedication during MIST procedure using the same technique 
as in the observational study. Standard comfort care was given in both groups, which 
consisted of administering sucrose in the cheek pouch of the infant and containment. 
We assessed the percentage of infants that were comfortable during the procedure 
(COMFORTneo-score < 14), as well as complications of both the MIST procedure and 
low dose sedation administration. We observed that preterm infants were more often 
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comfortable during the MIST procedure (percentage of infants with COMFORTneo 
score < 14: 32/42 (76%) vs 8/36 (22%), p<0.001). Although more often desaturation 
occurred (38/42 (91%) vs 25/36 (69%), p=0.023) and nIMV was given (39/42 (93%) 
vs 17/36 (47%), p<0.001), there was no increase in failed MIST procedure for which 
intubation was needed. We concluded that the low dose sedation could help increase 
comfort during MIST and might reduce the risk for neurodevelopmental complications 
due to stress of a painful stimulus. However, because of the relatively small sample size 
we are not able to distinguish the effect on complications between different gestational 
age strata. Therefore, a large and adequately powered randomized trial is warranted in 
order to guide recommendations for infants of different gestational ages.
In conclusion, the success of non-invasive ventilation depends on the effectiveness of 
spontaneous breathing both during transition and on the NICU. Therefore, the focus 
of the caregiver needs to shift towards stimulation instead of trying to take over the 
spontaneous breathing efforts of the infant with positive pressure ventilation. While 
different ways for supporting and stimulating breathing effort have been investigated 
separately, combining these interventions in a bundle of care will potentially increase 
the success in maintaining effective breathing of the preterm infant, which could 






De meeste kinderen die te vroeg (prematuur) geboren worden ademen zelfstandig 
bij de geboorte. Doordat hun longen en ademhalingssysteem onderontwikkeld zijn, 
is ondersteuning van hun ademhaling noodzakelijk om voldoende zuurstofopname te 
garanderen. Om schade aan hun onderontwikkelde longen te voorkomen, wordt deze 
ondersteuning niet standaard via een beademingsbuisje gegeven, maar wordt er een 
masker geplaatst over neus en mond (non-invasieve ondersteuning). Via dit masker 
voorziet een continue luchtstroom de longen van positieve druk en eventueel een 
verhoogde zuurstofconcentratie. Deze ondersteuning is echter alleen effectief als de 
luchtstroom de longen kan bereiken – in het geval van een open luchtweg. Bij de geboorte 
zijn de stembanden voornamelijk gesloten, tenzij een spontane ademhalingsteug 
wordt genomen. Ten gevolge hiervan is de ademhalingsondersteuning slechts effectief 
wanneer er spontane ademhaling plaats vindt. Stimulatie van de spontane ademhaling 
kan daardoor het succes van de non-invasieve ondersteuning bevorderen.
Het behouden van effectieve spontane ademhaling, en daarmee het voorkomen van 
de noodzaak tot het plaatsen van een beademingsbuisje (intubatie) en het geven 
van beademing, is niet alleen belangrijk bij de geboorte, maar ook na opname op de 
neonatale intensive care unit (NICU). Een veelvoorkomend probleem in de eerste uren 
na de geboorte, is het respiratoir distress syndroom (RDS). Bij dit ziektebeeld is er een 
tekort aan de oppervlakteverlagende stof surfactant, waardoor longblaasjes makkelijk 
dichtvallen tijdens de uitademing. Hierdoor kan er minder zuurstof worden opgenomen 
in het bloed. Het opnieuw openen van de longblaasjes kost veel kracht, iets waar het 
een prematuur kind nu juist aan ontbreekt. Om deze problemen te verhelpen, kan 
surfactant worden toegediend aan de longen. Deze toediening gebeurde lange tijd 
via een beademingsbuisje. Echter, om intubatie en beademing te voorkomen, zijn 
nieuwe methoden ontwikkeld om surfactant te kunnen toedienen terwijl de spontane 
ademhaling behouden blijft.
Dit proefschrift had tot doel om het effect te evalueren van verscheidene interventies 
die vlak na de geboorte en na opname op de NICU worden toegepast om de spontane 
ademhaling te stimuleren en behouden. Dit proefschrift omvat een experimenteel 
onderzoek, observationele klinische studies en gerandomiseerd klinische trials.  
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STIMULATIE VAN DE SPONTANE ADEMHALING BIJ 
GEBOORTE
Tactiele stimulatie
Het gebruik van tactiele stimulatie om de ademhalingskracht te bevorderen is de eerste 
interventie die wordt geëvalueerd in dit proefschrift.
Hoofdstuk 1 beschrijft het gebruik van tactiele stimulatie tijdens de opvang van 
premature kinderen, geboren na een zwangerschapsduur van ten hoogste 32 weken, en 
de methoden die hiertoe worden gebruikt. In totaal werden 245 opnames geanalyseerd, 
bestaande uit videobeelden van de opvang en opnames van een respiratoire functie 
monitor (RFM) die gebruikt wordt om fysiologische metingen, zoals de longfunctie, te 
beoordelen. Details met betrekking tot tactiele stimulatie in de eerste 7 minuten na 
geboorte werden genoteerd. Aan 164/245 (67%) kinderen werd tactiele stimulatie 
gegeven tijdens de opvang na de geboorte. Bij 67% van deze kinderen was hier een 
klinische reden voor, zoals het ontbreken van een effectieve spontane ademhaling, 
een lage hartslag of een lage zuurstofsaturatie in het bloed. Er was echter ook een 
groep kinderen waarbij wel een klinische indicatie bestond voor het gebruik van tactiele 
stimulatie, maar waarbij dit vervolgens niet werd toegepast. We hebben verschillen 
geobserveerd in het tijdstip waarop tactiele stimulatie werd gestart, de duur van tactiele 
stimulatie en de gebruikte methode. Vervolgonderzoek is noodzakelijk om specifieke 
aanbevelingen te kunnen doen met betrekking tot de meest optimale duur en methode 
van tactiele stimulatie om de spontane ademhaling te stimuleren.
Vervolgens werd een gerandomiseerde klinische trial opgezet, welke wordt 
beschreven in hoofdstuk 2. Door middel van loting werden kinderen, geboren 
na een zwangerschapsduur van ten hoogste 32 weken, toegewezen aan 1 van de 
behandelgroepen. Eén groep kinderen ontving herhaalde tactiele stimulatie, waarbij 
er afwisselend 10 seconden werd gewreven over de voetzool of de rug van het kind, 
en 10 seconden geen stimulatie plaats vond. De andere groep kinderen ontving 
standaard tactiele stimulatie, waarbij er over de voetzool of rug van het kind gewreven 
werd wanneer de zorgverlener hier een klinische reden toe zag. In beide groepen 
werd de ademhalingskracht beoordeeld door middel van de RFM. Ook al konden er 
geen statistisch significante verschillen worden aangetoond, waren alle parameters 
van ademhalingskracht (ademminuut volume (AMV), teugvolumes (Vt) en snelheid 
waarmee de maximale teugvolumes werden bereikt) hoger in de herhaalde stimulatie-
groep. Omdat alle gemeten parameters dezelfde kant op wijzen, is het waarschijnlijk 
dat de bevindingen klinisch relevant zijn. Door het uitvoeren van deze studie werd 
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het bewustzijn onder de zorgverleners vergroot met betrekking tot het nut van tactiele 
stimulatie. Dit bleek uit het feit dat in 96 % van de kinderen in de standaard stimulatie-
groep tactiele stimulatie werd toegepast, een percentage dat aanzienlijk hoger is dan 
het percentage kinderen dat tactiele stimulatie ontving in het onderzoek beschreven 
in hoofdstuk 1. Mogelijk zijn de verschillen in uitkomsten tussen de groepen hierdoor 
kleiner dan verwacht. Desondanks was de zuurstofsaturatie (SpO2) van het bloed 
significant hoger in de herhaalde stimulatie-groep (SpO2 87.6 ± 3.3% vs 81.7 ± 8.7%, 
p=0.01), terwijl de concentratie zuurstof die werd toegediend aan het einde van de 
opvang significant lager was in deze groep (28.2 (22.8 – 35.0) % vs 33.6 (29.4 – 44.1) 
%, p=0.04). Ook al was de ademhalingskracht niet statistisch significant hoger in de 
herhaalde stimulatie-groep, zijn de gevonden verschillen biologisch wel significant.
Zuurstof
Een te laag zuurstofgehalte in het bloed (hypoxie) heeft een remmende werking op 
de ademhaling bij geboorte. Zowel een experimenteel onderzoek alsmede een 
gerandomiseerde klinische trial zijn opgezet om te evalueren of het zuurstofgehalte in het 
bloed kan worden verhoogd indien extra zuurstof wordt gegeven bij geboorte, teneinde 
de ademhalingskracht te stimuleren. Daarnaast hebben we in een observationele studie 
geëvalueerd hoelang het duurt totdat de ingestelde zuurstofconcentratie daadwerkelijk 
het kind bereikt.
Hoofdstuk 3 beschrijft het experimentele onderzoek waarbij de ademhaling van 
premature konijnen bij geboorte wordt onderzocht wanneer zij worden ondersteund 
met 21% of 100% zuurstof. Hierbij werden zowel de stabiliteit van ademhaling gemeten, 
alsmede de luchthoudendheid van de long (gemeten door het longvolume dat in 
de long achterblijft na een uitademing (de functionele residu capaciteit (FRC)). Het 
FRC werd gemeten door middel van röntgenstraling met hoge resolutie, waarvoor de 
synchrotron in Japan gebruikt werd. 
Wanneer tijdens de start van het experiment 21% zuurstof werd gegeven, leidde dit tot een 
instabieler ademhalingspatroon (hogere variatie in lengte tussen 2 ademteugen, lagere 
ademhalingsfrequentie) dan wanneer het experiment werd gestart met 100% zuurstof. 
Tevens trad er vaker een apneu op (21% zuurstof-groep: 11/12 (92%) vs 100% zuurstof-
groep: 1/8 (13%), p=0.001). Wanneer vervolgens ten tijde van de apneu beademing 
werd gegeven met 21% zuurstof, leidde dit na hervatting van de spontane ademhaling 
opnieuw tot een meer instabiel ademhalingspatroon, dan wanneer er beademing werd 
gegeven met 100% zuurstof. Ondanks het verschil in ademhalingspatroon, was de 
mate van luchthoudendheid van de long (gemeten door FRC) vergelijkbaar tussen 
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de groepen. Concluderend kunnen we stellen uit de resultaten van dit onderzoek dat 
het voorkomen van apneu en stabiliseren van de ademhaling hoofdzakelijk beïnvloed 
worden door de verzadiging met zuurstof vlak na geboorte. 
Tijdens de opvang van premature kinderen wordt de SpO2 continu gemeten, en 
vergeleken met referentiewaarden opgesteld door Dawson et al. (2010). Na de geboorte 
wordt iedere 30 seconden geëvalueerd of de toegediende zuurstofconcentratie moet 
worden aangepast, teneinde het risico op zowel een te lage (hypoxie) als een te hoge 
zuurstofconcentratie in het bloed (hyperoxie) te voorkomen. In de observationele studie 
die beschreven wordt in hoofdstuk 4 wordt de tijd onderzocht die verstrijkt tussen het 
aanpassen (titratie) van de zuurstofconcentratie op de zuurstofblender en het moment 
waarop de gewenste concentratie het kind bereikt. Deze tijd is geëvalueerd tijdens 
zowel bench tests, als tijdens klinische observaties van de opvang van premature 
kinderen. Hieruit bleek een duidelijke vertraging in het bereiken van de gewenste 
zuurstofconcentratie bij het kind (bench tests: 34.2 (21.8 – 69.1) s, klinische observaties: 
19.0 (0.0 – 57.0) s). Indien tijdens de opvang na geboorte, volgens de internationale 
richtlijnen, iedere 30 seconden wordt geëvalueerd of de zuurstofconcentratie dient te 
worden getitreerd, heeft mogelijk de zuurstofconcentratie van de vorige titratie het kind 
nog niet bereikt – iets wat in de helft van de titratiemomenten werd aangetoond in dit 
onderzoek. Zorgverleners dienen zich bewust te zijn van de vertraging die optreed 
na titratie van de zuurstofconcentratie op de zuurstofblender indien de titratie geen 
verschil in SpO2 tot gevolg heeft. 
In hoofdstuk 5 wordt het studieprotocol beschreven voor een gerandomiseerde 
klinische trial waarbij tijdens de opvang na de geboorte premature kinderen worden 
ondersteund met non-invasieve ondersteuning met 100% of 30% zuurstof. Na deze 
initiële concentratie zal de zuurstofconcentratie worden getitreerd op basis van 
SpO2. Ondanks dat er eerdere onderzoeken zijn gedaan naar klinische uitkomsten bij 
verschillen in initiële zuurstofconcentratie, is de effectiviteit van de spontane ademhaling 
nooit eerder geëvalueerd.  
De resultaten van deze gerandomiseerde klinische trial worden weergegeven in 
hoofdstuk 6. In totaal werden 52 kinderen door middel van loting toegewezen aan 1 
van de behandelgroepen: een initiële zuurstofconcentratie van 100%, dan wel 30%. 
Fysiologische metingen van ademhalingskracht en SpO2 werden verkregen van 44 
kinderen (20 kinderen in de 100% zuurstof-groep, 24 kinderen in de 30% zuurstof-
groep). AMV, Vt en snelheid waarmee de maximale Vt werden bereikt waren significant 
hoger onder kinderen in de 100% zuurstofgroep. Tevens was de tijd dat deze kinderen 
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tijdens de opvang maskerbeademing kregen significant korter. SpO2 was significant 
hoger in kinderen in de 100% zuurstof-groep (SpO2 100% O2-groep: 85 (64 – 93)% vs 
30% O2-groep: 58 (46 – 67)%, p<0.001). De duur van hypoxie tijdens de opvang was 
lager in de 100% zuurstof-groep, terwijl er geen verschillen werden aangetoond in de 
duur van hyperoxie. Deze resultaten laten zien dat een hoge initiële zuurstofconcentratie 
tijdens de opvang na geboorte, gevolgd door nauwlettende titratie van zuurstof, een 
gunstige methode is om de ademhalingskracht te stimuleren en de noodzaak voor 
masker beademing te verminderen.
Cafeïne
In hoofdstuk 7 wordt het effect van het toedienen van cafeïne vlak na de geboorte op 
de ademhalingskracht van premature kinderen geëvalueerd. In deze gerandomiseerde 
klinische trial werd bij 30 kinderen op basis van het lot bepaald of zij een gift cafeïne 
kregen toegediend tijdens de opvang vlak na geboorte, of na opname op de NICU 
(standaard zorg). Om de ademhalingskracht tijdens de opvang na geboorte te meten, 
werd de RFM gebruikt. Het AMV bleek significant hoger 7 - 9 minuten na geboorte, indien 
kinderen bij geboorte een gift cafeïne toegediend kregen. Vt en snelheid waarmee de 
maximale teugvolumes werden bereikt waren ook significant hoger in de groep kinderen 
die cafeïne kreeg bij geboorte. Hiernaast vonden we ook dat in de cafeïnegroep een 
significante relatie bestond tussen het AMV en de zwangerschapsduur (p<0.001), 
waarbij het AMV toenam met 4.1 mL/min/kg voor elke dag dat de zwangerschapsduur 
toenam. Hoewel er in de groep die geen cafeïne kreeg ook een relatie leek te zijn tussen 
AMV en de zwangerschapsduur, was deze toename kleiner dan in de cafeïnegroep 
(2.3 mL/min/kg per dag dat de zwangerschapsduur toenam), en tevens niet significant 
(p=0.09). Deze resultaten tonen aan dat het stimulerende effect van cafeïne toeneemt 
met de zwangerschapsduur. Het geven van cafeïne tijdens de opvang vlak na de 
geboorte kan een rol spelen in het stimuleren van de spontane ademhaling, en daardoor 
mogelijk de effectiviteit van de non-invasieve ondersteuning bevorderen.
BEHOUDEN VAN DE SPONTANE ADEMHALING
Het merendeel van de premature kinderen verlaat de opvangkamer met non-invasieve 
ademhalingsondersteuning. Echter wordt de spontane ademhaling van een groot 
gedeelte van deze kinderen belemmerd door RDS, wat toediening van surfactant 
noodzakelijk maakt. In de laatste jaren werd aangetoond dat het toedienen van 
surfactant terwijl het kind non-invasief wordt ondersteund, haalbaar en effectief is. Deze 
procedure is echter alleen succesvol in het voorkomen van intubatie en beademing in 
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het geval van een stabiel spontaan ademhalingspatroon. Omdat bij deze procedure 
gebruik wordt gemaakt van een laryngoscoop om de luchtweg in beeld te brengen, kan 
er mogelijk discomfort optreden. 
In hoofdstuk 8 wordt een observationele studie beschreven waarbij het comfort 
van premature kinderen tijdens minimaal invasieve surfactanttherapie (MIST) 
werd geëvalueerd. Surfactant werd toegediend aan 38 kinderen, geboren na een 
zwangerschapsduur tussen 26-37 weken, volgens de methode die eerder werd 
beschreven door Dargaville et al. (2011). Voorafgaand aan de procedure kon een lage 
dosis sedatie (propofol, 1 mg/kg) worden gegeven op basis van de beoordeling van 
de zorgverlener. COMFORT scores werden vergeleken tussen gesedeerde kinderen 
en kinderen die geen sedatie ontvingen. Een COMFORT score < 14 werd gezien 
als een indicator voor comfort. In deze studie bleek dat kinderen meer comfortabel 
waren wanneer zij een lage dosis sedatie kregen voorafgaand aan de MIST procedure 
(COMFORT score sedatiegroep: 12 (9 – 17) vs de niet gesedeerde groep: 20 (15 – 
23), p=0.002). Echter werd er wel een toename in complicaties gezien die betrekking 
hebben op de spontane ademhaling. De incidentie van tijdelijke non-invasieve positieve 
druk beademing (nIPPV) was significant hoger in de groep kinderen die een lage dosis 
sedatie ontving (23/23 (100%) vs 5/15 (33%), p<0.001), en hoewel deze bevinding niet 
significant is, werden er meer kinderen in de sedatie groep geïntubeerd (8/23 (35%) 
vs 2/15 (13%), ns). Om te kunnen aantonen of het voordeel met betrekking tot comfort 
zwaarder weegt dan het nadeel met betrekking tot het risico op complicaties, is er een 
gerandomiseerde klinische trial noodzakelijk.
Deze gerandomiseerde klinische trial werd opgezet, en de resultaten hiervan worden 
beschreven in hoofdstuk 9. Tijdens deze trial werden 78 premature kinderen 
(zwangerschapsduur 26 - 37 weken) door middel van loting toegewezen aan de sedatie 
groep of de geen-sedatie groep. Kinderen in de sedatie groep ontvingen een lage dosis 
sedatie (1 mg/kg propofol iv) voorafgaand aan de procedure, terwijl kinderen in de 
niet gesedeerde groep geen medicatie kregen. Beide groepen kregen standaard zorg 
om het comfort te verhogen, bestaande uit het toedienen van sucrose en containen, 
waarbij het kind wordt vastgehouden op een wijze die vergelijkbaar is aan de positie in 
de baarmoeder. De mate van comfort werd, net als in hoofdstuk 8, geëvalueerd door 
middel van de COMFORT score. De bevindingen van deze gerandomiseerde klinische 
trial zijn vergelijkbaar aan die van de observationele studie: het percentage kinderen 
met een COMFORT score < 14 was significant hoger in de sedatie groep (sedatie 
groep: 32/42 (76%) vs geen-sedatie groep: 8/36 (22%), p<0.001). In de sedatie groep 
trad vaker desaturatie op waarvoor nIPPV werd gegeven (sedatie groep: 39/42 (93%) vs 
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niet gesedeerde groep: 17/36 (47%), p<0.001), echter was er geen significant verschil 
in de incidentie van intubatie. Naar aanleiding hiervan hebben we geconcludeerd dat 
een lage dosis sedatie kan helpen om het comfort van premature kinderen tijdens MIST 
te verhogen. Door het verminderen van stress ten gevolge van een (pijnlijke) stimulus 
kan het geven van een lage dosis sedatie tijdens MIST daarmee mogelijk leiden 
tot een verminderd risico op een verstoorde neurologische ontwikkeling. Mogelijk 
kunnen de uitkomsten variëren, afhankelijk van de zwangerschapsduur bij geboorte. 
Vervolgonderzoek is nodig om dit aan te kunnen tonen.
Concluderend, het succes van non-invasieve ondersteuning van de ademhaling hangt af 
van de effectiviteit van de spontane ademhaling, zowel tijdens de opvang na geboorte, 
als na opname op de NICU. Stimuleren en ondersteunen van de spontane ademhaling 
zou daarom de voornaamste focus moeten zijn van de zorgverlener, om intubatie te 
voorkomen. Ook al is de effectiviteit van verschillende interventies afzonderlijk van 
elkaar aangetoond door de studies in dit proefschrift, kan het combineren van deze 
interventies in één zorgbundel mogelijk leiden tot een verdere toename in effectiviteit 








AUC  Area Under the Curve
AUMC  Amsterdam University Medical Center
BPD  BronchoPulmonary Dysplasia
CPAP  Continuous Positive Airway Pressure
ECG  ElectroCardioGram
EMG  ElectroMyoGraphy
FiO2  Fraction of inspired Oxygen
FRC  Functional Residual Capacity
INSURE  INtubation-SURfactant-Extubation
(I)PPV  (Intermittent) Positive Pressure Ventilation
IVH  IntraVentricular Hemorrhage 
LUMC  Leiden University Medical Center
MIFR  Mean Inspiratory Flow Rate
MIST  Minimal Invasive Surfactant Therapy
MV  Minute Volume
NEC  Necrotizing EnteroColitis
NICU  Neonatal Intensive Care Unit
nIMV  nasal Intermittent Mandatory Ventilation
PEEP  Positive End-Expiratory Pressure
PIP  Peak Inspiratory Pressure
PVL  PeriVentricular Leucomalacia
RDS  Respiratory Distress Syndrome
REM  Rapid Eye Movement
ROP  Retinopathy Of Prematurity
RoR  Rate of Rise to maximum tidal volumes
RFM  Respiratory Function Monitor
SpO2  Oxygen Saturation
Vt   tidal Volume
WMO  Wet Medisch-wetenschappelijk Onderzoek met mensen
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